Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3011391	s-d-1	pmol/l (pmol/l)	3863	4638	0.00%
3011391	s-d-1	PMOL/L (pmol/l)	22	23	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Disorders of calcium metabolism

281

188

16.49

323.31

1.3

1.2

114.42

111.17

pmol/l

0.21

281

188

Disorders of mineral metabolism

321

248

14.03

307.65

1.4

1.2

113.48

110.51

pmol/l

0.22

321

248

Sarcoidosis

373

427

9.26

300.53

1.8

1.2

114.23

107.38

pmol/l

1.43

373

427

Certain disorders involving the immune mechanism

443

629

7.36

296.74

1.7

1.2

113.36

109.69

pmol/l

0.53

443

629

Hypercalcemia

190

124

17.09

222.01

1.4

1.1

115.34

106.48

pmol/l

0.51

190

124

Diagnoses used for exclusion with ILD

428

805

5.47

215.45

1.7

1.1

111.62

109.61

pmol/l

0.22

428

805

Disorders of parathyroid gland

381

707

5.50

191.65

1.4

1.2

112.35

109.05

pmol/l

0.28

381

707

Chronic kidney disease

419

840

4.90

184.72

1.2

85.91

110.76

pmol/l

6.93

419

840

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1058

2597

2.77

183.53

1.4

1.1

105.93

113.36

pmol/l

3.87

1058

2597

Disorders of other endocrine glands

608

1681

3.62

181.00

1.3

1.2

114.08

112.10

pmol/l

0.26

608

1681

Renal failure

553

1240

3.86

173.41

1.2

85.74

110.98

pmol/l

11.23

553

1240

Hyperparathyroidism

309

611

5.15

144.89

1.4

1.2

110.00

110.27

pmol/l

0.02

309

611

All chronic kidney diseases

588

1471

3.23

138.85

1.3

1.2

90.81

112.49

pmol/l

10.94

588

1471

ILD medications

1030

2392

2.34

119.39

1.3

1.2

107.37

114.00

pmol/l

3.06

1030

2392

ILD medications: prednisolone, methylprednisolone, prednisone

993

2362

2.35

117.96

1.3

1.2

107.19

113.73

pmol/l

2.90

993

2362

Primary hyperparathyroidism

214

378

5.88

115.95

1.4

1.2

115.03

111.03

pmol/l

0.35

214

378

Osteoporosis

360

877

3.85

114.83

1.3

1.2

107.64

109.06

pmol/l

0.15

360

877

Osteopathies and chondropathies

607

2035

2.76

112.87

1.3

1.2

108.14

110.79

pmol/l

0.54

607

2035

Oral corticosteroids

976

2512

2.29

111.25

1.3

1.2

108.20

112.66

pmol/l

1.61

976

2512

ILD medications: immunosuppressive drugs

616

2168

2.60

101.91

1.3

1.2

106.24

114.31

pmol/l

2.99

616

2168

Inflammatory bowel disease treatment related agents

1011

2586

2.18

101.14

1.3

1.2

107.43

112.95

pmol/l

2.30

1011

2586

First line medication for Crohn's disease

956

2332

2.22

98.73

1.3

1.2

108.06

113.56

pmol/l

2.10

956

2332

Metabolic disorders

854

2282

2.26

94.89

1.3

1.2

107.21

113.50

pmol/l

1.88

854

2282

Renal tubulo-interstitial diseases

782

2566

2.25

90.25

1.3

1.2

94.96

116.13

pmol/l

14.69

782

2566

Acute renal failure

241

596

4.11

86.84

1.2

87.65

111.97

pmol/l

3.29

241

596

All kidney diseases

863

2747

2.12

84.29

1.3

1.2

102.54

115.10

pmol/l

3.96

863

2747

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

592

2262

2.30

74.55

1.3

1.2

106.26

109.09

pmol/l

0.60

592

2262

General examination and investigation of persons without complaint and reported diagnosis

527

1078

2.56

73.12

1.3

1.2

109.86

112.60

pmol/l

0.45

527

1078

Dialysis, with operation codes

162

340

4.88

72.20

1.2

73.66

109.46

pmol/l

14.67

162

340

Other disorders of fluid, electrolyte and acid-base balance

306

938

3.11

71.46

1.3

1.2

97.30

109.62

pmol/l

2.82

306

938

Abnormal findings on diagnostic imaging of lung

434

1629

2.55

69.97

1.3

1.2

104.13

106.76

pmol/l

0.43

434

1629

Care involving dialysis

122

207

6.08

68.94

1.2

1.1

71.01

106.04

pmol/l

10.08

122

207

Hypocalcemia

11.59

68.67

1.2

1.1

100.78

111.91

pmol/l

0.65

Anaemias

213

334

4.13

67.01

1.2

105.91

124.39

pmol/l

4.57

213

334

Implicit Sepsis

633

2178

2.16

66.23

1.3

1.2

98.58

113.06

pmol/l

5.86

633

2178

Persons encountering health services for other counselling and medical advice, not elsewhere classified

891

2438

1.95

66.23

1.3

1.2

108.40

112.61

pmol/l

1.42

891

2438

Asthma (only as main-diagnosis), excluding more controls

555

1331

2.32

64.28

1.2

1.1

110.25

115.32

pmol/l

1.13

555

1331

Implicit bacterial Sepsis, including avohilmo

397

1291

2.58

63.96

1.3

1.2

87.09

110.11

pmol/l

13.16

397

1291

Heart failure, not strict

591

1820

2.20

63.53

1.3

1.2

93.75

114.08

pmol/l

12.92

591

1820

Asthma (only as main-diagnosis)

573

1424

2.26

62.98

1.2

1.1

109.92

113.76

pmol/l

0.79

573

1424

Implicit Sepsis, including avohilmo

677

2370

2.05

62.12

1.3

1.2

100.17

113.97

pmol/l

5.89

677

2370

Nephropathy related operations

156

364

4.39

61.04

1.2

74.63

104.86

pmol/l

10.67

156

364

Persons encountering health services in other circumstances, wide

895

2442

1.89

60.45

1.3

1.2

107.53

112.55

pmol/l

1.87

895

2442

Implicit viral Sepsis

216

641

3.42

59.78

1.4

1.2

97.06

112.26

pmol/l

2.62

216

641

Implicit bacterial Sepsis

358

1186

2.61

59.54

1.3

1.2

86.53

110.26

pmol/l

12.35

358

1186

Viral Sepsis

216

643

3.41

59.49

1.4

1.2

97.06

112.33

pmol/l

2.65

216

643

Asthma (mode)

594

1437

2.18

59.06

1.2

1.1

108.30

113.71

pmol/l

1.41

594

1437

Asthma, excluding more controls

573

1331

2.22

59.01

1.2

1.1

108.17

115.32

pmol/l

2.06

573

1331

Used for control exclusion in common control thyroid runs

786

2025

1.97

58.98

1.2

110.84

112.46

pmol/l

0.27

786

2025

General symptoms and signs

821

2138

1.93

58.57

1.2

108.69

114.92

pmol/l

2.33

821

2138

Malaise and fatigue

449

1516

2.35

58.57

1.3

1.2

102.71

113.51

pmol/l

3.45

449

1516

Abnormalities of breathing

708

2028

2.01

58.13

1.2

107.34

113.47

pmol/l

2.40

708

2028

Hypoparathyroidism

119

7.53

58.07

1.4

1.1

123.25

110.25

pmol/l

0.38

119

Bacterial Sepsis

393

1336

2.45

56.94

1.3

1.2

87.97

110.45

pmol/l

12.72

393

1336

Condition for Implicit Sepsis (Organ dysfunction codes)

686

2412

1.98

56.81

1.3

1.2

101.58

114.50

pmol/l

5.35

686

2412

Asthma

590

1424

2.15

56.16

1.2

1.1

107.40

113.76

pmol/l

1.79

590

1424

Fever of other and unknown origin

462

1786

2.26

56.10

1.3

1.2

101.41

114.39

pmol/l

5.16

462

1786

Hypothyroidism (congenital or acquired)

220

346

3.59

54.89

1.2

108.61

123.73

pmol/l

4.41

220

346

Autoimmune diseases

838

2286

1.87

54.41

1.2

110.39

112.78

pmol/l

0.57

838

2286

Endocrine, nutritional and metabolic diseases

574

1356

2.15

54.31

1.2

1.1

108.78

116.83

pmol/l

3.40

574

1356

Transplanted organ and tissue status

129

285

4.63

54.14

1.5

1.2

89.30

112.50

pmol/l

4.88

129

285

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

716

2528

1.92

54.05

1.3

1.2

102.86

114.98

pmol/l

5.12

716

2528

Hypothyroidism, other/unspecified

716

2464

1.92

53.65

1.2

111.14

111.61

pmol/l

0.06

716

2464

Disorders of the thyroid gland

745

2564

1.89

53.43

1.2

109.99

111.24

pmol/l

0.20

745

2564

Implicit viral Sepsis, including avohilmo

281

1037

2.73

52.88

1.4

1.2

101.74

111.16

pmol/l

1.83

281

1037

Pain in throat and chest

662

1991

1.98

52.75

1.2

112.92

113.17

pmol/l

0.02

662

1991

Hypothyroidism, drug reimbursement

146

230

4.49

52.55

1.4

1.2

110.77

126.11

pmol/l

1.05

146

230

Hypothyroidism, levothyroxine purchases

214

345

3.51

51.71

1.2

109.68

123.81

pmol/l

3.94

214

345

Hypothyroidism and >3 levothyroxin purchases

214

345

3.51

51.71

1.2

109.68

123.81

pmol/l

3.94

214

345

Enlarged lymph nodes

174

500

3.53

50.74

1.2

115.09

113.57

pmol/l

0.12

174

500

Persons encountering health services for specific procedures and health care

833

2738

1.80

50.24

1.2

106.19

114.14

pmol/l

2.16

833

2738

Hypothyreosis and Thyroxine purchase for inclusion criteria

731

2593

1.86

49.41

1.2

111.00

111.70

pmol/l

0.10

731

2593

Asthma, unspecified (mode), excluding more controls

400

1256

2.29

48.52

1.3

1.1

108.42

114.90

pmol/l

1.27

400

1256

Autoimmune diseases excluding thyroid diseases

763

2274

1.83

47.03

1.2

108.72

112.72

pmol/l

1.16

763

2274

Hypothyroidism, strict autoimmune

554

1825

2.00

46.90

1.2

109.95

112.66

pmol/l

0.54

554

1825

Kidney transplant status

152

5.86

46.75

1.2

1.1

86.30

109.94

pmol/l

3.39

152

Diseases of oesophagus, stomach and duodenum

820

2744

1.77

46.73

1.3

1.2

109.86

111.98

pmol/l

0.41

820

2744

Polyarthropathies

534

1699

2.03

46.67

1.3

1.2

98.94

113.06

pmol/l

8.85

534

1699

Autoimmune diseases excluding thyroid diseases, strict definition

724

2146

1.84

45.98

1.2

108.51

112.49

pmol/l

1.17

724

2146

Medical observation and evaluation for suspected diseases and conditions

460

1079

2.19

45.93

1.3

1.2

108.51

112.54

pmol/l

0.71

460

1079

L04AD Calcineurin inhibitors

132

337

4.00

45.89

1.2

94.41

111.35

pmol/l

3.04

132

337

Tramadol

610

1912

1.93

45.45

1.2

105.94

112.28

pmol/l

2.17

610

1912

L04AX Other immunosuppressants

473

2350

2.03

44.86

1.3

1.2

106.41

112.44

pmol/l

1.78

473

2350

Asthma, unspecified (mode)

407

1346

2.20

44.69

1.3

1.1

108.43

113.25

pmol/l

0.85

407

1346

Other soft tissue disorders, not elsewhere classified

715

2240

1.82

44.43

1.3

1.2

106.78

113.01

pmol/l

2.34

715

2240

Osteoporosis with pathological fracture (FG)

102

222

4.71

43.73

1.4

1.2

104.11

106.33

pmol/l

0.15

102

222

Non-invasive ventilation

218

664

2.86

43.43

1.2

1.1

105.00

118.38

pmol/l

3.32

218

664

Second line medication for Crohn's disease

480

2426

1.99

43.33

1.2

106.42

112.59

pmol/l

1.89

480

2426

Preparatory care for dialysis

116

6.44

43.04

1.2

1.1

72.90

103.09

pmol/l

4.73

116

Symptoms and signs involving the circulatory and respiratory systems

732

2036

1.81

43.01

1.2

110.04

113.50

pmol/l

0.77

732

2036

Dyspnoea

694

2807

1.79

42.96

1.2

102.44

112.52

pmol/l

5.28

694

2807

Extracorporeal dialysis

159

5.44

42.39

1.2

66.46

105.48

pmol/l

8.92

159

Other bacterial diseases

712

2660

1.78

42.36

1.3

1.2

96.46

114.22

pmol/l

7.00

712

2660

Other metabolic disorders

155

477

3.30

40.73

1.3

1.2

119.80

114.84

pmol/l

0.23

155

477

Headache

505

2024

1.94

40.41

1.2

112.96

115.22

pmol/l

0.42

505

2024

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

106

162

4.65

39.85

1.2

1.1

100.87

122.75

pmol/l

1.89

106

162

Examination and observation for other reasons

405

1073

2.14

39.44

1.3

1.2

107.97

112.66

pmol/l

0.82

405

1073

Other bacterial diseases, including avohilmo

759

2773

1.72

39.28

1.3

1.2

98.54

115.39

pmol/l

7.00

759

2773

Autoimmune diseases related-to ILD

648

3079

1.77

39.20

1.2

109.27

111.78

pmol/l

0.63

648

3079

Pain in limb

625

2208

1.81

38.76

1.3

1.2

104.78

113.08

pmol/l

3.55

625

2208

Disorders resulting from impaired renal tubular function

102

6.52

38.71

1.3

1.1

81.58

105.59

pmol/l

2.64

102

Dialysis

102

6.50

38.67

1.3

1.1

71.34

108.69

pmol/l

6.67

102

Unspecified kidney failure

110

279

4.01

38.61

1.2

1.1

92.79

113.62

pmol/l

0.89

110

279

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

733

2703

1.72

38.45

1.3

1.2

108.65

113.37

pmol/l

1.16

733

2703

Dermatitis and eczema

831

2964

1.67

38.23

1.2

109.45

111.48

pmol/l

0.53

831

2964

Excluding asthma or asthma-COPD overlap

549

1447

1.91

38.14

1.2

1.1

112.76

113.69

pmol/l

0.11

549

1447

COPD differential diagnosis

546

1437

1.91

38.10

1.2

1.1

113.01

113.71

pmol/l

0.08

546

1437

ILD differential diagnosis

546

1437

1.91

38.09

1.2

1.1

113.01

113.71

pmol/l

0.08

546

1437

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

310

1402

2.23

37.87

1.2

115.97

112.30

pmol/l

0.33

310

1402

Gout

204

642

2.75

37.85

1.2

83.96

106.36

pmol/l

7.19

204

642

Aplastic and other anaemias

352

1524

2.13

37.63

1.2

94.07

108.15

pmol/l

4.80

352

1524

Infections, IBD-co-morbidities

139

278

3.55

37.16

1.2

1.1

97.75

121.10

pmol/l

3.60

139

278

Bacterial infection, other or unspecified, including avohilmo

435

1817

1.97

37.14

1.2

90.36

112.14

pmol/l

15.43

435

1817

Renal tubulo-interstitial disorders in diseases classified elsewhere

14.90

36.99

1.9

1.2

134.56

118.16

pmol/l

0.18

Explicit Sepsis, including avohilmo

338

1436

2.15

36.97

1.3

1.2

89.12

111.84

pmol/l

11.91

338

1436

Other functional intestinal disorders

377

1674

2.06

36.95

1.2

108.32

111.53

pmol/l

0.59

377

1674

Bacterial infection, other or unspecified

400

1680

2.02

36.74

1.2

89.91

111.45

pmol/l

13.65

400

1680

Explicit Sepsis

330

1401

2.16

36.64

1.3

1.2

88.99

112.05

pmol/l

11.86

330

1401

Depression medications

208

362

2.91

36.46

1.1

1.2

113.17

124.04

pmol/l

2.27

208

362

Postprocedural endocrine and metabolic disorders, not elsewhere classified

143

450

3.23

36.30

1.3

1.2

119.76

115.65

pmol/l

0.17

143

450

Gastro-oesophageal reflux disease

520

2397

1.84

36.14

1.2

111.90

110.78

pmol/l

0.14

520

2397

664

2238

1.74

35.79

1.3

1.2

102.26

114.77

pmol/l

6.98

664

2238

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

664

2238

1.74

35.79

1.3

1.2

102.26

114.77

pmol/l

6.98

664

2238

Secondary hypertension

177

4.70

35.61

1.2

93.55

115.77

pmol/l

0.81

177

Other nutritional deficiencies

534

2713

1.81

35.53

1.3

1.2

112.42

112.55

pmol/l

0.02

534

2713

Any gastric operation

544

1467

1.87

35.47

1.2

110.08

114.96

pmol/l

1.46

544

1467

GASTRO-related operations

544

1467

1.87

35.47

1.2

110.08

114.96

pmol/l

1.46

544

1467

Influenza and pneumonia

775

2895

1.66

35.35

1.3

1.2

102.79

114.56

pmol/l

7.51

775

2895

Low back pain

581

2209

1.78

35.04

1.3

1.2

115.17

111.78

pmol/l

0.41

581

2209

Finngen Rheumatological endpoints

694

2314

1.71

34.81

1.2

107.31

114.42

pmol/l

3.27

694

2314

Other antidepressants

714

2144

1.71

34.75

1.1

1.2

110.18

111.27

pmol/l

0.20

714

2144

All pneumoniae

748

2941

1.66

34.55

1.3

1.2

101.92

114.42

pmol/l

8.20

748

2941

Other anaemias

323

1434

2.12

34.51

1.2

95.41

108.42

pmol/l

3.86

323

1434

Gout, FINNGEN

204

796

2.57

34.19

1.2

83.96

105.26

pmol/l

6.12

204

796

Asthma (diagnoses ohter than nonallergic)

652

3120

1.69

34.03

1.3

1.2

108.19

111.65

pmol/l

0.91

652

3120

Other and unspecified anaemias

320

1428

2.12

34.03

1.2

95.59

108.39

pmol/l

3.71

320

1428

Pneumonias (Asthma/COPD co-morbidities)

742

2942

1.65

33.91

1.3

1.2

101.72

114.37

pmol/l

8.36

742

2942

Pain in joint

419

1312

1.97

33.68

1.3

1.2

109.10

112.18

pmol/l

0.64

419

1312

Cough

319

1420

2.11

33.59

1.5

1.2

108.61

113.13

pmol/l

1.00

319

1420

Other diseases of intestines

767

2601

1.65

33.56

1.3

1.2

109.15

113.03

pmol/l

1.24

767

2601

Constipation

659

2645

1.70

33.33

1.2

110.49

110.20

pmol/l

0.03

659

2645

Symptoms and signs involving the nervous and musculoskeletal systems

448

2422

1.86

33.25

1.3

1.2

106.06

110.66

pmol/l

1.17

448

2422

Persons encountering health services in other circumstances

312

1478

2.10

32.90

1.2

105.54

113.88

pmol/l

1.82

312

1478

Other special examinations and investigations of persons without complaint or reported diagnosis

421

1079

1.99

32.87

1.2

108.90

112.54

pmol/l

0.61

421

1079

Codeine

658

2087

1.71

32.79

1.2

106.55

113.42

pmol/l

2.72

658

2087

Mood disorders, excluding more controls

672

2345

1.69

32.72

1.2

107.84

112.60

pmol/l

1.51

672

2345

Anxiety disorders, excluding more controls

607

2251

1.73

32.68

1.2

110.35

113.53

pmol/l

0.75

607

2251

Septicaemia

313

1365

2.10

32.60

1.4

1.2

87.95

110.89

pmol/l

12.41

313

1365

Other pulmonary diagnosis

527

1447

1.83

32.45

1.2

1.1

112.17

113.69

pmol/l

0.18

527

1447

Other symptoms and signs involving the nervous and musculoskeletal systems

341

1699

2.02

32.37

1.2

106.28

112.34

pmol/l

1.39

341

1699

Covid-19 confirmed case

296

1400

2.13

32.23

1.3

1.2

98.77

109.21

pmol/l

2.71

296

1400

Depression

704

2867

1.65

31.98

1.1

1.2

110.39

112.90

pmol/l

0.64

704

2867

Asthma, hospital admissions , main diagnosis only

611

3160

1.69

31.91

1.2

109.52

111.74

pmol/l

0.48

611

3160

ILD medications: azathioprine

130

419

3.14

31.70

1.3

1.2

103.38

117.32

pmol/l

1.66

130

419

Opioids

682

2107

1.68

31.38

1.2

109.85

113.50

pmol/l

1.04

682

2107

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

718

2941

1.63

31.34

1.3

1.2

101.84

114.06

pmol/l

7.76

718

2941

Mood [affective] disorders

742

2949

1.62

31.06

1.2

109.17

112.34

pmol/l

0.92

742

2949

Mood disorders

743

2949

1.62

31.04

1.2

109.17

112.32

pmol/l

0.91

743

2949

Pneumonia, organism unspecified

653

2703

1.66

30.88

1.3

1.2

100.92

114.21

pmol/l

8.13

653

2703

Exclusions for E4_PCOS_BROAD

165

616

2.71

30.77

1.2

115.56

110.32

pmol/l

0.61

165

616

Dermatitis

473

2605

1.78

30.65

1.2

108.79

111.34

pmol/l

0.51

473

2605

Hypothyroidism, strict autoimmune, 3 medication purchases required

613

2449

1.69

30.61

1.2

109.81

112.32

pmol/l

0.57

613

2449

Systemic connective tissue disorders

291

1398

2.10

30.59

1.2

105.30

111.27

pmol/l

1.11

291

1398

Dental caries

201

778

2.46

30.47

1.3

1.2

96.91

108.42

pmol/l

2.29

201

778

Other disorders of lacrimal gland

313

1549

2.04

30.37

1.3

1.2

113.00

111.30

pmol/l

0.23

313

1549

Nutritional anaemias

376

1886

1.91

30.21

1.2

102.50

110.31

pmol/l

1.91

376

1886

Asthma-related infections

444

2405

1.81

30.10

1.2

104.15

111.50

pmol/l

2.35

444

2405

Asthma, hospital admission 2, infections

444

2405

1.81

30.10

1.2

104.15

111.50

pmol/l

2.35

444

2405

Glomerular disorders in diseases classified elsewhere

113

346

3.32

30.07

1.2

74.27

104.32

pmol/l

8.19

113

346

Heart failure,strict

338

1173

2.02

30.07

1.3

1.2

89.15

113.55

pmol/l

11.12

338

1173

Disorders of lacrimal system

363

1865

1.93

30.02

1.3

1.2

110.83

111.02

pmol/l

0.02

363

1865

Pain, not elsewhere classified

228

1005

2.29

29.74

1.2

108.76

116.15

pmol/l

1.17

228

1005

Other septicaemia, including avohilmo

281

1258

2.11

29.71

1.4

1.2

87.56

111.35

pmol/l

11.65

281

1258

L04AA Selective immunosuppressants

203

852

2.41

29.71

1.4

1.2

100.24

113.00

pmol/l

2.25

203

852

Other dialysis

6.52

29.70

1.3

1.1

69.63

103.54

pmol/l

4.60

Symptoms and signs involving cognition, perception, emotional state and behaviour

695

2879

1.62

29.48

1.2

108.74

112.02

pmol/l

0.93

695

2879

Other septicaemia

275

1231

2.12

29.47

1.4

1.2

87.48

110.73

pmol/l

10.96

275

1231

Hypo-osmolality and hyponatraemia

146

520

2.82

29.34

1.2

100.47

111.52

pmol/l

1.22

146

520

Episodal and paroxysmal disorders

755

2399

1.60

28.95

1.2

110.97

112.93

pmol/l

0.44

755

2399

Intestinal infectious diseases, including avohilmo, including avohilmo

810

2894

1.56

28.68

1.2

108.33

111.91

pmol/l

0.82

810

2894

Nausea and vomiting

223

963

2.28

28.65

1.3

1.2

101.94

109.94

pmol/l

1.51

223

963

Azathioprine

130

446

2.95

28.49

1.3

1.2

103.38

111.88

pmol/l

0.94

130

446

Recurrent or chronic depression

301

1016

2.07

28.42

1.1

1.3

115.45

114.35

pmol/l

0.13

301

1016

Provisional assignment of new diseases of uncertain etiology

401

2183

1.83

28.40

1.2

106.29

111.28

pmol/l

0.69

401

2183

Codes for special purposes

401

2184

1.83

28.35

1.2

106.29

111.27

pmol/l

0.69

401

2184

Depression or dysthymia

442

1317

1.84

28.32

1.1

1.3

109.51

110.93

pmol/l

0.21

442

1317

Acute tubulo-interstitial nephritis

435

2051

1.80

28.30

1.3

1.2

91.97

115.49

pmol/l

18.68

435

2051

Other heart diseases, wide

659

2454

1.63

28.28

1.3

1.2

105.97

115.24

pmol/l

3.19

659

2454

Glomerular diseases

154

583

2.67

28.04

1.1

1.2

78.97

105.62

pmol/l

8.48

154

583

Iron deficiency anaemia

330

1680

1.94

27.84

1.3

1.2

99.04

110.69

pmol/l

3.61

330

1680

Oedema, not elsewhere classified

241

1093

2.17

27.57

1.3

1.2

104.36

113.13

pmol/l

1.58

241

1093

Gout, unspecified

147

548

2.71

27.56

1.3

1.2

84.07

100.11

pmol/l

3.59

147

548

All influenza

201

869

2.33

27.47

1.3

1.2

103.63

112.56

pmol/l

1.28

201

869

Codeine or tramadol medication

786

2745

1.56

27.46

1.2

106.98

112.74

pmol/l

2.17

786

2745

Caries of dentine

178

702

2.47

27.35

1.3

1.2

96.68

108.73

pmol/l

2.12

178

702

Neurotic, stress-related and somatoform disorders

650

2794

1.61

27.08

1.2

111.04

113.01

pmol/l

0.43

650

2794

Fibromyalgia

107

339

3.21

27.00

1.1

107.97

119.89

pmol/l

1.33

107

339

Other systemic involvement of connective tissue (FG)

206

892

2.29

26.80

1.3

1.2

105.31

111.63

pmol/l

1.00

206

892

Anxiety disorders

653

2807

1.60

26.73

1.2

111.06

112.96

pmol/l

0.41

653

2807

Diabetic nephropathy, excluding more controls

135

389

2.86

26.70

1.3

1.2

77.73

101.85

pmol/l

6.49

135

389

Other heart diseases

348

1180

1.93

26.70

1.3

1.2

105.43

119.36

pmol/l

5.93

348

1180

Other and unspecified iron deficiency

268

1313

2.05

26.64

1.2

99.62

111.87

pmol/l

3.04

268

1313

Other specific joint derangements/joint disorders

518

1898

1.71

26.63

1.3

1.2

108.36

114.29

pmol/l

1.85

518

1898

Dorsalgia

680

2253

1.60

26.60

1.3

1.2

113.33

111.80

pmol/l

0.18

680

2253

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

223

476

2.36

26.58

1.1

1.2

107.86

118.01

pmol/l

2.18

223

476

Diseases of the skin and subcutaneous tissue

653

2025

1.62

26.45

1.2

112.78

112.26

pmol/l

0.05

653

2025

Heart failure and antihypertensive medication

186

491

2.48

26.41

1.4

1.2

90.15

119.20

pmol/l

10.77

186

491

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

713

2926

1.57

26.35

1.2

108.87

111.79

pmol/l

0.56

713

2926

Lower back pain or/and sciatica

756

3043

1.55

26.34

1.3

1.2

113.24

110.62

pmol/l

0.39

756

3043

Asthma, including avohilmo

817

2948

1.53

26.32

1.2

109.16

111.78

pmol/l

0.71

817

2948

344

1831

1.87

26.31

1.2

105.11

114.33

pmol/l

2.67

344

1831

Chronic lower respiratory diseases

836

2894

1.53

26.30

1.2

109.49

112.07

pmol/l

0.67

836

2894

Cardiovascular diseases

430

1263

1.81

26.20

1.1

1.2

112.82

121.58

pmol/l

3.34

430

1263

Gout, idiopatic and unspecified

173

716

2.44

26.15

1.3

1.2

84.55

104.77

pmol/l

4.77

173

716

Neurological diseases

573

1726

1.67

26.06

1.2

108.77

115.98

pmol/l

2.29

573

1726

Diseases of the digestive system

323

1691

1.91

26.03

1.3

1.2

103.91

108.86

pmol/l

0.90

323

1691

Asthma-related pneumonia

269

1329

2.03

26.01

1.2

97.33

109.99

pmol/l

3.42

269

1329

Gout, strict definition

133

486

2.76

25.96

1.3

1.2

83.24

99.71

pmol/l

3.39

133

486

Other and unspecified dermatitis

393

2210

1.79

25.83

1.2

110.28

111.94

pmol/l

0.26

393

2210

Oxycodone

273

1155

2.03

25.79

1.2

110.16

108.73

pmol/l

0.07

273

1155

Diabetic nephropathy

135

493

2.74

25.72

1.3

1.2

77.73

99.42

pmol/l

3.59

135

493

Asthma-related pneumonia or sepsis

269

1335

2.02

25.69

1.2

97.33

109.97

pmol/l

3.42

269

1335

Asthma, hospital admissions 3, pneumonia

269

1335

2.02

25.69

1.2

97.33

109.97

pmol/l

3.42

269

1335

Adrenocortical insufficiency

101

5.30

25.63

1.2

1.1

107.25

109.13

pmol/l

0.07

101

Obesity and other hyperalimentation

477

2667

1.69

25.39

1.2

111.82

112.63

pmol/l

0.12

477

2667

Hyperkalaemia

138

4.50

25.03

1.2

1.1

77.39

105.33

pmol/l

4.63

138

Abnormalities of heart beat

260

1251

2.03

24.97

1.2

105.12

112.09

pmol/l

1.73

260

1251

Complications of surgical and medical care, not elsewhere classified

693

2986

1.55

24.82

1.2

103.70

112.39

pmol/l

4.34

693

2986

Implicit fungal Sepsis, including avohilmo

219

3.67

24.62

1.2

102.38

108.25

pmol/l

0.33

219

Obesity

472

2659

1.68

24.58

1.2

111.45

112.74

pmol/l

0.20

472

2659

Other arthritis (FG)

230

1102

2.10

24.47

1.2

100.33

114.20

pmol/l

4.81

230

1102

Sleep apnoea

650

2616

1.57

24.25

1.3

1.2

108.06

110.85

pmol/l

0.70

650

2616

Disorders of eyelid, lacrimal system and orbit

612

2843

1.58

24.21

1.3

1.2

110.75

110.38

pmol/l

0.06

612

2843

Care involving use of rehabilitation procedures

444

2357

1.70

24.15

1.2

104.95

112.81

pmol/l

2.86

444

2357

Benign thyroid growths and nodules

257

1194

2.01

24.05

1.2

108.87

112.44

pmol/l

0.49

257

1194

Heart failure and coronary heart disease

266

924

2.03

24.00

1.3

1.2

88.94

107.91

pmol/l

6.91

266

924

Other disorders of adrenal gland

127

4.60

23.90

1.2

1.1

107.68

107.86

pmol/l

0.01

127

Disorders of thyroid, IBD co-morbidities

138

350

2.72

23.90

1.2

1.1

110.01

125.70

pmol/l

2.24

138

350

All-cause Heart Failure

360

1379

1.82

23.79

1.3

1.2

89.71

109.30

pmol/l

8.38

360

1379

Obesity related asthma

265

1351

1.98

23.78

1.2

105.79

112.06

pmol/l

1.30

265

1351

Symptoms and signs involving the skin and subcutaneous tissue

520

3040

1.62

23.69

1.2

109.03

111.43

pmol/l

0.57

520

3040

Disorders of lens

448

1624

1.72

23.61

1.3

1.2

105.29

110.53

pmol/l

0.88

448

1624

Cardiovascular diseases (excluding rheumatic etc)

448

1492

1.72

23.52

1.1

1.2

108.66

120.78

pmol/l

6.15

448

1492

Any mental disorder

726

2371

1.54

23.52

1.2

107.85

112.45

pmol/l

1.41

726

2371

Postmenopausal osteoporosis with pathological fracture

236

3.51

23.49

1.4

1.2

102.65

115.66

pmol/l

0.73

236

Abnormal findings on examination of blood, without diagnosis

313

1523

1.87

23.47

1.1

1.2

101.70

107.76

pmol/l

0.68

313

1523

Parasetamol

459

1350

1.72

23.43

1.2

107.91

117.01

pmol/l

3.20

459

1350

Anxiety (asthma-related co-morbidities)

450

2030

1.69

23.36

1.2

111.70

115.32

pmol/l

0.76

450

2030

ILD, hospital admission 2, with pulmonary infections

246

3.42

23.34

1.3

1.2

97.17

110.53

pmol/l

0.82

246

Migraine

395

1764

1.75

23.26

1.1

1.2

117.65

115.11

pmol/l

0.53

395

1764

Heart failure, strict

364

1411

1.80

23.09

1.3

1.2

90.23

109.33

pmol/l

8.14

364

1411

Other specified/unspecified arthritis

204

958

2.15

22.92

1.2

102.23

112.49

pmol/l

2.50

204

958

Vitamin D deficiency

6.65

22.81

1.8

1.1

121.70

106.97

pmol/l

0.76

Persons encountering health services for examination and investigation

386

1079

1.80

22.75

1.2

107.41

112.54

pmol/l

0.95

386

1079

Hypertension, essential

520

1799

1.64

22.62

1.3

1.2

106.77

116.03

pmol/l

2.34

520

1799

Myocarditis

5.03

22.55

1.4

1.2

100.94

114.97

pmol/l

1.26

Intestinal infectious diseases

651

3171

1.53

22.36

1.2

106.17

112.26

pmol/l

1.50

651

3171

Dizziness and giddiness

517

2505

1.61

22.30

1.2

109.04

111.31

pmol/l

0.45

517

2505

Sleep apnoea, including avohilmo

677

2685

1.53

22.27

1.3

1.2

108.26

111.62

pmol/l

0.94

677

2685

Hypokalaemia

107

380

2.85

22.15

1.5

1.2

106.19

114.55

pmol/l

0.53

107

380

Hypopituitarism

183

3.77

22.13

1.3

1.1

121.62

109.50

pmol/l

1.00

183

Presence of other functional implants

382

1499

1.75

22.07

1.2

105.88

109.03

pmol/l

0.35

382

1499

Sleep disorders (combined)

728

2522

1.51

22.07

1.2

111.69

110.88

pmol/l

0.12

728

2522

Obesity, other/unspecified

271

1431

1.91

21.96

1.3

1.2

118.98

113.03

pmol/l

0.95

271

1431

Other diseases of urinary system

654

2390

1.54

21.94

1.2

106.88

112.42

pmol/l

1.28

654

2390

Soft tissue disorders

675

2259

1.53

21.82

1.2

111.82

113.12

pmol/l

0.24

675

2259

Cardiac arrhythmias

432

1644

1.69

21.72

1.2

110.91

119.63

pmol/l

1.76

432

1644

All anxiety disorders

459

2170

1.65

21.69

1.2

112.15

114.80

pmol/l

0.51

459

2170

Other disorders of urethra and urinary system

491

2108

1.63

21.61

1.2

104.95

112.78

pmol/l

2.68

491

2108

Symptoms and signs involving the urinary system

512

2417

1.60

21.57

1.2

101.64

110.59

pmol/l

3.25

512

2417

Dysphagia

186

865

2.17

21.46

1.3

1.2

117.63

107.17

pmol/l

0.80

186

865

Symptoms and signs involving the digestive system and abdomen

634

2056

1.55

21.32

1.2

110.68

110.42

pmol/l

0.03

634

2056

Other medical care

321

1501

1.80

21.23

1.1

1.2

109.02

110.07

pmol/l

0.06

321

1501

Hypertensive diseases (excluding secondary)

358

1173

1.78

21.22

1.3

1.2

112.08

118.66

pmol/l

0.91

358

1173

Other disorders of kidney and ureter

113

425

2.69

21.00

1.4

1.2

85.81

104.59

pmol/l

3.62

113

425

Certain infectious and parasitic diseases

639

2083

1.54

20.97

1.2

108.49

115.33

pmol/l

1.84

639

2083

Undetermined asthma, excluding more controls

101

358

2.85

20.94

1.2

1.1

113.50

116.28

pmol/l

0.12

101

358

Diarrhoea and gastroenteritis of presumed infectious origin

485

2713

1.60

20.93

1.3

1.2

105.26

112.10

pmol/l

1.33

485

2713

Chronic sinusitis

309

1725

1.80

20.86

1.3

1.2

113.84

111.26

pmol/l

0.39

309

1725

Pain (limb, back, neck, head abdominally)

449

1346

1.68

20.77

1.2

105.80

111.60

pmol/l

1.72

449

1346

Asthma/COPD (KELA code 203)

652

2892

1.51

20.73

1.2

109.54

112.06

pmol/l

0.56

652

2892

Other disorders of skin and subcutaneous tissue

501

2672

1.59

20.70

1.4

1.2

105.74

110.73

pmol/l

1.33

501

2672

Disorders of lipoprotein metabolism and other lipidaemias

508

1930

1.61

20.70

1.3

1.2

101.22

111.78

pmol/l

5.17

508

1930

COPD/asthma related infections

676

2238

1.52

20.68

1.2

108.09

114.77

pmol/l

2.42

676

2238

COPD/asthma/ILD related infections

676

2238

1.52

20.68

1.2

108.09

114.77

pmol/l

2.42

676

2238

Other noninfective gastroenteritis and colitis

196

945

2.09

20.58

1.1

1.2

112.13

112.41

pmol/l

0.02

196

945

Hypertensive diseases

522

1849

1.60

20.53

1.3

1.2

107.93

116.05

pmol/l

1.94

522

1849

Malignant neoplasm, wide definition

592

2235

1.55

20.41

1.2

109.64

110.40

pmol/l

0.10

592

2235

Hypertension

521

1848

1.60

20.37

1.3

1.2

107.99

116.06

pmol/l

1.92

521

1848

Malignant neoplasm, including Hilmo

590

2232

1.54

20.22

1.2

109.44

110.49

pmol/l

0.14

590

2232

Senile cataract

395

1416

1.70

20.20

1.3

1.2

106.34

109.61

pmol/l

0.39

395

1416

Benzodiazepine use

680

3093

1.49

20.14

1.2

107.31

111.67

pmol/l

1.03

680

3093

Drug-induced adrenocortical insufficiency

6.33

20.00

1.2

112.79

107.13

pmol/l

0.20

Certain infectious and parasitic diseases, including avohilmo

463

1416

1.64

19.88

1.2

110.70

115.79

pmol/l

0.83

463

1416

Hypertensive Renal Disease

5.17

19.82

1.2

69.54

111.35

pmol/l

6.43

Abdominal and pelvic pain

624

2056

1.53

19.78

1.2

114.16

110.42

pmol/l

0.44

624

2056

Bacterial pneumoniae

266

1260

1.86

19.74

1.3

1.2

97.83

111.70

pmol/l

3.68

266

1260

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

310

1085

1.81

19.65

1.3

1.2

107.38

118.23

pmol/l

3.75

310

1085

Other anxiety disorders

346

1719

1.72

19.57

1.2

111.38

115.12

pmol/l

0.73

346

1719

Nonorganic sleeping disorders, excluding more controls

158

715

2.23

19.57

1.3

1.2

112.18

116.26

pmol/l

0.48

158

715

Other dorsopathies, not elsewhere classified

653

2258

1.51

19.51

1.2

113.31

111.83

pmol/l

0.17

653

2258

Neoplasms

489

1600

1.61

19.49

1.2

110.64

113.47

pmol/l

0.64

489

1600

Noninfective enteritis and colitis

326

1889

1.73

19.38

1.1

1.2

110.09

112.55

pmol/l

0.38

326

1889

Idiopathic hypercalciuria

19.53

19.34

1.3

1.2

127.28

113.41

pmol/l

0.61

Syncope and collapse

285

1317

1.81

19.31

1.2

102.57

112.21

pmol/l

2.16

285

1317

Other respiratory diseases principally affecting the interstitium

132

557

2.39

19.28

1.3

1.2

96.23

105.67

pmol/l

1.18

132

557

Any reimbursement code in KELA

368

1068

1.73

19.20

1.2

109.07

121.54

pmol/l

5.04

368

1068

Bacterial pneumonia (organism specified)

291

1477

1.79

19.19

1.2

98.46

109.67

pmol/l

2.75

291

1477

Antihypertensive medication - note that there are other indications

416

1310

1.67

18.98

1.2

114.09

120.74

pmol/l

1.96

416

1310

Vocal cord dysfunction

309

2.78

18.85

1.3

1.1

109.13

120.89

pmol/l

1.44

309

Undetermined asthma

101

379

2.69

18.83

1.2

113.50

108.52

pmol/l

0.31

101

379

Allergic asthma (mode), excluding more controls

160

720

2.18

18.82

1.3

1.1

109.02

118.24

pmol/l

1.38

160

720

Genitourinary diseases

307

854

1.81

18.51

1.2

103.88

114.66

pmol/l

3.47

307

854

Other systemic involvement of connective tissue

210

1082

1.96

18.43

1.3

1.2

105.94

112.09

pmol/l

0.86

210

1082

Bronchitis

732

3044

1.45

18.41

1.2

106.60

112.43

pmol/l

2.38

732

3044

Complications of medical and surgical care

500

2924

1.54

18.40

1.2

102.50

111.67

pmol/l

3.79

500

2924

Acute sinusitis

379

2106

1.64

18.26

1.2

111.46

114.67

pmol/l

0.56

379

2106

Fungal Sepsis

116

4.23

18.21

1.2

1.1

107.69

112.72

pmol/l

0.16

116

Arthropathies

580

1930

1.52

18.18

1.2

111.06

114.32

pmol/l

0.82

580

1930

Implicit fungal Sepsis

108

4.35

18.13

1.1

108.83

114.89

pmol/l

0.19

108

Personality disorders, excluding more controls

177

862

2.06

18.06

1.3

1.2

108.60

117.76

pmol/l

1.52

177

862

Neurological diseases, wide definition

188

444

2.14

18.03

1.1

107.65

125.24

pmol/l

3.55

188

444

Allergic asthma (mode)

160

733

2.14

18.02

1.3

1.1

109.03

116.59

pmol/l

1.04

160

733

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

612

3236

1.48

17.94

1.2

112.84

110.93

pmol/l

0.40

612

3236

Other disorders involving the immune mechanism, not elsewhere classified

5.06

17.90

1.3

1.2

106.89

103.42

pmol/l

0.10

Chronic rhinitis, nasopharyngitis and pharyngitis

239

1297

1.85

17.88

1.2

110.51

109.87

pmol/l

0.08

239

1297

747

2638

1.44

17.73

1.2

107.24

112.96

pmol/l

2.18

747

2638

Erysipelas, including avohilmo

460

2182

1.57

17.68

1.3

1.2

100.09

113.42

pmol/l

2.33

460

2182

Malignant neoplasm

564

2192

1.51

17.64

1.2

110.16

110.18

pmol/l

0.00

564

2192

Nerve, nerve root and plexus disorders

697

2900

1.45

17.64

1.2

105.68

112.01

pmol/l

2.68

697

2900

Pure hypercholesterolaemia

447

1794

1.59

17.63

1.2

101.17

111.04

pmol/l

3.83

447

1794

Viral pneumonia

100

387

2.61

17.62

1.4

1.2

93.58

109.39

pmol/l

2.49

100

387

Other headache syndromes

299

1735

1.73

17.61

1.2

109.28

114.58

pmol/l

1.08

299

1735

Gastrointestinal diseases

365

1087

1.69

17.44

1.1

1.2

111.39

114.25

pmol/l

0.50

365

1087

Solid cancers, including Hilmo

565

2191

1.51

17.41

1.2

110.62

110.21

pmol/l

0.05

565

2191

Rheumatism, unspecified

117

491

2.41

17.39

1.2

1.1

107.69

115.11

pmol/l

0.72

117

491

ILD, hospital admissions 1, main diag only

105

419

2.53

17.39

1.3

1.2

99.51

100.05

pmol/l

0.04

105

419

Spondylopathies

493

1887

1.55

17.31

1.2

108.48

109.50

pmol/l

0.09

493

1887

Symptoms and signs concerning food and fluid intake

322

2.76

17.25

1.1

1.2

103.18

114.76

pmol/l

0.79

322

Intracranial trauma

369

1517

1.65

17.20

1.2

108.89

116.66

pmol/l

1.90

369

1517

Obesity due to excess calories

334

2019

1.66

17.14

1.2

110.36

112.67

pmol/l

0.34

334

2019

Diseases of arteries, arterioles and capillaries (FINNGEN)

152

479

2.20

17.07

1.2

94.91

118.03

pmol/l

4.91

152

479

Malignant neoplasm

561

2194

1.50

17.05

1.2

110.01

110.27

pmol/l

0.03

561

2194

Hernia of abdominal wall, postoperative

120

510

2.35

16.99

1.5

1.2

106.38

111.09

pmol/l

0.48

120

510

Psychiatric diseases

603

2035

1.49

16.97

1.2

109.77

112.15

pmol/l

0.36

603

2035

Concussion

324

1494

1.69

16.93

1.2

110.47

116.39

pmol/l

1.14

324

1494

Liquid cancers, including Hilmo

229

1093

1.86

16.92

1.2

108.12

104.53

pmol/l

0.40

229

1093

Bacterial pneumonia, not elsewhere classified

244

1184

1.82

16.86

1.2

97.32

111.52

pmol/l

3.55

244

1184

Other intervertebral disc disorders

524

2065

1.52

16.78

1.3

1.2

109.07

110.96

pmol/l

0.37

524

2065

Behavioural syndromes associated with physiological disturbances and physical factors

632

2951

1.45

16.73

1.2

114.45

111.03

pmol/l

0.66

632

2951

Other symptoms and signs involving cognitive functions and awareness

299

1558

1.71

16.72

1.2

98.99

108.42

pmol/l

2.68

299

1558

Factors influencing health status and contact with health services

157

355

2.23

16.72

1.2

105.51

111.45

pmol/l

0.75

157

355

Dorsopathies

651

2266

1.46

16.62

1.2

111.58

111.85

pmol/l

0.04

651

2266

Irritable bowel syndrome

208

1107

1.89

16.61

1.1

1.2

117.04

114.89

pmol/l

0.25

208

1107

ILD, hospital admissions

112

472

2.40

16.50

1.3

1.2

98.16

100.87

pmol/l

0.28

112

472

Insulin, fast-acting

235

1301

1.82

16.50

1.4

1.2

89.91

112.77

pmol/l

7.62

235

1301

ILD, hospital admissions 3, with pneumonia sepsis

222

3.10

16.47

1.3

1.2

97.12

98.66

pmol/l

0.10

222

Non-allergic asthma (mode), excluding more controls

118

504

2.33

16.44

1.2

1.1

106.08

116.25

pmol/l

1.14

118

504

Benign neoplasms

619

2305

1.47

16.44

1.3

1.2

111.34

111.21

pmol/l

0.02

619

2305

Other interstitial pulmonary diseases

112

477

2.37

16.13

1.3

1.2

98.16

100.71

pmol/l

0.26

112

477

Migraine without aura

158

774

2.06

16.06

1.1

1.2

121.07

119.69

pmol/l

0.14

158

774

Cystitis

549

2203

1.49

15.96

1.3

1.2

111.44

112.89

pmol/l

0.19

549

2203

Asthma and allergy, excluding more controls

366

2.56

15.92

1.1

109.28

118.25

pmol/l

1.11

366

Interstitial lung disease endpoints

112

481

2.35

15.83

1.3

1.2

98.16

100.68

pmol/l

0.26

112

481

Interstitial lung disease

112

481

2.35

15.83

1.3

1.2

98.16

100.68

pmol/l

0.26

112

481

Insulin, combination of fast acting with intermediate-acting or long-acting

376

2158

1.59

15.78

1.4

1.2

91.91

110.73

pmol/l

9.39

376

2158

Myalgia

182

944

1.94

15.75

1.2

111.41

116.97

pmol/l

0.76

182

944

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

436

2601

1.53

15.73

1.3

1.2

110.00

114.09

pmol/l

1.09

436

2601

Selective serotonin reuptake inhibitors

604

2156

1.46

15.64

1.2

111.78

111.27

pmol/l

0.08

604

2156

Insulin medication

376

1973

1.59

15.61

1.4

1.2

91.91

112.83

pmol/l

12.09

376

1973

Hyperkinetic disorders, excluding more controls

331

2.58

15.59

1.1

1.2

120.10

123.77

pmol/l

0.32

331

Acute upper respiratory infections

681

2884

1.42

15.55

1.2

109.72

111.56

pmol/l

0.40

681

2884

Other joint disorders

548

1929

1.49

15.48

1.2

111.66

114.31

pmol/l

0.62

548

1929

Other bacterial intestinal infections, including avohilmo

168

853

1.98

15.48

1.1

1.2

99.56

111.70

pmol/l

1.75

168

853

Osteonecrosis

179

3.29

15.47

1.3

1.1

102.09

106.09

pmol/l

0.22

179

Nontoxic multinodular goitre

146

707

2.08

15.36

1.2

106.49

112.85

pmol/l

0.72

146

707

Insulin, fast-acting or short human

235

1332

1.77

15.29

1.4

1.2

89.91

112.09

pmol/l

7.29

235

1332

Sleep disorders

604

2899

1.44

15.28

1.2

114.07

111.18

pmol/l

0.51

604

2899

Vitamin deficiency

151

3.51

15.27

1.7

1.1

117.00

107.72

pmol/l

0.55

151

Vitamin deficiency, wide

151

3.51

15.27

1.7

1.1

117.00

107.72

pmol/l

0.55

151

Other arrhythmias

412

1992

1.55

15.18

1.2

115.54

114.08

pmol/l

0.09

412

1992

Shoulder lesions

478

1899

1.51

15.18

1.2

108.68

111.25

pmol/l

0.47

478

1899

Use of hypnotics and sedatives

680

2756

1.41

15.11

1.2

107.96

111.33

pmol/l

0.96

680

2756

Diseases of the eye and adnexa

491

1630

1.51

15.06

1.2

112.37

113.60

pmol/l

0.21

491

1630

Heart failure and bmi 25plus

209

749

1.87

15.05

1.1

1.2

87.22

110.47

pmol/l

5.66

209

749

Special screening examination for other diseases and disorders

317

2.64

15.04

1.2

111.05

107.93

pmol/l

0.24

317

Disorders of sclera, cornea, iris and ciliary body

360

2292

1.58

15.01

1.3

1.2

115.63

110.79

pmol/l

0.95

360

2292

Candidiasis, including avohilmo

229

1297

1.78

15.01

1.2

113.10

112.11

pmol/l

0.10

229

1297

Malignant neoplasm of endocrine gland, including Hilmo

279

2.76

14.96

1.3

1.2

120.12

110.01

pmol/l

0.27

279

Disorders of gallbladder, biliary tract and pancreas

631

2761

1.43

14.95

1.2

109.13

110.82

pmol/l

0.19

631

2761

Infections of the skin and subcutaneous tissue

383

2434

1.55

14.92

1.3

1.2

110.86

111.56

pmol/l

0.05

383

2434

Follow-up examination after treatment for conditions other than malignant neoplasms

252

958

1.76

14.89

1.2

111.05

113.04

pmol/l

0.20

252

958

Acute upper respiratory infections of multiple and unspecified sites

514

2554

1.47

14.83

1.2

108.66

112.68

pmol/l

0.99

514

2554

Other CVD (FINNGEN)

202

2.85

14.82

1.1

1.2

93.01

117.61

pmol/l

3.54

202

Non-allergic asthma (mode)

118

528

2.23

14.79

1.2

1.1

106.08

114.52

pmol/l

0.89

118

528

Other bacterial intestinal infections

131

618

2.14

14.77

1.2

93.11

110.04

pmol/l

2.48

131

618

Haemorrhage from respiratory passages

199

954

1.85

14.77

1.2

100.32

108.39

pmol/l

1.61

199

954

Volume depletion

253

2.83

14.75

1.2

86.45

114.40

pmol/l

2.50

253

Immunodeficiencies

160

3.38

14.69

1.7

1.1

110.45

109.41

pmol/l

0.04

160

Complications of procedures, not elsewhere classified

522

2892

1.46

14.57

1.2

105.51

112.09

pmol/l

2.17

522

2892

Asthma and allergy

382

2.45

14.57

1.1

109.28

117.00

pmol/l

0.90

382

Disorders of conjunctiva

564

3046

1.44

14.56

1.2

113.76

111.96

pmol/l

0.19

564

3046

Other general symptoms and signs

159

3.35

14.55

1.2

119.53

115.48

pmol/l

0.26

159

Other disorders of bone

136

656

2.09

14.48

1.2

114.87

114.03

pmol/l

0.06

136

656

Urticaria and erythema

265

1581

1.68

14.40

1.3

1.2

113.17

113.67

pmol/l

0.05

265

1581

Noninfectious colitis NAS

110

489

2.27

14.40

1.1

1.2

113.35

108.94

pmol/l

0.40

110

489

Emergency coronary revascularization (for ACS)

522

2153

1.47

14.37

1.3

1.2

102.31

111.05

pmol/l

1.41

522

2153

Generalized anxiety disorder

123

573

2.16

14.28

1.2

119.70

117.14

pmol/l

0.22

123

573

Other/unspecified dorsalgia

249

1447

1.71

14.22

1.2

110.72

110.39

pmol/l

0.03

249

1447

Atrial fibrillation and flutter

192

659

1.89

14.19

1.2

101.21

118.47

pmol/l

4.61

192

659

Diabetes mellitus

662

2732

1.40

14.15

1.3

1.2

102.34

115.49

pmol/l

3.75

662

2732

Other arthrosis

324

1346

1.62

14.14

1.3

1.2

107.46

111.42

pmol/l

0.75

324

1346

Diseases of the respiratory system

397

1276

1.56

14.14

1.2

110.03

113.76

pmol/l

0.68

397

1276

Presence of cardiac and vascular implants and grafts

239

1010

1.75

14.12

1.2

93.58

108.19

pmol/l

4.11

239

1010

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

393

2535

1.53

14.10

1.3

1.2

103.23

110.45

pmol/l

2.14

393

2535

Liquid cancers

183

932

1.87

14.06

1.2

110.82

103.77

pmol/l

0.81

183

932

Other neurological diseases

441

2289

1.50

14.06

1.2

104.01

109.11

pmol/l

1.20

441

2289

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

4.74

14.05

1.3

1.2

110.19

103.91

pmol/l

0.17

Other abnormal findings of blood chemistry

145

3.44

14.01

1.2

1.1

98.20

109.00

pmol/l

0.75

145

Other diseases of the digestive system

195

1076

1.82

13.96

1.3

1.2

99.70

106.63

pmol/l

0.96

195

1076

Other disorders of skin and subcutaneous tissue, not elsewhere classified

108

483

2.26

13.95

1.3

1.2

104.37

107.09

pmol/l

0.21

108

483

Erysipelas

329

1791

1.59

13.91

1.4

1.2

99.99

110.78

pmol/l

1.06

329

1791

Special screening examination for infectious and parasitic diseases

149

538

2.03

13.90

1.1

1.2

115.95

117.23

pmol/l

0.12

149

538

Diabetes, varying definitions

658

2733

1.40

13.89

1.3

1.2

102.75

115.37

pmol/l

3.47

658

2733

Other endocrine disorders

134

3.48

13.87

1.3

1.1

113.69

114.41

pmol/l

0.03

134

Solid cancers

532

2152

1.45

13.86

1.2

110.49

109.94

pmol/l

0.06

532

2152

Spondylosis

336

1663

1.58

13.82

1.2

110.22

109.05

pmol/l

0.07

336

1663

Other reaction to severe stress, and adjustment disorders

255

1522

1.68

13.82

1.3

1.2

110.35

115.29

pmol/l

0.91

255

1522

KRA_PSY_EATING, excluding more controls

232

2.85

13.81

1.1

1.2

125.83

122.13

pmol/l

0.24

232

Malignant neoplasm of endocrine gland

247

2.79

13.70

1.2

120.82

111.56

pmol/l

0.21

247

Disturbances of skin sensation

201

1127

1.79

13.68

1.2

113.97

113.78

pmol/l

0.02

201

1127

Type 2 diabetes

630

2600

1.41

13.68

1.3

1.2

102.48

115.30

pmol/l

3.35

630

2600

AV-block

107

405

2.27

13.67

1.3

1.1

92.08

106.72

pmol/l

2.89

107

405

Nontoxic goitre/thyroid nodule

212

1209

1.77

13.63

1.2

108.11

112.08

pmol/l

0.51

212

1209

Other sleep disorders

334

2.51

13.60

1.4

1.2

108.07

106.47

pmol/l

0.14

334

Conjunctivitis

516

2891

1.44

13.57

1.3

1.2

114.64

112.67

pmol/l

0.20

516

2891

Insulin, intermediate and long-acting

323

1980

1.58

13.55

1.3

1.2

89.23

110.84

pmol/l

10.50

323

1980

Fall on same level

725

2820

1.37

13.50

1.2

108.34

113.20

pmol/l

1.68

725

2820

Visual disturbances and blindness

343

2215

1.55

13.43

1.2

113.45

110.17

pmol/l

0.34

343

2215

Falls/tendency to fall

672

2423

1.39

13.42

1.2

110.85

113.31

pmol/l

0.56

672

2423

Percutaneous Coronary Intervention

484

2010

1.47

13.42

1.3

1.2

103.57

112.33

pmol/l

1.28

484

2010

Congenital malformations, deformations and chromosomal abnormalities

384

2408

1.52

13.39

1.3

1.2

109.10

114.59

pmol/l

1.53

384

2408

Early onset COPD, excluding more controls

111

510

2.19

13.37

1.2

101.78

105.92

pmol/l

0.33

111

510

Hypertensive heart and/or renal disease

145

527

2.02

13.37

1.1

1.2

84.05

113.43

pmol/l

9.88

145

527

Diseases of the myoneural junction and muscle

386

2.38

13.32

1.3

1.2

106.03

104.06

pmol/l

0.15

386

Carbimazole or st.post thyroidectomy, condition for graves disease

163

865

1.90

13.28

1.2

109.98

114.00

pmol/l

0.45

163

865

Sciatica+with lumbago

332

1884

1.57

13.26

1.2

110.05

111.10

pmol/l

0.15

332

1884

GI-bleeding

191

1065

1.80

13.23

1.4

1.2

99.16

106.34

pmol/l

0.99

191

1065

Diseases of the musculoskeletal system and connective tissue

320

994

1.62

13.21

1.2

107.84

117.54

pmol/l

2.64

320

994

Coeliac disease

431

2.30

13.21

1.2

113.36

112.82

pmol/l

0.04

431

Soft tissue disorders related to use, overuse and pressure

184

1016

1.82

13.19

1.2

110.02

112.19

pmol/l

0.23

184

1016

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

327

2023

1.56

13.16

1.2

112.46

110.00

pmol/l

0.39

327

2023

Disorders of skin appendages

333

2138

1.56

13.13

1.2

111.58

114.18

pmol/l

0.45

333

2138

Bacterial intestinal infections, IBD co-morbidities

130

641

2.04

13.10

1.2

94.74

109.65

pmol/l

2.02

130

641

Nonorganic sleeping disorders

158

835

1.90

13.03

1.3

1.2

112.18

113.32

pmol/l

0.11

158

835

Disorders of phosphorus metabolism and phosphatases

13.65

12.99

2.4

1.3

95.05

118.06

pmol/l

1.17

Other cataract

263

1182

1.66

12.98

1.4

1.2

103.77

108.53

pmol/l

0.92

263

1182

Arthropathies in other diseases classified elsewhere

4.03

12.94

2.3

1.2

99.33

112.91

pmol/l

0.67

Any event in cancer register

582

2416

1.41

12.92

1.2

110.03

111.53

pmol/l

0.21

582

2416

Type 2 diabetes, wide definition

484

2104

1.45

12.89

1.3

1.2

99.72

113.73

pmol/l

2.58

484

2104

Viral infections characterized by skin and mucous membrane lesions

276

1713

1.62

12.86

1.2

110.75

111.88

pmol/l

0.13

276

1713

Pacemaker

207

1105

1.75

12.83

1.2

92.24

105.15

pmol/l

3.02

207

1105

Primary_lymphoid and hematopoietic malignant neoplasms

153

805

1.91

12.80

1.2

110.95

107.66

pmol/l

0.22

153

805

Other skin changes

136

688

1.99

12.77

1.2

103.35

111.57

pmol/l

0.94

136

688

Endometriosis

238

808

1.72

12.75

1.2

1.1

116.13

115.83

pmol/l

0.03

238

808

Insomnia

583

2907

1.40

12.74

1.2

115.21

111.75

pmol/l

0.63

583

2907

Spinal stenosis

296

1365

1.60

12.73

1.2

101.06

107.30

pmol/l

1.40

296

1365

Other diseases of upper respiratory tract

670

2538

1.38

12.73

1.2

114.40

109.48

pmol/l

1.12

670

2538

Ulcer of lower limb, not elsewhere classified

432

2.26

12.69

1.6

1.2

86.35

107.13

pmol/l

2.44

432

Chronic gastritis

169

921

1.85

12.66

1.2

99.27

108.67

pmol/l

1.35

169

921

Malignant neoplasm of thyroid gland

224

2.81

12.65

1.1

1.2

119.87

112.85

pmol/l

0.14

224

Functional dyspepsia

184

1031

1.79

12.60

1.1

1.2

112.48

113.25

pmol/l

0.06

184

1031

Hard cardiovascular diseases

517

2138

1.43

12.57

1.3

1.2

99.36

112.40

pmol/l

7.85

517

2138

Coronary revascularization (ANGIO or CABG)

479

2011

1.45

12.52

1.3

1.2

99.90

112.33

pmol/l

6.60

479

2011

Short stature, not elsewhere classified

5.03

12.37

1.4

1.2

114.67

121.29

pmol/l

0.21

Vasomotor and allergic rhinitis

254

1525

1.63

12.35

1.3

1.2

114.91

112.12

pmol/l

0.44

254

1525

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

147

670

1.92

12.25

1.2

1.1

115.72

120.23

pmol/l

0.55

147

670

Malignant neoplasm of thyroid gland, including Hilmo

245

2.69

12.24

1.1

1.2

119.92

111.44

pmol/l

0.18

245

Conduction disorders

172

755

1.83

12.20

1.2

98.02

111.47

pmol/l

3.51

172

755

Candidiasis

113

544

2.10

12.20

1.3

1.2

112.87

109.61

pmol/l

0.25

113

544

Budesonide

446

2.21

12.19

1.2

109.87

110.16

pmol/l

0.02

446

Drug-induced osteoporosis with pathological fracture

5.39

12.10

1.5

1.1

113.79

108.61

pmol/l

0.15

Internal derangement of knee

228

1358

1.67

12.07

1.2

107.81

112.62

pmol/l

0.81

228

1358

Cytomegaloviral disease, including avohilmo

4.39

12.01

1.2

1.1

98.03

109.81

pmol/l

0.57

Mycoses, including avohilmo

588

3254

1.38

12.00

1.3

1.2

111.03

111.36

pmol/l

0.05

588

3254

Valvular heart disease excluding rheumatic fever

263

1158

1.63

11.98

1.2

100.55

111.26

pmol/l

3.02

263

1158

Lumbar disc prolapse

393

1967

1.48

11.97

1.3

1.2

110.59

110.94

pmol/l

0.04

393

1967

Ischemic heart diseases

500

2091

1.43

11.96

1.3

1.2

99.88

112.21

pmol/l

6.92

500

2091

Diplopia

450

2.20

11.95

1.2

103.01

107.60

pmol/l

0.40

450

Non-rheumatic valve diseases

261

1147

1.63

11.94

1.2

100.93

111.18

pmol/l

2.79

261

1147

Multiple myeloma, including Hilmo

126

3.39

11.80

1.1

1.3

96.64

102.11

pmol/l

0.18

126

Mycoses

188

1083

1.75

11.74

1.3

1.2

108.26

109.79

pmol/l

0.15

188

1083

Other/unspecified cytomegaloviral diseases

4.86

11.73

1.2

1.1

99.15

107.96

pmol/l

0.37

Visual disturbances

317

2080

1.53

11.69

1.2

114.46

110.44

pmol/l

0.40

317

2080

Atrial fibrillation and flutter with reimbursement

146

477

1.94

11.69

1.2

99.85

117.41

pmol/l

3.90

146

477

All influenza (not pneumonia)

441

2.19

11.68

1.3

1.2

107.69

112.23

pmol/l

0.37

441

Migraine without aura and triptan purchases

130

669

1.96

11.68

1.1

1.2

121.55

117.54

pmol/l

0.51

130

669

Enterocolitis due to Clostridium difficile

341

2.37

11.64

1.2

82.08

109.56

pmol/l

3.10

341

Other external causes of accidental injury

495

1737

1.43

11.64

1.2

110.25

113.82

pmol/l

0.74

495

1737

Other diseases of pleura

251

1352

1.62

11.59

1.4

1.2

100.54

106.03

pmol/l

0.76

251

1352

Non-selective monoamine reuptake inhibitors

229

1337

1.65

11.58

1.2

103.44

112.84

pmol/l

2.05

229

1337

Major coronary heart disease event

500

2115

1.42

11.56

1.3

1.2

98.95

111.52

pmol/l

7.00

500

2115

Other diseases of blood and blood-forming organs, wide

150

819

1.84

11.26

1.2

105.38

107.90

pmol/l

0.22

150

819

Rheumatoid arthritis

197

1025

1.71

11.24

1.3

1.2

99.51

111.73

pmol/l

3.24

197

1025

Other necrotizing vasculopathies (FG)

161

3.02

11.23

1.1

1.2

106.17

106.32

pmol/l

0.01

161

Exposure to unspecified factor

640

3236

1.35

11.17

1.3

1.2

108.49

111.72

pmol/l

0.90

640

3236

Cervicalgia

138

736

1.89

11.15

1.2

108.11

111.08

pmol/l

0.31

138

736

Unspecified haematuria

235

1176

1.63

11.14

1.1

1.2

101.23

108.24

pmol/l

1.02

235

1176

Cytomegalovirus infection, IBD co-morbidity

4.25

11.14

1.2

1.1

94.45

107.53

pmol/l

0.68

Cytomegaloviral disease

4.24

11.13

1.2

1.1

94.45

109.81

pmol/l

0.86

Viral and other specified intestinal infections, including avohilmo

186

1043

1.72

11.10

1.2

107.97

116.90

pmol/l

1.44

186

1043

Paralytic ileus and intestinal obstruction

157

872

1.81

11.10

1.3

1.2

110.13

108.47

pmol/l

0.05

157

872

Diseases of liver

217

1320

1.65

11.10

1.3

1.2

106.86

109.27

pmol/l

0.23

217

1320

Osteomyelitis

157

3.03

11.07

2.0

1.2

96.00

101.92

pmol/l

0.34

157

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

591

2742

1.36

11.07

1.2

104.96

111.35

pmol/l

2.35

591

2742

Disorders of synovium and tendon

335

1899

1.50

11.06

1.2

110.46

113.20

pmol/l

0.43

335

1899

Somatoform disorder

117

592

1.99

11.06

1.3

1.2

108.98

116.34

pmol/l

0.88

117

592

Hydronephrosis

319

2.37

10.98

1.3

1.1

101.39

112.05

pmol/l

1.00

319

Reimbursement for rheumatic diseases

362

2458

1.47

10.97

1.2

103.72

111.94

pmol/l

2.69

362

2458

Continuous positive airway pressure

109

444

2.06

10.94

1.3

1.1

95.72

116.86

pmol/l

4.31

109

444

Migraine with aura

172

988

1.75

10.87

1.2

117.53

116.91

pmol/l

0.06

172

988

Arthrosis

412

1555

1.46

10.83

1.3

1.2

108.61

112.09

pmol/l

0.74

412

1555

Accidents

489

1737

1.41

10.80

1.2

109.79

113.82

pmol/l

0.89

489

1737

Other and unspecified polyneuropathies, also in other diseases

119

612

1.96

10.74

1.4

1.2

97.09

103.50

pmol/l

0.73

119

612

Ovarian cyst

237

832

1.64

10.61

1.2

1.1

117.29

115.76

pmol/l

0.15

237

832

Rotator cuff syndrome

371

1747

1.47

10.59

1.2

110.74

111.11

pmol/l

0.04

371

1747

Symptoms and signs involving speech and voice

217

1337

1.63

10.58

1.2

104.61

111.50

pmol/l

1.36

217

1337

Non-ischemic cardiomyopathy

178

817

1.74

10.57

1.3

1.2

96.60

111.64

pmol/l

3.05

178

817

Other complications of surgical and medical care, not elsewhere classified

326

2.32

10.49

1.2

103.85

112.63

pmol/l

0.74

326

Personality disorders

177

1037

1.72

10.47

1.3

1.2

108.60

117.78

pmol/l

1.59

177

1037

238

1347

1.60

10.46

1.2

100.95

105.46

pmol/l

0.70

238

1347

Iridocyclitis

151

846

1.80

10.45

1.5

1.2

117.10

109.46

pmol/l

0.99

151

846

Polyarthrosis

137

667

1.86

10.45

1.2

117.09

110.63

pmol/l

0.19

137

667

Immunodeficiency with predominantly antibody defects

3.93

10.44

1.4

1.1

108.50

110.92

pmol/l

0.07

Polyneuropathies and other disorders of the peripheral nervous system

130

696

1.88

10.41

1.3

1.2

99.41

103.21

pmol/l

0.36

130

696

Other eating disorders

158

2.95

10.34

1.1

120.09

118.03

pmol/l

0.10

158

Abnormal findings on diagnostic imaging of other body structures

105

525

2.02

10.31

1.2

111.73

110.04

pmol/l

0.12

105

525

Bleeding

484

2449

1.39

10.29

1.3

1.2

106.58

109.57

pmol/l

0.29

484

2449

Exclusions for E4_PCOS_CONSORTIUM

488

2195

1.39

10.28

1.2

116.52

114.34

pmol/l

0.40

488

2195

Dipeptidyl peptidase 4 (DPP-4) inhibitors

313

1640

1.50

10.27

1.2

89.33

110.78

pmol/l

10.96

313

1640

Papulosquamous disorders

246

1576

1.57

10.20

1.2

107.94

111.47

pmol/l

0.51

246

1576

Urinary track infection

421

1472

1.44

10.19

1.3

1.2

111.95

118.87

pmol/l

1.08

421

1472

Gonarthrosis [arthrosis of knee](FG)

425

1719

1.43

10.16

1.2

105.57

111.86

pmol/l

1.95

425

1719

Diverticular disease of intestine

412

1798

1.43

10.15

1.2

106.98

109.84

pmol/l

0.23

412

1798

Disorders of choroid and retina

471

2375

1.39

10.14

1.2

103.06

109.60

pmol/l

1.86

471

2375

Other inflammation of eyelid, including avohilmo

296

1977

1.50

10.12

1.3

1.2

119.69

113.51

pmol/l

1.26

296

1977

Type 2 diabetes, definitions combined, including avohilmo

585

2510

1.35

10.11

1.3

1.2

104.83

115.24

pmol/l

2.15

585

2510

Multiple myeloma and malignant plasma cell neoplasms

139

3.07

10.11

1.1

1.2

95.95

101.86

pmol/l

0.19

139

Diseases of the ear and mastoid process

705

2686

1.32

10.06

1.2

115.61

111.02

pmol/l

0.78

705

2686

Other gastritis (incl. Duodenitis)

133

726

1.84

10.04

1.5

1.2

105.33

109.18

pmol/l

0.31

133

726

Adjustment and management of implanted device

483

2.04

10.00

1.2

96.00

102.77

pmol/l

0.75

483

Phobic anxiety disorders

429

2.11

9.98

1.1

1.2

123.07

119.26

pmol/l

0.27

429

Other necrotizing vasculopathies

218

2.60

9.97

1.1

1.2

107.43

103.17

pmol/l

0.30

218

Diaphragmatic hernia

220

1381

1.60

9.96

1.2

110.43

108.96

pmol/l

0.16

220

1381

STROKE

321

1455

1.49

9.91

1.2

100.17

115.19

pmol/l

6.19

321

1455

Migraine with aura and triptan purchases

119

630

1.90

9.90

1.2

117.25

118.53

pmol/l

0.12

119

630

Chronic ulcer of skin, not elsewhere classified

214

2.60

9.80

1.3

1.2

100.36

105.43

pmol/l

0.31

214

Viral and other specified intestinal infections

134

722

1.82

9.72

1.2

109.33

117.01

pmol/l

0.82

134

722

Chorioretinal inflammation

3.63

9.70

1.9

1.1

123.32

113.16

pmol/l

0.37

Anaemia in chronic diseases classified elsewhere

4.25

9.68

1.2

1.1

68.72

102.20

pmol/l

2.25

Type 2 diabetes, strict (exclude DM1)

580

2520

1.34

9.67

1.3

1.2

103.82

114.71

pmol/l

2.30

580

2520

Type 2 diabetes, definitions combined

577

2506

1.34

9.64

1.3

1.2

103.86

114.79

pmol/l

2.29

577

2506

Urticaria

204

1269

1.62

9.61

1.2

113.30

112.96

pmol/l

0.03

204

1269

Presence of other devices

139

767

1.79

9.59

1.2

105.53

107.87

pmol/l

0.22

139

767

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

350

2436

1.44

9.57

1.2

102.81

109.88

pmol/l

1.91

350

2436

Zoster [herpes zoster], including avohilmo

320

2118

1.46

9.55

1.2

111.72

109.07

pmol/l

0.39

320

2118

Endometriosis of pelvic peritoneum

118

571

1.89

9.53

1.2

1.1

111.88

115.03

pmol/l

0.31

118

571

Other inflammation of eyelid

103

527

1.97

9.51

1.4

1.2

114.56

110.92

pmol/l

0.28

103

527

Inflammatory diseases of female pelvic organs

443

2186

1.39

9.51

1.2

117.90

115.24

pmol/l

0.48

443

2186

Oesophagitis

150

2.90

9.45

1.3

1.1

104.12

102.51

pmol/l

0.08

150

Extrapyramidal and movement disorders

233

1502

1.56

9.44

1.2

105.94

108.45

pmol/l

0.33

233

1502

Deforming dorsopathies

174

1045

1.67

9.42

1.1

1.2

107.91

112.71

pmol/l

0.62

174

1045

Artrosis, including avohilmo

487

1943

1.37

9.40

1.2

108.39

111.09

pmol/l

0.59

487

1943

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

369

2496

1.42

9.39

1.3

1.2

111.67

113.59

pmol/l

0.37

369

2496

Cerebrovascular diseases (FINNGEN)

179

748

1.68

9.39

1.1

1.2

99.24

118.14

pmol/l

6.13

179

748

Malignant neoplasm of breast, HER-positive

232

1103

1.57

9.38

1.2

118.69

112.36

pmol/l

0.33

232

1103

Atopic dermatitis, strict definition with reimbursement

192

1136

1.63

9.37

1.2

119.51

117.62

pmol/l

0.23

192

1136

Coxarthrosis [arthrosis of hip](FG)

300

1389

1.49

9.36

1.2

109.81

110.89

pmol/l

0.06

300

1389

Retention of urine

178

865

1.67

9.30

1.2

93.57

105.85

pmol/l

2.22

178

865

Trochanteric bursitis

106

553

1.93

9.26

1.2

114.75

117.50

pmol/l

0.20

106

553

Malignant neoplasm of breast, ER-positive, including Hilmo

232

1105

1.57

9.26

1.2

118.69

112.38

pmol/l

0.33

232

1105

External causes of morbidity and mortality

390

1371

1.43

9.23

1.2

110.01

115.83

pmol/l

1.25

390

1371

Cardiomyopathy

457

2.02

9.21

1.2

89.58

109.68

pmol/l

4.00

457

Fitting and adjustment of other devices

200

1097

1.61

9.21

1.2

104.97

108.11

pmol/l

0.41

200

1097

Allergic conjunctivitis

383

2632

1.40

9.15

1.2

111.11

114.51

pmol/l

0.77

383

2632

Other acute lower respiratory infections

318

2092

1.45

9.14

1.3

1.2

101.77

110.86

pmol/l

2.83

318

2092

Anterior Iridocyclitis

131

735

1.79

9.10

1.5

1.2

118.18

109.01

pmol/l

1.13

131

735

Malignant neoplasm of urinary organs, including Hilmo

296

2.28

9.07

1.0

1.2

94.75

100.20

pmol/l

0.42

296

Demyelinating diseases of the central nervous system

297

2.28

9.02

1.0

1.2

127.58

112.75

pmol/l

1.22

297

Other degenerative diseases of the nervous system

159

680

1.71

8.95

1.1

1.2

113.01

113.68

pmol/l

0.04

159

680

Idiopathic gout

236

2.44

8.94

1.2

81.63

98.49

pmol/l

2.47

236

Gonarthrosis

357

1408

1.44

8.91

1.2

105.54

111.22

pmol/l

1.39

357

1408

Calculus of kidney and ureter

165

993

1.67

8.91

1.4

1.2

132.50

105.57

pmol/l

1.55

165

993

Sicca syndrome [Sjögren]

299

2.26

8.89

1.3

1.2

106.87

110.12

pmol/l

0.24

299

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

243

2.41

8.88

1.2

87.93

104.02

pmol/l

2.27

243

Injuries to the head

682

3131

1.29

8.88

1.2

108.02

112.12

pmol/l

1.33

682

3131

Eating disorder

292

2.28

8.88

1.1

1.2

125.83

119.78

pmol/l

0.45

292

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

3.66

8.87

1.2

1.3

89.75

99.76

pmol/l

0.34

Multiple myeloma

3.66

8.87

1.2

1.3

89.75

99.76

pmol/l

0.34

Papillary adenocarcinoma of thyroid gland

173

2.70

8.82

1.1

131.04

114.72

pmol/l

0.27

173

Nephrotic syndrome

3.47

8.81

1.1

81.67

105.90

pmol/l

2.21

Iron deficiency anaemia secondary to blood loss (chronic)

104

549

1.91

8.79

1.3

1.2

95.62

110.55

pmol/l

1.92

104

549

Atopic dermatitis

374

2125

1.40

8.78

1.2

115.71

114.31

pmol/l

0.23

374

2125

Other diseases of liver

122

678

1.81

8.77

1.2

107.29

110.07

pmol/l

0.22

122

678

Diabetes medication

637

2858

1.30

8.76

1.3

1.2

102.32

114.80

pmol/l

3.23

637

2858

Cutaneous abscess, furuncle and carbuncle

162

975

1.67

8.76

1.4

1.2

113.27

111.79

pmol/l

0.04

162

975

Nonalcoholic fatty liver disease

333

2.18

8.76

1.1

1.2

111.44

111.82

pmol/l

0.02

333

Diseases of oral cavity, salivary glands and jaws

318

1121

1.47

8.67

1.2

110.34

107.10

pmol/l

0.21

318

1121

Temporomandibular joint disorders, including avohilmo

300

2009

1.45

8.65

1.2

117.90

114.30

pmol/l

0.70

300

2009

Psoriasis vulgaris

117

645

1.82

8.64

1.2

110.80

108.46

pmol/l

0.18

117

645

Other diseases of pancreas

265

2.32

8.63

1.2

102.67

102.23

pmol/l

0.03

265

Other disorders of glucose regulation and pancreatic internal secretion

259

2.34

8.60

1.7

1.2

92.45

109.77

pmol/l

2.33

259

Actinic keratosis

211

1233

1.56

8.60

1.3

1.2

99.22

104.58

pmol/l

0.93

211

1233

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

259

2.33

8.60

1.0

1.2

96.45

100.40

pmol/l

0.26

259

Cervical disc disorders

205

1313

1.57

8.59

1.2

109.88

109.50

pmol/l

0.04

205

1313

Weight loss

349

2.14

8.58

1.1

1.2

107.00

105.56

pmol/l

0.08

349

Pain in thoracic spine

101

533

1.91

8.55

1.2

106.36

114.46

pmol/l

0.96

101

533

Other and unspecified myopathies

266

2.31

8.55

1.2

107.90

102.23

pmol/l

0.40

266

Other retinal disorders

358

1933

1.41

8.55

1.2

99.18

108.38

pmol/l

2.57

358

1933

Gout due to impairment of renal function

7.61

8.54

1.2

1.3

76.32

98.58

pmol/l

1.24

Injuries to the abdomen, lower back, lumbar spine and pelvis

242

1588

1.51

8.47

1.2

98.74

110.86

pmol/l

3.62

242

1588

Meniscus derangement

305

1394

1.46

8.46

1.1

1.2

105.27

111.85

pmol/l

1.62

305

1394

Other disorders of ear

553

2713

1.32

8.45

1.2

108.86

110.75

pmol/l

0.40

553

2713

Hyperplasia of prostate

151

493

1.73

8.42

1.2

96.13

97.13

pmol/l

0.09

151

493

Benign neoplasm of colon, rectum, anus and anal canal

361

2185

1.40

8.41

1.2

109.17

107.33

pmol/l

0.17

361

2185

Osteonecrosis due to drugs

4.76

8.41

1.3

1.1

123.74

102.93

pmol/l

0.67

Other benign neoplasms of skin

224

1472

1.53

8.38

1.3

1.2

110.19

110.27

pmol/l

0.01

224

1472

Urolithiasis

174

1079

1.62

8.38

1.4

1.2

133.17

105.25

pmol/l

1.78

174

1079

Acute and subacute iridocyclitis

122

688

1.78

8.37

1.5

1.2

118.99

108.75

pmol/l

1.24

122

688

Glomerulonephritis

301

2.21

8.33

1.1

1.2

80.76

107.61

pmol/l

3.75

301

Collagenous colitis

321

2.17

8.30

1.2

108.62

109.52

pmol/l

0.06

321

Other viral diseases

179

1118

1.60

8.25

1.4

1.2

107.67

112.97

pmol/l

0.73

179

1118

Intestinal malabsorption

134

2.87

8.24

1.3

1.1

114.32

109.87

pmol/l

0.20

134

Skin changes due to chronic exposure to nonionizing radiation

217

1285

1.53

8.18

1.3

1.2

99.80

104.78

pmol/l

0.84

217

1285

Disturbance of activity and attention

439

1.97

8.17

1.1

119.32

121.01

pmol/l

0.13

439

Allergic rhinitis

198

1258

1.56

8.14

1.3

1.2

115.57

116.64

pmol/l

0.11

198

1258

Conjunctivitis (acute, non atopic), including avohilmo

604

2814

1.30

8.12

1.2

118.08

109.99

pmol/l

1.27

604

2814

Agranulocytosis

377

2.06

8.11

1.2

109.78

109.63

pmol/l

0.01

377

Chronic pancreatitis

377

2.06

8.11

1.2

101.30

103.02

pmol/l

0.09

377

Mental retardation, excluding more controls

3.16

8.10

1.3

1.2

101.16

115.29

pmol/l

0.91

Intestinal stricture

178

1121

1.59

8.06

1.3

1.2

106.93

108.29

pmol/l

0.04

178

1121

Other symptoms and signs involving the digestive system and abdomen

114

638

1.80

8.04

1.2

116.22

112.63

pmol/l

0.33

114

638

Other disorders starting during childhood or adolecense, excluding more controls

3.14

8.04

1.3

1.2

114.28

125.49

pmol/l

0.71

Testicular hypofunction

3.67

8.03

1.1

1.2

109.12

105.87

pmol/l

0.15

Acute bronchitis

238

1568

1.49

8.00

1.3

1.2

101.60

111.27

pmol/l

2.40

238

1568

Benign neoplasm: Colon

304

2006

1.43

8.00

1.2

109.97

107.03

pmol/l

0.25

304

2006

Voice disturbances

172

1077

1.60

8.00

1.3

1.2

105.67

110.40

pmol/l

0.77

172

1077

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

142

2.78

7.98

1.3

88.08

101.04

pmol/l

0.86

142

Hyperkinetic disorders

470

1.92

7.96

1.1

1.2

119.71

119.86

pmol/l

0.01

470

Intracranial injury

339

2266

1.40

7.94

1.2

105.62

110.73

pmol/l

1.16

339

2266

Medicines for HER+ breast cancer

247

1560

1.48

7.90

1.2

118.47

111.93

pmol/l

0.37

247

1560

Missing teeth due to accident, extraction or parodontitis

357

2308

1.38

7.89

1.3

1.2

108.27

108.32

pmol/l

0.01

357

2308

L02BG Aromatase inhibitors

202

1301

1.54

7.86

1.1

1.2

118.78

112.08

pmol/l

0.30

202

1301

Other diseases of hard tissues of teeth

310

1116

1.44

7.86

1.2

109.17

107.28

pmol/l

0.25

310

1116

Molar incisor enamel hypoplasia, with caries

7.21

7.84

1.4

1.3

100.72

127.19

pmol/l

1.02

Procreative management

212

1146

1.53

7.78

1.2

114.76

113.84

pmol/l

0.11

212

1146

Bipolar affective disorders

115

652

1.77

7.78

1.1

1.2

102.68

120.02

pmol/l

3.10

115

652

Spondylolisthesis/Spondylolysis

114

645

1.78

7.77

1.1

1.2

107.61

111.02

pmol/l

0.29

114

645

Zoster [herpes zoster]

119

682

1.75

7.76

1.1

1.2

113.29

110.00

pmol/l

0.24

119

682

Hypoglycaemia, other or unspecified

203

2.44

7.74

1.8

1.1

94.12

110.39

pmol/l

1.75

203

Psoriasis

171

1078

1.59

7.74

1.2

109.80

109.55

pmol/l

0.02

171

1078

Allergic contact dermatitis

495

1.89

7.73

1.1

110.01

116.04

pmol/l

0.54

495

Chronic diseases of tonsils and adenoids

464

2197

1.33

7.70

1.2

119.04

110.99

pmol/l

1.76

464

2197

Protozoal diseases

3.31

7.69

1.3

1.1

129.71

104.07

pmol/l

0.86

Faecal incontinence

318

2.12

7.69

1.1

1.2

101.90

109.88

pmol/l

0.78

318

Fracture of femur

155

858

1.63

7.68

1.4

1.2

101.52

102.94

pmol/l

0.11

155

858

Specific personality disorders

147

895

1.65

7.67

1.3

1.2

110.07

117.90

pmol/l

1.04

147

895

Injury, poisoning and certain other consequences of external causes

321

1130

1.43

7.66

1.2

109.56

118.09

pmol/l

1.93

321

1130

Congenital malformations of the urinary system, including avohilmo

192

2.47

7.66

1.2

1.1

93.91

112.06

pmol/l

1.76

192

Other viral diseases, including avohilmo

237

1591

1.48

7.66

1.3

1.2

110.41

114.57

pmol/l

0.66

237

1591

Abnormal weight loss

319

2.12

7.63

1.1

1.2

108.76

103.93

pmol/l

0.30

319

Type of accident

177

1129

1.57

7.62

1.1

1.2

100.69

113.21

pmol/l

2.66

177

1129

Supplementary factors related to causes of morbidity and mortality classified elsewhere

189

1224

1.55

7.61

1.2

101.23

113.06

pmol/l

2.56

189

1224

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

554

2531

1.30

7.58

1.3

1.2

99.73

114.60

pmol/l

3.59

554

2531

Other or unspecified ileus, impaction or obstruction

107

599

1.79

7.55

1.3

1.2

112.64

108.46

pmol/l

0.09

107

599

Diseases of salivary glands

205

1354

1.52

7.55

1.4

1.2

110.31

111.94

pmol/l

0.20

205

1354

Cholelithiasis, broad definition with cholecystitis

512

2605

1.31

7.55

1.2

111.18

110.62

pmol/l

0.05

512

2605

Polyuria

121

703

1.73

7.53

1.2

107.32

104.80

pmol/l

0.22

121

703

Injuries to the thorax

255

1759

1.45

7.52

1.3

1.2

101.49

108.76

pmol/l

1.45

255

1759

Other enthesopathies

184

1188

1.55

7.51

1.3

1.2

112.19

113.41

pmol/l

0.14

184

1188

Other diseases of intestine

507

1.86

7.50

1.6

1.2

99.24

109.80

pmol/l

1.09

507

Fracture of lumbar spine and pelvis

137

822

1.67

7.50

1.2

94.15

106.18

pmol/l

1.99

137

822

Other renal tubulo-interstitial diseases

3.71

7.49

1.4

1.1

79.70

117.17

pmol/l

3.47

Acetic acid derivatives and related substances

151

466

1.68

7.48

1.1

1.3

107.32

102.78

pmol/l

0.50

151

466

Pneumocystosis

3.98

7.48

1.1

128.00

101.57

pmol/l

0.64

Pneumocystosis, including avohilmo

3.98

7.48

1.1

128.00

101.57

pmol/l

0.64

Childhood asthma (age<16), excluding more controls

304

2.01

7.47

1.4

1.1

122.35

119.45

pmol/l

0.14

304

Dental operations

333

1218

1.41

7.46

1.2

111.45

108.46

pmol/l

0.20

333

1218

Injuries to the hip and thigh

273

1709

1.44

7.46

1.3

1.2

106.68

108.45

pmol/l

0.20

273

1709

Viral warts, including avohilmo

139

841

1.66

7.45

1.3

1.2

120.50

111.54

pmol/l

1.39

139

841

Protozoal diseases, including avohilmo

3.23

7.42

1.3

1.1

129.71

103.84

pmol/l

0.87

Enthesopathies of lower limb, excluding foot

140

851

1.65

7.37

1.2

109.57

112.86

pmol/l

0.34

140

851

MS-disease / Multiple Sclerosis

252

2.24

7.36

1.0

1.2

126.55

113.47

pmol/l

0.86

252

Childhood asthma (age<16)

306

2.00

7.35

1.4

1.1

122.35

119.22

pmol/l

0.16

306

Other congenital malformations, including avohilmo

468

1.89

7.34

1.2

116.72

114.21

pmol/l

0.23

468

Disorders of adult personality and behaviour

174

1116

1.57

7.34

1.3

1.2

110.06

117.62

pmol/l

1.19

174

1116

Viral pneumonia (unknown virus, not influenza)

190

2.44

7.33

1.9

1.1

89.54

107.91

pmol/l

1.88

190

Erosion of teeth , including avohilmo

169

1077

1.58

7.33

1.2

113.70

114.87

pmol/l

0.11

169

1077

Pruritus

420

1.94

7.31

1.1

1.2

105.49

108.48

pmol/l

0.21

420

Malignant neoplasm of urinary organs

253

2.23

7.28

1.0

1.2

92.09

100.13

pmol/l

0.60

253

Testicular dysfunction

3.41

7.26

1.1

1.2

109.12

106.93

pmol/l

0.10

5-aminosalicylic acid

119

696

1.72

7.25

1.1

1.2

109.14

114.61

pmol/l

0.56

119

696

Diseases of arteries, arterioles and capillaries

355

1903

1.37

7.22

1.3

1.2

99.76

107.66

pmol/l

0.71

355

1903

Disorders of vitreous body and globe

307

2085

1.40

7.22

1.3

1.2

111.80

109.04

pmol/l

0.43

307

2085

Biological medicines for asthma

3.61

7.18

1.1

101.74

112.86

pmol/l

0.85

Other diseases of anus and rectum

172

1102

1.56

7.17

1.2

108.91

109.66

pmol/l

0.07

172

1102

Hypoplasia of dental enamel

6.25

7.14

1.3

1.2

102.17

118.47

pmol/l

0.57

Gastroduodenal ulcer

128

764

1.68

7.14

1.3

1.2

104.77

105.21

pmol/l

0.03

128

764

Coxarthrosis

262

1171

1.45

7.12

1.2

112.14

110.49

pmol/l

0.08

262

1171

Respiratory insufficiency

168

2.51

7.11

1.2

100.64

102.08

pmol/l

0.06

168

SLE (Finngen)

101

3.01

7.10

1.1

106.47

106.32

pmol/l

0.01

101

Cerebral cysts

163

2.54

7.10

1.1

116.10

112.16

pmol/l

0.17

163

Inflammatory diseases of the central nervous system

269

2.17

7.09

1.2

1.1

107.19

107.60

pmol/l

0.02

269

Eating disorders

355

2.01

7.08

1.1

1.2

128.06

117.38

pmol/l

1.04

355

Other (not insulin) diabetes medications

578

2655

1.28

7.02

1.3

1.2

103.15

114.24

pmol/l

2.32

578

2655

Injuries to the elbow and forearm

432

2811

1.32

7.00

1.2

113.46

111.63

pmol/l

0.32

432

2811

Nummular dermatitis

251

2.21

7.00

1.2

112.93

104.31

pmol/l

0.86

251

Other demyelinating diseases of the central nervous system

124

2.78

6.98

1.1

131.47

114.12

pmol/l

0.70

124

Thyrotoxicosis, other and/or unspecified

126

758

1.67

6.94

1.2

113.43

116.91

pmol/l

0.30

126

758

Disorder of mineral metabolism, other/unspecified

18.65

6.93

2.5

1.2

70.80

87.67

pmol/l

—

Pain and other conditions associated with female genital organs and menstrual cycle

136

693

1.65

6.91

1.1

112.26

116.29

pmol/l

0.48

136

693

Degeneration of macula and posterior pole

255

1372

1.44

6.91

1.2

103.50

106.10

pmol/l

0.32

255

1372

Explicit bacterial Sepsis

305

2.08

6.89

1.2

93.24

107.58

pmol/l

1.64

305

Cholelithiasis

490

2579

1.30

6.86

1.2

108.73

110.67

pmol/l

0.38

490

2579

Exposure to other specified factors

482

3198

1.30

6.85

1.3

1.2

111.74

112.10

pmol/l

0.06

482

3198

Malignant neoplasm of breast

280

1277

1.42

6.84

1.2

118.87

113.18

pmol/l

0.37

280

1277

Cystic kidney disease, including avohilmo

3.00

6.83

1.3

1.1

90.79

109.92

pmol/l

1.19

Dentofacial anomalies [including malocclusion]

438

2613

1.31

6.81

1.2

115.47

113.03

pmol/l

0.54

438

2613

Malignant neoplasm of breast, HER2-negative

279

1274

1.42

6.78

1.2

118.95

113.09

pmol/l

0.38

279

1274

Venous thromboembolism

296

2059

1.39

6.78

1.2

101.76

108.09

pmol/l

1.29

296

2059

Disorder of lipoprotein metabolism, unspecified

341

2.01

6.77

1.9

1.2

96.93

112.04

pmol/l

1.06

341

Explicit bacterial Sepsis, including avohilmo

314

2.05

6.77

1.2

93.63

107.00

pmol/l

1.50

314

Hypertensive Heart Disease

112

492

1.73

6.77

1.1

1.2

88.83

113.34

pmol/l

5.64

112

492

Paroxysmal tachycardia

119

585

1.70

6.76

1.4

1.2

112.47

119.14

pmol/l

0.90

119

585

Complications of internal orthopaedic prosthetic devices, implants and grafts

129

787

1.65

6.74

1.3

1.2

102.46

109.64

pmol/l

0.84

129

787

Idiopathic hypoparathyroidism

13.40

6.74

1.5

1.3

113.45

103.44

pmol/l

—

Malignant neoplasm of breast, including Hilmo

283

1288

1.41

6.73

1.2

118.51

113.24

pmol/l

0.34

283

1288

Rheumatoid arthritis, including avohilmo

221

1520

1.46

6.72

1.2

99.58

110.85

pmol/l

3.01

221

1520

Neuromuscular dysfunction of bladder

295

2.08

6.72

1.1

1.2

101.15

108.75

pmol/l

0.70

295

Haemolytic anaemias

2.97

6.72

1.2

1.1

112.31

107.63

pmol/l

0.13

Amputation of ankle bones

3.77

6.67

3.1

1.2

68.85

97.57

pmol/l

1.49

Diseases of male genital organs

212

712

1.50

6.65

1.2

102.55

102.33

pmol/l

0.02

212

712

IgA nephropathy (IgA glomerulonephritis)

3.62

6.62

1.2

1.1

92.24

107.36

pmol/l

0.56

Stomatitis and related lesions

124

753

1.65

6.61

1.3

1.2

116.86

108.65

pmol/l

0.91

124

753

Chronic iridocyclitis

157

2.51

6.61

1.7

1.2

110.13

110.69

pmol/l

0.03

157

Other disorders of white blood cells

157

2.51

6.61

1.2

1.1

109.41

107.96

pmol/l

0.06

157

Speech and linguistic disorders, excluding more controls

198

2.29

6.60

1.3

1.2

104.63

118.35

pmol/l

0.82

198

Total colectomy

128

2.69

6.59

1.1

89.53

106.70

pmol/l

1.21

128

Total colectomy operation

128

2.69

6.59

1.1

89.53

106.70

pmol/l

1.21

128

Malignant neoplasm of breast, HER2-negative, including Hilmo

282

1288

1.41

6.59

1.2

118.59

113.24

pmol/l

0.34

282

1288

Viral pneumonia (known virus, not influenza)

3.29

6.58

1.0

1.2

78.96

102.57

pmol/l

1.42

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

155

982

1.56

6.56

1.2

105.10

116.62

pmol/l

2.24

155

982

Congenital malformations of the urinary system

182

2.39

6.55

1.1

92.33

112.03

pmol/l

1.86

182

Autoimmune hepatitis, wide definition

123

2.71

6.51

2.1

1.2

117.79

109.51

pmol/l

0.18

123

Disorders of vitreous body

296

2049

1.38

6.50

1.3

1.2

111.65

109.14

pmol/l

0.37

296

2049

Malignant neoplasm of kidney, except renal pelvis

233

2.20

6.50

1.0

1.2

93.98

98.20

pmol/l

0.25

233

Cardiomyopathy, other and unspecified

195

2.33

6.49

1.2

1.1

97.44

109.50

pmol/l

1.06

195

Pneumonia due to other infectious organisms, not elsewhere classified

3.10

6.48

1.2

1.1

124.38

103.08

pmol/l

0.59

Chronic laryngitis and laryngotracheitis

489

1.81

6.46

1.4

1.2

121.49

107.34

pmol/l

0.49

489

Pain associated with micturition

432

1.86

6.44

1.2

105.03

108.10

pmol/l

0.25

432

Coxibs

147

478

1.62

6.41

1.2

1.3

106.04

103.61

pmol/l

0.24

147

478

Polycystic ovarian syndrome, consortium definition

481

2137

1.29

6.38

1.2

115.71

115.38

pmol/l

0.05

481

2137

Streptococcal septicaemia, including avohilmo

261

2.12

6.38

1.2

88.87

108.80

pmol/l

2.50

261

Heartburn

377

1.92

6.37

1.3

1.2

114.68

110.31

pmol/l

0.32

377

Generalized skin eruption due to drugs and medicaments

119

2.72

6.36

1.2

106.53

108.47

pmol/l

0.09

119

Thyrotoxicosis

163

1067

1.53

6.35

1.2

112.25

114.19

pmol/l

0.18

163

1067

Streptococcal septicaemia

255

2.13

6.34

1.2

88.33

109.38

pmol/l

2.66

255

Fracture of rib(s), sternum and thoracic spine

166

1091

1.53

6.34

1.2

99.52

108.40

pmol/l

1.26

166

1091

Other and unspecified effects of external causes

167

1100

1.52

6.32

1.2

105.19

114.01

pmol/l

1.49

167

1100

Acute peritonitis

173

2.39

6.29

1.2

79.10

103.79

pmol/l

2.75

173

Triptan medication for migraine, min. 3 purchases

364

2044

1.33

6.29

1.2

118.68

115.73

pmol/l

0.54

364

2044

Algoneurodystrophy

103

2.86

6.28

1.5

1.1

125.48

112.77

pmol/l

0.68

103

Use of biperiden

149

2.51

6.28

1.1

101.24

109.15

pmol/l

0.51

149

Open wound of lower leg

524

1.77

6.23

1.2

99.70

109.00

pmol/l

1.17

524

Drug-induced neutropenia

231

2.18

6.23

1.2

113.80

107.68

pmol/l

0.29

231

Substance abuse, excluding more controls

281

1702

1.38

6.22

1.2

99.73

111.55

pmol/l

3.61

281

1702

Other obstetric conditions, not elsewhere classified

207

889

1.47

6.21

1.2

1.1

123.18

119.12

pmol/l

0.60

207

889

Hypotension

539

1.75

6.21

1.1

1.2

92.78

105.55

pmol/l

1.39

539

Other and unspecified immunodeficiencies with predominantly antibody defects

5.47

6.21

1.3

1.1

104.24

109.06

pmol/l

0.11

Coagulation defects, purpura and other haemorrhagic conditions

118

720

1.65

6.20

1.2

110.32

107.23

pmol/l

0.26

118

720

Impingement syndrome of shoulder

131

822

1.60

6.15

1.3

1.2

110.27

110.74

pmol/l

0.03

131

822

Cystic kidney disease

3.00

6.13

1.2

1.1

91.04

110.51

pmol/l

1.06

Other pleural conditions

299

2.02

6.13

1.9

1.2

92.43

98.70

pmol/l

0.43

299

Other CVD

108

646

1.68

6.13

1.1

1.2

93.67

105.95

pmol/l

1.59

108

646

Congenital malformations of the musculoskeletal system, not elsewhere classified

3.83

6.13

1.2

143.72

117.17

pmol/l

1.32

Glucagon-like peptide-1 (GLP-1) analogues

179

1205

1.49

6.12

1.4

1.2

96.28

114.24

pmol/l

5.29

179

1205

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

179

1205

1.49

6.12

1.4

1.2

96.28

114.24

pmol/l

5.29

179

1205

Cholecystectomy

415

2715

1.30

6.11

1.1

1.2

109.73

110.22

pmol/l

0.07

415

2715

Seborrhoeic dermatitis

313

1.99

6.11

1.1

1.2

109.79

104.72

pmol/l

0.37

313

Statin medication

401

1716

1.32

6.11

1.1

1.2

105.97

116.17

pmol/l

4.72

401

1716

Other extrapyramidal and movement disorders in other diseases

149

966

1.55

6.09

1.2

106.44

109.96

pmol/l

0.37

149

966

FESS (DNB20)

426

1.84

6.08

1.8

1.2

112.40

109.65

pmol/l

0.18

426

Unspecified fall

291

2098

1.36

6.08

1.3

1.2

105.98

110.31

pmol/l

0.84

291

2098

Localized swelling, mass and lump of skin and subcutaneous tissue

182

1231

1.48

6.08

1.3

1.2

108.38

111.69

pmol/l

0.44

182

1231

Rosacea

499

1.77

6.07

1.1

1.2

106.76

111.85

pmol/l

0.45

499

Noninflammatory disorders of female genital tract

245

861

1.43

6.07

1.2

110.89

116.19

pmol/l

0.79

245

861

Disease of hard tissues of teeth, NOS

290

1097

1.39

6.05

1.2

112.70

107.56

pmol/l

0.89

290

1097

Other disorders of bone density and structure

3.20

6.04

1.3

1.1

120.13

116.38

pmol/l

0.12

Triptan medication for migraine, single purchase ok

463

2445

1.28

6.03

1.1

1.2

116.93

112.70

pmol/l

1.16

463

2445

Migraine, single triptan purchase ok & required. ICD-code if available is included

463

2445

1.28

6.03

1.1

1.2

116.93

112.70

pmol/l

1.16

463

2445

Diabetes, insulin treatment (Kela reimbursement)

584

2779

1.25

6.02

1.3

1.2

99.79

113.60

pmol/l

3.36

584

2779

Cardiac murmurs and other cardiac sounds

284

2.03

6.01

1.1

1.2

101.84

116.17

pmol/l

1.75

284

Polyp of the female genital tract

190

722

1.50

6.01

1.3

1.1

117.00

114.68

pmol/l

0.12

190

722

Hyperlipidaemia, other/unspecified

181

1098

1.49

6.01

1.2

97.11

109.06

pmol/l

2.35

181

1098

Attention to artificial openings

100

2.83

6.00

1.1

68.46

107.10

pmol/l

3.81

100

Acute pancreatitis

105

629

1.68

5.94

1.2

99.15

109.08

pmol/l

1.15

105

629

Excessive, frequent and irregular menstruation

231

860

1.44

5.94

1.2

110.30

116.28

pmol/l

0.94

231

860

Recurrent aphthous stomatitis , including avohilmo

547

1.73

5.93

1.2

116.77

109.68

pmol/l

0.60

547

Bulimia nervosa (incl. atypical)

101

2.81

5.91

1.1

125.86

117.66

pmol/l

0.38

101

Other diseases of oesophagus

276

2.04

5.91

1.5

1.2

114.54

100.92

pmol/l

1.18

276

Disorders of parathyroid gland, other and/or unspecified

8.33

5.90

1.2

1.3

158.42

115.13

pmol/l

1.13

Other diseases of the respiratory system

108

653

1.66

5.90

1.2

104.68

105.02

pmol/l

0.02

108

653

Other respiratory disorders and diseases

108

653

1.66

5.90

1.2

104.68

105.02

pmol/l

0.02

108

653

Hypogonadotropic hypogonadism

3.23

5.88

1.2

115.73

109.32

pmol/l

0.20

Poisoning by medicine

127

801

1.59

5.86

1.2

102.16

116.04

pmol/l

2.50

127

801

Drug-induced osteoporosis

3.88

5.86

1.4

1.1

112.12

106.47

pmol/l

0.18

Gingivitis and periodontal diseases

565

2326

1.26

5.86

1.2

110.06

111.45

pmol/l

0.25

565

2326

Sequelae of external causes of morbidity and mortality

148

968

1.54

5.83

1.4

1.2

102.18

108.54

pmol/l

0.95

148

968

Benign neoplasm of other and unspecified endocrine glands

476

1.78

5.82

1.2

115.60

106.86

pmol/l

0.73

476

Erythema nodosum

2.90

5.80

1.3

1.1

111.31

111.67

pmol/l

0.01

Keratitis

205

1433

1.44

5.79

1.3

1.2

113.51

111.52

pmol/l

0.22

205

1433

Decubitus ulcer and pressure area

180

2.30

5.78

1.2

94.56

100.49

pmol/l

0.32

180

Benign neoplasm: Pancreas

2.95

5.76

1.2

1.1

112.00

104.19

pmol/l

0.34

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

169

1126

1.49

5.75

1.3

1.2

111.51

116.01

pmol/l

0.60

169

1126

Colectomy operation

567

1.70

5.75

1.1

1.2

99.65

104.45

pmol/l

0.42

567

Injuries to the knee and lower leg

699

3093

1.22

5.73

1.2

106.74

112.25

pmol/l

2.23

699

3093

Ethmoidectomy

442

1.80

5.72

1.7

1.2

112.54

109.51

pmol/l

0.20

442

Excessive earwax

350

2414

1.32

5.72

1.2

114.53

107.73

pmol/l

0.59

350

2414

Gastric ulcer

508

1.74

5.72

1.2

109.58

107.58

pmol/l

0.10

508

Schizophrenia or delusion, excluding more controls

158

1039

1.51

5.71

1.2

102.78

116.24

pmol/l

2.62

158

1039

Seropositive rheumatoid arthritis

132

841

1.57

5.70

1.2

101.13

110.83

pmol/l

1.56

132

841

Atopic dermatitis, strict definition

178

1189

1.47

5.67

1.1

1.2

119.03

117.75

pmol/l

0.14

178

1189

Inflammatory diseases of prostate (prostatitis)

267

2.03

5.66

1.1

1.2

112.72

96.93

pmol/l

1.57

267

Other disorders of binocular vision

4.84

5.65

1.1

1.2

127.65

106.17

pmol/l

0.58

Hernia

537

2855

1.25

5.65

1.3

1.2

107.89

110.93

pmol/l

0.74

537

2855

Need for other prophylactic measures

176

2.29

5.63

2.5

1.1

99.32

111.72

pmol/l

0.97

176

Amyloidosis

3.23

5.62

1.6

1.2

91.00

113.52

pmol/l

1.26

3.44

5.60

1.1

121.68

115.32

pmol/l

0.26

Purpura and other haemorrhagic conditions

467

1.77

5.60

1.2

109.73

105.62

pmol/l

0.27

467

Disorders of magnesium metabolism

6.07

5.60

1.1

1.2

97.71

102.63

pmol/l

0.11

Other abnormal uterine and vaginal bleeding

142

660

1.55

5.60

1.2

1.1

118.32

114.78

pmol/l

0.30

142

660

Amputation

282

2.00

5.58

2.0

1.2

79.52

101.80

pmol/l

3.09

282

Persons encountering health services for specific procedures, not carried out

269

2.02

5.56

1.3

1.1

101.43

113.29

pmol/l

1.06

269

Abnormal serum enzyme levels

138

866

1.54

5.56

1.1

1.2

110.96

103.22

pmol/l

0.39

138

866

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

100

585

1.67

5.55

1.1

1.2

98.78

111.75

pmol/l

2.01

100

585

Juvenile arthritis (FINNGEN)

140

2.45

5.54

1.5

1.1

106.91

120.22

pmol/l

0.78

140

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

199

868

1.45

5.52

1.2

1.1

123.56

119.53

pmol/l

0.57

199

868

Thyroiditis, ILD-related definition

440

1.78

5.52

1.3

1.2

113.91

111.78

pmol/l

0.17

440

Other viral diseases, not elsewhere classified

106

648

1.64

5.51

1.5

1.2

106.00

112.56

pmol/l

0.64

106

648

Elevated blood glucose level

277

2.00

5.50

1.1

1.2

86.85

107.71

pmol/l

2.77

277

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

3.29

5.48

1.2

1.1

138.90

115.52

pmol/l

1.24

Other congenital malformations of the digestive system, including avohilmo

158

2.35

5.48

1.5

1.2

108.22

111.70

pmol/l

0.14

158

Carpal tunnel syndrome

356

2367

1.31

5.48

1.2

104.46

111.85

pmol/l

2.25

356

2367

Excessive attrition of teeth

362

2762

1.30

5.47

1.2

113.51

112.37

pmol/l

0.19

362

2762

Inflammatory disease of uterus

100

606

1.66

5.47

1.1

1.2

117.05

121.44

pmol/l

0.36

100

606

Transient ischemic attack

269

1576

1.36

5.47

1.2

100.04

108.14

pmol/l

1.74

269

1576

Other abnormal immunological findings in serum

3.39

5.47

1.1

130.79

114.19

pmol/l

0.76

Endometriosis ASRM stages 1,2

120

761

1.59

5.46

1.2

111.50

119.71

pmol/l

1.09

120

761

Fibroblastic disorders

121

769

1.58

5.44

1.1

1.2

107.83

110.99

pmol/l

0.27

121

769

Disorders of continuity of bone

334

1.90

5.43

1.3

1.1

107.95

111.16

pmol/l

0.22

334

Disorders of ocular muscles, binocular movement, accommodation and refraction

280

2067

1.35

5.42

1.3

1.2

119.40

113.41

pmol/l

0.61

280

2067

Crohn disease

436

1.78

5.38

1.1

1.2

104.31

112.44

pmol/l

0.89

436

Psoriasis (vulgaris), strict definition

2.77

5.38

1.2

1.1

117.65

108.20

pmol/l

0.45

Lack of expected normal physiological development

3.54

5.37

1.3

1.2

104.56

120.44

pmol/l

0.77

Adverse effects, not elsewhere classified

120

764

1.58

5.37

1.2

108.87

114.88

pmol/l

0.66

120

764

Mental retardation, wide definition

135

2.45

5.36

1.3

1.2

101.67

111.82

pmol/l

0.63

135

Cholangitis (primary sclerosing, PSC), with reimbursement 202

3.60

5.35

1.1

87.76

113.54

pmol/l

1.44

Disorders of psychological development

363

1.82

5.35

1.3

1.1

105.15

117.58

pmol/l

1.06

363

Juvenile rheumatoid arthirtis

3.22

5.34

1.5

1.1

117.00

117.51

pmol/l

0.01

Endocrine disorders, other/unspecified

3.45

5.33

1.2

1.1

114.39

111.19

pmol/l

0.09

Chronic apical periodontitis

649

2983

1.22

5.33

1.3

1.2

111.11

111.21

pmol/l

0.01

649

2983

Diabetic retinopathy, excluding more controls

145

528

1.54

5.33

1.2

90.22

103.01

pmol/l

2.27

145

528

Other and unspecified injuries of lower leg

260

2.01

5.32

1.3

1.2

104.67

112.94

pmol/l

0.74

260

Herpesviral [herpes simplex] infections

438

1.77

5.31

1.2

1.3

115.03

109.64

pmol/l

0.35

438

Other juvenile arthritis

113

2.59

5.31

1.5

1.2

95.55

120.12

pmol/l

2.47

113

Endometriosis of ovary

105

610

1.63

5.31

1.1

121.73

116.72

pmol/l

0.46

105

610

Other congenital malformations of the digestive system

136

2.43

5.30

1.5

1.2

104.39

111.78

pmol/l

0.32

136

Artificial joint operation, meniscal resection

498

2546

1.25

5.28

1.2

104.65

109.55

pmol/l

1.42

498

2546

Mental retardation

130

2.47

5.28

1.3

1.2

101.16

111.91

pmol/l

0.65

130

Pulmonary heart disease, diseases of pulmonary circulation

169

1161

1.46

5.28

1.2

100.99

107.48

pmol/l

0.73

169

1161

Ascites

214

2.12

5.26

1.1

1.2

77.76

104.97

pmol/l

3.83

214

Disorders of breast

326

2190

1.31

5.26

1.3

1.2

116.25

115.13

pmol/l

0.14

326

2190

Disorders of vestibular function (Vertigo)

263

1900

1.35

5.23

1.2

112.90

108.93

pmol/l

0.66

263

1900

Follow-up care involving plastic surgery

126

2.49

5.22

1.2

1.1

108.23

115.58

pmol/l

0.42

126

Other condition

500

1.71

5.21

1.1

1.2

100.48

109.14

pmol/l

1.00

500

Acquired haemolytic anaemia

3.17

5.21

1.1

109.85

101.34

pmol/l

0.19

Other and unspecified disorders of vitreous body

240

1718

1.37

5.21

1.2

113.65

109.67

pmol/l

0.60

240

1718

Non-Hodgkin lymphoma, all, including Hilmo

375

1.82

5.20

1.3

1.2

121.03

103.34

pmol/l

1.55

375

Use of pramipexole

127

826

1.54

5.19

1.1

1.2

106.61

109.63

pmol/l

0.24

127

826

Poisoning by drugs, medicaments and biological substances

136

898

1.52

5.18

1.2

101.80

116.97

pmol/l

2.99

136

898

471

1.73

5.18

1.2

113.90

118.23

pmol/l

0.28

471

Deviated nasal septum

160

1091

1.47

5.17

1.3

1.2

109.88

106.02

pmol/l

0.47

160

1091

2.83

5.17

1.9

1.1

105.92

106.95

pmol/l

0.04

Acute pancreatitis (for exclusion)

105

654

1.61

5.16

1.2

99.15

104.28

pmol/l

0.50

105

654

Other and unspecified rosacea

319

1.89

5.16

1.1

109.12

109.67

pmol/l

0.03

319

Cardiomyopathy (excluding other)

305

1.91

5.14

1.1

1.2

88.88

108.49

pmol/l

2.66

305

Fentanyl

263

1.98

5.13

1.2

100.56

105.57

pmol/l

0.28

263

Disorders of refraction and accommodation

170

1172

1.45

5.12

1.4

1.2

125.78

113.15

pmol/l

0.96

170

1172

Cervicocranial syndrome

377

1.81

5.12

1.1

1.2

114.37

113.63

pmol/l

0.04

377

Plantar fascial fibromatosis

327

1.88

5.11

1.1

1.2

102.61

117.03

pmol/l

1.52

327

Benign neoplasm: Colon, unspecified

133

877

1.52

5.11

1.2

109.16

107.50

pmol/l

0.06

133

877

Haemorrhoids and perianal venous thrombosis

182

1267

1.43

5.11

1.3

1.2

105.19

109.01

pmol/l

0.54

182

1267

Menorrhagia

202

792

1.43

5.09

1.4

1.2

112.82

115.61

pmol/l

0.31

202

792

Alcohol abuse counselling and surveillance

3.47

5.06

1.1

1.2

90.65

115.78

pmol/l

1.34

Other disorders of veins

242

1756

1.36

5.04

1.2

104.64

112.71

pmol/l

1.96

242

1756

Other secondary gonarthrosis

153

2.31

5.03

1.3

1.2

93.89

105.33

pmol/l

0.91

153

Other enthesopathy of foot (+metatarsalgia)

372

1.81

5.03

1.5

1.2

112.76

116.82

pmol/l

0.27

372

Nail disorders

280

1.94

5.01

1.2

105.56

109.45

pmol/l

0.26

280

Perioral dermatitis

3.00

5.01

1.0

1.1

113.48

111.35

pmol/l

0.09

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

150

2.30

5.00

1.4

1.2

119.51

117.77

pmol/l

0.07

150

Psoriatic and enteropathic arthropathies

366

1.81

4.98

1.2

107.11

113.60

pmol/l

0.47

366

Obsessive-compulsive disorder

199

2.12

4.97

1.3

1.1

118.38

119.99

pmol/l

0.08

199

Psoriatic arthropathies

316

1.88

4.97

1.2

1.3

106.78

114.34

pmol/l

0.50

316

Seronegative rheumatoid arthritis

359

1.82

4.97

1.3

1.2

95.63

113.68

pmol/l

2.30

359

Other symptoms and signs involving the circulatory and respiratory systems

186

2.16

4.96

1.1

1.2

152.18

113.25

pmol/l

0.38

186

Oxicams

117

419

1.59

4.96

1.2

1.3

108.11

100.90

pmol/l

0.77

117

419

Pyoderma gangrenosum

6.20

4.96

1.2

1.3

107.67

103.05

pmol/l

0.12

Peripheral artery disease

206

1166

1.40

4.96

1.4

1.2

90.68

104.95

pmol/l

0.84

206

1166

Cardiomyopathies, Primary/intrinsic

295

1.91

4.95

1.1

1.2

88.23

110.27

pmol/l

3.08

295

Unspecified mental disorder

223

1629

1.37

4.94

1.2

100.09

112.89

pmol/l

3.88

223

1629

Unspecified/other endometriosis

310

1.87

4.93

1.1

117.71

120.82

pmol/l

0.18

310

Molar incisor enamel hypoplasia

106

2.55

4.93

1.3

1.2

107.64

122.90

pmol/l

0.74

106

Dependence on enabling machines and devices, not elsewhere classified

5.52

4.93

1.2

1.3

79.31

112.50

pmol/l

1.22

Parkinson's disease, excluding more controls

310

1.85

4.91

1.2

106.05

109.83

pmol/l

0.18

310

Other specified/unspecified systemic involvement of connective tissue

207

2.10

4.91

1.3

1.1

106.49

109.90

pmol/l

0.18

207

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

537

1.65

4.91

1.1

1.2

97.43

111.01

pmol/l

1.98

537

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

479

1.70

4.90

1.2

105.67

103.71

pmol/l

0.13

479

Other specified/unspecified soft tissue disorders

130

2.40

4.89

1.1

97.74

111.62

pmol/l

0.85

130

Other and unspecified disorders of white blood cells

118

2.48

4.89

1.2

1.1

112.41

106.74

pmol/l

0.25

118

Unspecified acute lower respiratory infection

510

1.67

4.87

1.2

98.68

108.10

pmol/l

1.29

510

Other (seronegative) rheumatoid arthritis, wide

112

720

1.56

4.85

1.3

1.2

98.48

112.99

pmol/l

2.30

112

720

Gonarthrosis, primary, with knee surgery

309

1840

1.31

4.85

1.2

103.37

109.15

pmol/l

1.23

309

1840

Ehlers-Danlos syndrome

4.96

4.85

1.2

1.1

133.21

117.76

pmol/l

0.53

Varicose veins

338

1976

1.29

4.84

1.2

106.22

110.13

pmol/l

0.73

338

1976

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

123

808

1.53

4.84

1.1

1.2

121.13

119.22

pmol/l

0.16

123

808

Myocardial infarction, without ST-elevation

184

1176

1.41

4.84

1.2

91.63

104.47

pmol/l

2.80

184

1176

Systemic lupus erythematosus

125

2.43

4.82

1.1

106.47

113.48

pmol/l

0.37

125

Androgenic alopecia

5.35

4.81

1.0

1.1

133.46

107.56

pmol/l

2.08

Acute generalized exanthematous pustulosis

150

2.29

4.81

1.2

1.1

107.97

110.68

pmol/l

0.13

150

Diseases of external ear

192

1376

1.40

4.80

1.2

118.06

110.32

pmol/l

0.34

192

1376

Panic disorder

497

1.68

4.80

1.2

108.10

117.71

pmol/l

1.14

497

Inflammatory disorders of breast

243

1.99

4.79

1.5

1.1

107.90

113.14

pmol/l

0.29

243

Ischaemic heart disease, wide definition

403

1958

1.27

4.79

1.2

95.89

111.60

pmol/l

8.67

403

1958

Gonarthrosis,primary

484

2352

1.24

4.78

1.2

103.74

109.38

pmol/l

1.72

484

2352

Ehlers-Danlos syndrome, including avohilmo

3.48

4.78

1.3

1.0

128.50

114.11

pmol/l

0.58

Other disorders of eyelid

235

1642

1.35

4.75

1.2

110.17

107.35

pmol/l

0.38

235

1642

Nontoxic single thyroid nodule

244

1.98

4.74

1.3

1.2

108.58

113.13

pmol/l

0.27

244

Other and unspecified nerve root and plexus disorders, also in other diseases

117

764

1.54

4.74

1.2

114.74

112.57

pmol/l

0.19

117

764

SLE, ICD10

120

2.45

4.73

1.1

108.07

113.66

pmol/l

0.27

120

SLE, strict definition

120

2.45

4.73

1.1

108.07

113.66

pmol/l

0.27

120

L01XE Protein kinase inhibitors

164

2.22

4.73

1.3

1.2

117.97

103.39

pmol/l

0.69

164

Other disorders starting during childhood or adolescence

137

2.33

4.71

1.3

1.2

114.28

118.02

pmol/l

0.19

137

Impetigo

145

2.30

4.71

1.2

1.1

103.03

114.31

pmol/l

0.71

145

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

315

1.85

4.70

1.2

1.1

107.90

108.70

pmol/l

0.04

315

Cervicobrachial syndrome

127

846

1.51

4.69

1.2

113.02

112.49

pmol/l

0.04

127

846

Mixed hyperlipidaemia

2.73

4.68

1.1

95.65

108.61

pmol/l

0.51

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

121

773

1.52

4.67

1.1

1.2

125.98

104.93

pmol/l

0.70

121

773

DVT of lower extremities and pulmonary embolism

215

1571

1.37

4.66

1.2

102.06

107.86

pmol/l

0.80

215

1571

Marasmic kwashiorkor

15.04

4.66

1.4

1.8

90.43

110.40

pmol/l

—

Abnormal blood-pressure reading, without diagnosis

127

2.38

4.65

1.2

106.10

113.50

pmol/l

0.52

127

Other diseases of lip and oral mucosa

242

1810

1.34

4.65

1.2

110.90

112.00

pmol/l

0.13

242

1810

Parkinson's disease, strict definition, excluding more controls

287

1.86

4.65

1.2

108.82

109.34

pmol/l

0.02

287

Pneumonia due to Streptococcus pneumoniae

2.60

4.64

1.3

1.1

100.88

104.87

pmol/l

0.13

Metatarsalgia

331

1.82

4.63

1.6

1.2

112.35

116.18

pmol/l

0.22

331

Panhypopituitarism

3.39

4.63

1.3

1.2

121.94

98.96

pmol/l

0.64

Primary gonarthrosis, bilateral

277

1764

1.32

4.61

1.2

101.93

109.42

pmol/l

1.72

277

1764

Hypoplasia of dental enamel , including avohilmo

2.55

4.60

1.3

1.2

112.08

121.90

pmol/l

0.41

Alcohol use disorder, Swedish definition

271

1871

1.32

4.60

1.2

95.25

109.53

pmol/l

5.19

271

1871

Tubulo-interstitial nephritis, not specified as acute or chronic

199

2.07

4.59

1.1

96.07

111.40

pmol/l

1.48

199

Other or unspecified common variable immunodeficiency

10.58

4.59

2.5

1.5

134.13

117.25

pmol/l

—

Chondropathies

519

1.65

4.58

1.2

107.95

111.25

pmol/l

0.29

519

Emotional disorders starting during childhood or adolecense, excluding more controls

100

2.54

4.58

1.3

1.1

109.92

124.62

pmol/l

0.85

100

Dermatitis due to substances taken internally

186

2.11

4.58

1.3

1.1

111.67

110.36

pmol/l

0.06

186

Benign neoplasm: Transverse colon

347

1.80

4.57

1.5

1.2

105.44

103.99

pmol/l

0.09

347

Neuralgia and neuritis, unspecified

147

2.26

4.57

1.4

1.1

101.61

114.76

pmol/l

0.82

147

Paralytic ileus

2.63

4.57

1.2

86.92

106.20

pmol/l

1.08

Other secondary coxarthrosis

2.58

4.56

1.2

103.00

107.40

pmol/l

0.19

Juvenile osteochondrosis

2.58

4.56

1.1

100.52

113.24

pmol/l

0.83

Radiculopathy

512

1.65

4.56

1.1

1.2

105.48

107.88

pmol/l

0.17

512

Coronary atherosclerosis

314

1526

1.30

4.55

1.2

90.38

110.78

pmol/l

11.00

314

1526

Diseases of peritoneum

333

1.81

4.55

1.2

86.63

107.47

pmol/l

2.93

333

Problems related to lifestyle

297

1.86

4.54

1.3

1.2

97.13

111.34

pmol/l

1.26

297

Transport accidents

254

1592

1.33

4.54

1.2

109.90

114.67

pmol/l

0.88

254

1592

Valvular operations

348

1.79

4.52

1.2

95.06

108.91

pmol/l

1.55

348

Other diseases of stomach and duodenum

187

2.10

4.52

2.0

1.2

104.08

105.16

pmol/l

0.05

187

Melanocytic naevi

179

1283

1.40

4.51

1.2

114.87

112.29

pmol/l

0.34

179

1283

Leisure time condition

103

662

1.56

4.50

1.1

1.2

100.66

108.53

pmol/l

1.07

103

662

Postviral fatigue syndrome

5.36

4.49

1.1

1.0

135.42

120.09

pmol/l

0.44

Complications following infusion, transfusion and therapeutic injection

3.47

4.49

1.5

1.1

112.27

114.23

pmol/l

0.04

COPD (mode)

128

667

1.50

4.49

1.1

93.71

108.25

pmol/l

1.99

128

667

Benign neoplasm of thyroid gland

105

2.51

4.48

1.2

1.1

108.92

108.79

pmol/l

0.00

105

Benign neoplasm: Parathyroid gland

4.49

4.48

1.3

1.2

111.07

106.91

pmol/l

0.10

Hepatomegaly and splenomegaly, not elsewhere classified

5.93

4.47

1.4

1.2

109.73

110.84

pmol/l

0.02

Intestinal adhesions without obstruction

264

1.91

4.44

1.3

1.2

97.82

108.27

pmol/l

1.00

264

Other and unspecified urticaria

115

760

1.52

4.44

1.3

1.2

108.70

114.50

pmol/l

0.65

115

760

Calcific aortic valvular stenosis, operated

136

894

1.47

4.43

1.2

90.89

100.38

pmol/l

1.24

136

894

Calcific aortic valvular stenosis

136

894

1.47

4.43

1.2

90.89

100.38

pmol/l

1.24

136

894

Autoimmune hyperthyroidism

202

2.04

4.43

1.2

108.95

111.57

pmol/l

0.13

202

Type 1 diabetes

130

880

1.48

4.43

1.3

1.2

92.45

115.66

pmol/l

4.50

130

880

Conjunctivitis (acute, non atopic)

163

1149

1.42

4.41

1.3

1.2

121.67

112.69

pmol/l

0.34

163

1149

Mouth breathing

204

1498

1.36

4.40

1.2

113.85

109.35

pmol/l

0.70

204

1498

Crossbite

217

1.96

4.39

1.5

1.1

119.02

114.63

pmol/l

0.29

217

Common variable immunodeficiency

7.75

4.39

2.3

1.3

131.00

109.42

pmol/l

—

Irregular menses

315

1841

1.29

4.39

1.2

118.37

117.08

pmol/l

0.17

315

1841

Other bursopathies

419

1.70

4.37

1.2

108.18

109.93

pmol/l

0.10

419

Drug-induced cataract

2.77

4.37

1.5

1.1

100.10

108.79

pmol/l

0.47

Viral warts

360

1.76

4.35

1.4

1.2

115.33

110.67

pmol/l

0.38

360

Thyrotoxicosis with diffuse goitre

542

1.61

4.35

1.2

111.37

116.04

pmol/l

0.46

542

Restless leg syndrome

550

1.61

4.35

1.1

1.2

109.01

108.56

pmol/l

0.03

550

Congenital malformations of the respiratory system

3.38

4.34

1.3

1.2

143.13

99.07

pmol/l

1.77

Calcific aortic valvular stenosis, diagnosis (helper)

135

892

1.46

4.30

1.2

90.85

100.37

pmol/l

1.23

135

892

Operations 2 for CAVS

135

892

1.46

4.30

1.2

90.85

100.37

pmol/l

1.23

135

892

Disorders of optic nerve and visual pathways

325

1.80

4.29

1.3

1.2

116.57

111.26

pmol/l

0.30

325

Other viral diseases, not elsewhere classified, including avohilmo

151

1054

1.43

4.28

1.4

1.2

111.04

114.21

pmol/l

0.34

151

1054

Pleural effusion

460

1.66

4.26

1.3

1.2

104.11

99.82

pmol/l

0.25

460

Inflammatory bowel disease

173

1246

1.39

4.26

1.1

1.2

108.26

111.57

pmol/l

0.39

173

1246

Other shoulder lesions

304

1.82

4.25

1.6

1.2

105.24

111.67

pmol/l

0.40

304

Cellulitis

120

808

1.49

4.25

1.2

104.98

108.35

pmol/l

0.32

120

808

Abnormal results of function studies

297

1.83

4.24

1.1

1.2

110.41

107.19

pmol/l

0.16

297

Fracture of forearm

323

2283

1.27

4.23

1.2

113.51

111.94

pmol/l

0.22

323

2283

Convulsions, not elsewhere classified

111

727

1.51

4.21

1.2

100.85

117.56

pmol/l

2.20

111

727

Atherosclerosis, excluding cerebral and coronary sclerosis

186

1061

1.38

4.21

1.2

92.78

103.48

pmol/l

0.49

186

1061

Personal history of certain other diseases

3.30

4.20

1.4

1.2

125.87

117.63

pmol/l

0.34

Peripheral artery operations in Hilmo

349

1.75

4.19

1.9

1.2

77.26

101.64

pmol/l

3.99

349

Sequelae with surgical and medical care as external cause

111

738

1.51

4.19

1.4

1.2

99.51

107.83

pmol/l

1.19

111

738

Calcific aortic valvular stenosis, including rheumatic fever

135

896

1.45

4.19

1.2

90.85

100.35

pmol/l

1.23

135

896

Infective bursitis

2.93

4.18

1.2

1.1

88.61

104.55

pmol/l

0.81

Other immunodeficiencies

4.44

4.16

1.1

1.2

136.69

109.73

pmol/l

0.66

Suggestive for eosinophilic asthma

292

1.83

4.15

1.1

1.2

100.68

108.46

pmol/l

0.77

292

Other pulmonary heart/vessel disease

128

2.29

4.13

1.1

90.48

103.43

pmol/l

0.88

128

Volvulus

2.82

4.13

1.1

1.2

113.37

114.46

pmol/l

0.03

Other and unspecified mood [affective] disorders

215

1.97

4.10

1.2

1.1

101.88

116.83

pmol/l

1.35

215

Conductive and sensorineural hearing loss

423

2277

1.23

4.09

1.2

107.15

109.57

pmol/l

0.48

423

2277

Benign paroxysmal vertigo

165

1188

1.39

4.09

1.2

111.97

109.76

pmol/l

0.22

165

1188

8.18

4.08

1.1

1.0

91.63

107.50

pmol/l

—

Cystic fibrosis

10.69

4.08

1.1

1.4

105.57

122.43

pmol/l

—

Other disorders of nervous system

195

2.01

4.08

1.2

101.51

106.06

pmol/l

0.22

195

Chronic nephritic syndrome

104

2.43

4.07

1.2

1.1

76.20

106.83

pmol/l

2.14

104

Other and unspecified disorders of skin and subcutaneous tissue

209

1.98

4.06

1.3

1.1

104.59

107.33

pmol/l

0.14

209

Crohn's disease of small intestine

216

1.96

4.06

1.0

1.1

106.79

111.72

pmol/l

0.29

216

Pericarditis

2.58

4.06

1.1

95.86

112.36

pmol/l

0.73

Major coronary heart disease event excluding revascularizations

280

1428

1.30

4.05

1.3

1.2

98.48

109.33

pmol/l

0.86

280

1428

Other vitreous opacities

123

2.30

4.04

1.2

1.1

122.57

108.54

pmol/l

0.64

123

Other and unspecified drugs and medicaments

295

1.81

4.03

1.2

104.38

108.01

pmol/l

0.18

295

D07AA Corticosteroids, weak (group I)

560

1.58

4.03

1.2

115.50

113.31

pmol/l

0.16

560

Angina pectoris

262

1333

1.31

4.03

1.2

95.87

110.21

pmol/l

5.29

262

1333

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

136

2.22

4.02

1.4

1.1

111.27

115.07

pmol/l

0.16

136

Polymyalgia rheumatica

430

1.66

4.00

1.3

1.2

96.99

105.93

pmol/l

0.66

430

Kela-code for severe mental illness

192

1422

1.35

4.00

1.2

98.68

112.59

pmol/l

3.75

192

1422

Other specified and unspecified personality disorders

303

1.79

4.00

1.4

1.2

112.74

112.06

pmol/l

0.03

303

Familial hypercholesterolemia

377

1.70

4.00

1.3

1.2

100.05

110.82

pmol/l

0.64

377

Early onset COPD

111

746

1.49

3.99

1.2

101.78

107.89

pmol/l

0.53

111

746

Chronic periodontitis, including avohilmo

558

2973

1.20

3.99

1.3

1.2

105.60

111.17

pmol/l

1.86

558

2973

Glaucoma

290

1926

1.28

3.99

1.3

1.2

108.81

107.04

pmol/l

0.24

290

1926

Iridocyclitis in diseases classified elsewhere

3.06

3.98

2.2

1.2

109.75

109.45

pmol/l

0.01

ILD-related respiratory insufficiency

2.56

3.98

1.3

1.2

86.77

99.09

pmol/l

0.75

Syphilis

2.84

3.97

1.3

1.2

88.44

101.27

pmol/l

0.54

Syphilis, including avohilmo

2.84

3.97

1.3

1.2

88.44

101.27

pmol/l

0.54

Biguanides

534

2681

1.20

3.97

1.3

1.2

101.79

113.36

pmol/l

2.22

534

2681

Wide developmental disorders, excluding more controls

2.62

3.96

1.2

109.81

125.77

pmol/l

0.82

Seborrhoeic keratosis

134

936

1.44

3.96

1.4

1.2

110.83

110.86

pmol/l

0.00

134

936

Other hammer toe(s) (acquired)

525

1.56

3.96

1.2

111.78

110.35

pmol/l

0.11

525

Diseases of pulp and periapical tissues and dental caries

352

1433

1.26

3.96

1.2

109.94

110.70

pmol/l

0.05

352

1433

Other crystal arthropathies

3.17

3.94

1.3

113.80

101.37

pmol/l

0.44

Diseases of inner ear

293

2203

1.27

3.94

1.2

110.56

109.31

pmol/l

0.17

293

2203

Other contact dermatitis

261

1.85

3.94

1.1

115.67

109.81

pmol/l

0.32

261

Benign neoplasm of other and ill-defined parts of digestive system

101

668

1.52

3.93

1.2

109.92

111.09

pmol/l

0.07

101

668

Systemic lupus erythematosus, unspecified

106

2.39

3.92

1.1

109.80

115.36

pmol/l

0.23

106

Postprocedural disorders of nervous system

240

1.89

3.92

1.1

1.2

116.78

115.54

pmol/l

0.04

240

Persons with potential health hazards related to communicable diseases

206

1534

1.33

3.90

1.4

1.2

111.14

116.56

pmol/l

0.96

206

1534

Postmenopausal bleeding

155

573

1.42

3.88

1.5

1.2

111.74

112.11

pmol/l

0.02

155

573

Open wound of head

277

2034

1.28

3.88

1.2

105.09

109.37

pmol/l

0.78

277

2034

Defects in the complement system

5.43

3.86

1.1

1.3

119.50

101.42

pmol/l

—

Congenital malformations and deformations of the musculoskeletal system

312

1.76

3.86

1.3

1.2

124.07

114.34

pmol/l

0.94

312

Osteopathy in diseases classified elsewhere

5.42

3.86

1.0

1.1

155.00

108.21

pmol/l

—

Other and unspecified mental retardation

3.27

3.86

1.6

1.3

110.43

116.37

pmol/l

0.19

Cystic fibrosis with intestinal manifestations

13.22

3.85

1.2

1.4

106.83

127.60

pmol/l

—

Disorders of muscles

314

1.76

3.85

1.1

1.2

109.25

109.90

pmol/l

0.03

314

Cystic fibrosis, other manifestations/unspecified

13.13

3.85

1.2

102.83

117.00

pmol/l

—

Hernia of abdominal wall

230

1760

1.31

3.85

1.3

1.2

105.55

109.77

pmol/l

0.64

230

1760

Mild mental retardation

2.71

3.84

1.2

88.11

110.31

pmol/l

1.29

Other cranial nerve disorders in other disorders

9.31

3.84

3.1

1.5

115.71

100.00

pmol/l

—

Periodontitis

557

2976

1.19

3.84

1.3

1.2

105.48

111.18

pmol/l

1.93

557

2976

Wet age-related macular degeneration

555

1.55

3.82

1.1

1.2

100.16

100.44

pmol/l

0.02

555

Follow-up examination after treatment for malignant neoplasms

257

1.84

3.79

1.3

1.2

117.85

110.86

pmol/l

0.22

257

Late syphilis, including avohilmo

3.23

3.79

1.1

1.2

79.57

105.27

pmol/l

1.12

Myocardial infarction

220

1163

1.32

3.79

1.3

1.2

99.30

109.26

pmol/l

0.56

220

1163

Bullous disorders

180

2.02

3.79

1.2

103.36

107.26

pmol/l

0.22

180

Congenital malformations of trachea and bronchus

4.69

3.77

1.2

136.09

98.79

pmol/l

1.06

Primary biliary cholangitis, wide definition

2.76

3.77

2.8

1.1

91.44

103.86

pmol/l

0.55

Secondary parkinsonism, excluding more controls

2.76

3.76

1.1

1.2

115.28

105.68

pmol/l

0.24

Other and unspecified nonorganic psychotic disorders

103

691

1.50

3.76

1.2

102.89

114.39

pmol/l

1.92

103

691

Other and unspecified local infections of skin and subcutaneous tissue

324

1.74

3.76

1.2

109.59

108.04

pmol/l

0.09

324

Other congenital malformations

309

1.76

3.76

1.2

120.76

112.86

pmol/l

0.65

309

Herpesviral [herpes simplex] infections, including avohilmo

152

1097

1.39

3.75

1.3

1.2

118.03

114.23

pmol/l

0.37

152

1097

L02BA Anti-estrogens

104

700

1.49

3.75

1.3

1.2

127.04

114.62

pmol/l

0.30

104

700

Congenital malformations of the respiratory system, including avohilmo

2.95

3.75

1.3

1.1

139.00

100.13

pmol/l

1.58

Substance use, excluding alcohol

103

692

1.49

3.74

1.3

1.2

106.74

113.98

pmol/l

0.72

103

692

Speech and linguistic disorders

261

1.81

3.74

1.3

1.2

104.90

115.98

pmol/l

0.64

261

Other drug-induced secondary parkinsonism

4.24

3.73

1.1

1.2

110.58

95.07

pmol/l

0.31

Cardiodefibrillation

158

1145

1.38

3.73

1.2

99.08

104.82

pmol/l

0.67

158

1145

Cushing syndrome

4.22

3.73

1.0

1.2

93.58

104.69

pmol/l

0.48

Other and unspecified glaucoma

216

1.91

3.72

1.5

1.2

98.85

99.57

pmol/l

0.03

216

Diffuse large B-cell lymphoma

141

2.15

3.71

1.3

1.2

109.87

102.45

pmol/l

0.30

141

Diffuse large B-cell lymphoma, helper endpoint

141

2.15

3.71

1.3

1.2

109.87

102.45

pmol/l

0.30

141

Diffuse large B-cell lymphoma, including Hilmo

141

2.15

3.71

1.3

1.2

109.87

102.45

pmol/l

0.30

141

Convalescence

161

2.06

3.71

1.4

1.1

107.03

113.60

pmol/l

0.34

161

Abnormal findings on examination of urine, without diagnosis

128

2.21

3.71

1.1

83.32

105.60

pmol/l

1.70

128

Crystal arthropathies, rheuma endpoint

3.04

3.70

1.3

113.80

99.08

pmol/l

0.55

Fracture of neck

168

2.04

3.70

1.1

1.2

102.35

105.57

pmol/l

0.15

168

Disorders of pituitary gland, other and/or unspecified

5.81

3.70

1.2

1.3

108.56

105.50

pmol/l

—

IBD patients in KELA-register

123

858

1.44

3.69

1.2

107.96

113.07

pmol/l

0.55

123

858

Sulfonylureas

147

836

1.40

3.69

1.5

1.2

79.69

106.62

pmol/l

9.67

147

836

Diabetic maculopathy, excluding more controls

311

1.74

3.69

1.2

1.1

69.83

109.56

pmol/l

7.40

311

Other disorders of optic [2nd] nerve and visual pathways

203

1.93

3.67

1.4

1.1

111.85

108.37

pmol/l

0.17

203

Uterine polyps

165

699

1.38

3.66

1.3

1.1

119.88

114.35

pmol/l

0.29

165

699

Phlebitis and thrombophlebitis (not including DVT)

120

835

1.44

3.65

1.3

1.2

99.24

112.27

pmol/l

2.17

120

835

Corticotropin deficiency

4.52

3.65

1.3

1.2

127.45

94.36

pmol/l

1.31

Other diseases of spinal cord

2.50

3.64

1.5

1.2

111.90

104.64

pmol/l

0.37

Symptoms and signs involving emotional state

2.49

3.64

1.2

1.1

108.62

114.81

pmol/l

0.18

Hyperosmolality and hypernatraemia

4.47

3.64

1.2

60.27

100.56

pmol/l

2.74

Right bundle-branch block

2.49

3.63

1.1

1.2

96.19

112.08

pmol/l

0.73

Malignant neoplasm of skin, including Hilmo

262

1367

1.29

3.63

1.2

114.07

106.02

pmol/l

0.53

262

1367

Exclusion endpoint for clefts

2.89

3.63

1.3

1.2

98.00

114.29

pmol/l

0.71

Cerebrovascular diseases

368

2070

1.23

3.63

1.1

1.2

99.36

108.68

pmol/l

2.73

368

2070

L04AC Interleukin inhibitors

211

1.91

3.63

1.3

1.2

106.85

112.27

pmol/l

0.30

211

Ulcerative ileocolitis

110

2.29

3.62

1.2

1.1

108.28

110.95

pmol/l

0.08

110

Other problems related to primary support group, including family circumstances

415

1.62

3.61

1.1

1.2

110.06

117.53

pmol/l

0.62

415

Other embolism and thrombosis

404

1.64

3.61

1.1

1.2

107.52

111.56

pmol/l

0.21

404

Personal history of malignant neoplasm

336

1.71

3.60

1.2

108.51

115.27

pmol/l

0.51

336

Injuries to the neck

125

879

1.43

3.60

1.2

115.23

110.11

pmol/l

0.58

125

879

Nasal polyp

601

1.52

3.60

1.5

1.2

100.73

105.77

pmol/l

0.60

601

Orthopaedic devices associated with adverse incidents

2.99

3.59

1.3

1.1

95.33

102.20

pmol/l

0.20

Chronic conjunctivitis

2.37

3.59

1.3

1.1

100.83

108.43

pmol/l

0.40

Pyogenic arthritis

170

2.01

3.59

1.1

1.3

80.74

105.96

pmol/l

2.89

170

Hypermobility syndrome

205

1.92

3.58

1.2

1.1

118.92

117.71

pmol/l

0.05

205

Chronic tubulo-interstitial nephritis

117

2.24

3.58

1.1

81.54

116.39

pmol/l

2.86

117

Oter anti-inflammatory and antirheumatic agents, non-steroids

101

367

1.52

3.58

1.3

103.90

99.89

pmol/l

0.41

101

367

Systemic sclerosis (FG)

2.68

3.58

1.7

1.2

90.61

111.06

pmol/l

1.01

Other/unspecified rheumatoid arthritis

413

1.63

3.57

1.3

1.2

100.57

107.33

pmol/l

0.68

413

Subjective visual disturbances

142

1023

1.39

3.57

1.1

1.2

115.18

111.16

pmol/l

0.40

142

1023

Hypoplasia of dental enamel, prenatal

10.78

3.56

1.7

75.50

136.00

pmol/l

—

Other congenital malformations of skin, including avohilmo

285

1.76

3.56

1.2

1.1

123.36

109.73

pmol/l

1.63

285

Persistent mood disorders

102

692

1.48

3.55

1.2

107.83

113.69

pmol/l

0.65

102

692

Congenital malformation of biliary tract

10.53

3.54

1.2

1.5

89.67

143.17

pmol/l

—

Cyst of Bartholin Gland

144

2.10

3.54

1.1

151.27

114.62

pmol/l

1.47

144

Pulmonary embolism

146

1058

1.38

3.54

1.2

103.62

108.22

pmol/l

0.40

146

1058

Cholesteatoma of external ear

5.43

3.54

1.1

1.3

306.11

95.88

pmol/l

—

Squamous cell neoplasms and carcinomas of the skin

256

1.80

3.53

1.0

1.3

93.00

97.96

pmol/l

0.38

256

Malignant neoplasm of skin

245

1287

1.29

3.52

1.1

1.2

112.88

105.75

pmol/l

0.42

245

1287

Sleep disorders, other/unspecified

118

2.22

3.52

1.5

1.1

105.08

110.69

pmol/l

0.28

118

Cachexia

10.23

3.52

1.0

1.2

93.67

86.00

pmol/l

—

Lateral epicondylitis

455

1.59

3.48

1.2

113.60

115.82

pmol/l

0.16

455

Mastocytosis

4.73

3.48

1.0

1.2

146.00

106.09

pmol/l

—

Other specified congenital malformation syndromes affecting multiple systems

2.93

3.48

1.3

1.2

99.47

116.33

pmol/l

0.69

Polycystic kidney disease

2.56

3.48

1.3

1.1

80.26

108.44

pmol/l

1.76

Unstable angina pectoris

155

889

1.37

3.47

1.3

1.2

95.51

108.37

pmol/l

2.96

155

889

Paracetamol or NSAID medication

242

1.61

3.47

1.2

102.65

110.87

pmol/l

0.84

242

Benign neoplasm of eye and adnexa

363

1.66

3.45

1.2

105.18

107.18

pmol/l

0.17

363

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

448

1.59

3.45

1.6

1.2

86.94

103.85

pmol/l

1.72

448

Ulcerative colitis, NAS

472

1.57

3.44

1.0

1.2

111.41

110.23

pmol/l

0.07

472

Myositis

2.79

3.43

1.1

105.19

105.02

pmol/l

0.01

Burns and corrosions of external body surface, specified by site

341

1.68

3.42

1.2

114.86

110.99

pmol/l

0.29

341

Sensorineural hearing loss

391

2141

1.22

3.42

1.2

107.56

109.22

pmol/l

0.28

391

2141

Bronchiectasis

259

1.79

3.42

1.3

1.2

115.91

106.80

pmol/l

0.47

259

Bell's palsy

395

1.63

3.41

1.1

1.2

102.86

107.88

pmol/l

0.39

395

Pilonidal cyst

252

1.79

3.40

1.2

1.1

101.09

112.10

pmol/l

0.86

252

Retinal detachments and breaks

175

1314

1.34

3.40

1.2

108.70

108.83

pmol/l

0.01

175

1314

296

2063

1.25

3.40

1.2

96.11

110.46

pmol/l

5.73

296

2063

Allergic contact dermatitis due to drugs in contact with skin

2.61

3.40

1.1

103.67

108.54

pmol/l

0.13

Pulmonary heart disease

146

1066

1.37

3.40

1.2

103.62

108.05

pmol/l

0.39

146

1066

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

7.23

3.39

2.6

1.0

104.57

113.30

pmol/l

—

Injuries to the ankle and foot

412

2918

1.21

3.39

1.2

111.59

113.20

pmol/l

0.29

412

2918

Post-traumatic stress disorder

282

1.75

3.38

1.2

131.57

119.56

pmol/l

0.75

282

Psoriatic arthropathies, ICD10

350

1.67

3.38

1.2

106.84

109.49

pmol/l

0.16

350

Orchitis and epididymitis

188

1.92

3.37

1.2

101.75

97.91

pmol/l

0.17

188

Other and/or unspecified nontoxic goitre

290

1.73

3.37

1.2

109.08

111.36

pmol/l

0.11

290

Visual impairment including blindness (binocular or monocular)

224

1.84

3.36

1.2

1.1

102.51

106.41

pmol/l

0.23

224

Vitamin B12 deficiency anaemia

320

1.70

3.36

1.1

1.2

123.28

109.57

pmol/l

0.69

320

Fracture of lower leg, including ankle

297

2345

1.25

3.36

1.2

105.64

111.97

pmol/l

1.52

297

2345

Other Crohn's disease

210

1.87

3.35

1.0

1.1

101.08

112.13

pmol/l

0.71

210

Malignant melanoma, including Hilmo

539

1.53

3.35

1.1

1.2

114.04

104.45

pmol/l

1.14

539

Injuries to the shoulder and upper arm

468

3030

1.19

3.34

1.2

106.97

110.81

pmol/l

0.97

468

3030

Ingrowing nail

168

1.98

3.34

1.2

1.1

103.91

106.45

pmol/l

0.12

168

Lung transplant status

4.47

3.34

1.4

1.3

103.10

103.83

pmol/l

—

Lung transplantation

4.47

3.34

1.4

1.3

103.10

103.83

pmol/l

—

Dermatographic urticaria

254

1.78

3.33

1.1

121.11

113.86

pmol/l

0.35

254

Other disorders of electrolyte and fluid balance, not elsewhere classified

4.44

3.33

1.1

1.3

88.60

100.70

pmol/l

—

Other specified/unspecified necrotizing vasculopathies

3.48

3.33

1.0

1.1

103.15

101.13

pmol/l

0.06

Lesion of ulnar nerve

476

1.56

3.33

1.3

1.2

110.05

108.10

pmol/l

0.13

476

Pollen allergy

104

708

1.45

3.33

1.5

1.2

122.70

117.74

pmol/l

0.49

104

708

Adhesive capsulitis of shoulder

580

1.51

3.33

1.4

1.2

110.03

111.38

pmol/l

0.08

580

Corns and callosities

225

1.83

3.32

1.4

1.2

107.61

107.76

pmol/l

0.01

225

141

880

1.38

3.32

1.1

1.2

94.35

103.33

pmol/l

1.35

141

880

Congenital malformations of gallbladder, bile ducts and liver

3.72

3.32

1.9

1.2

92.50

107.30

pmol/l

0.50

Non-follicular lymphoma

299

1.71

3.31

1.4

1.2

122.98

98.91

pmol/l

2.02

299

Methotrexate

469

1.56

3.31

1.3

1.2

105.08

113.09

pmol/l

0.78

469

Acquired absence of organs, not elsewhere classified

4.00

3.30

1.0

1.2

104.27

102.79

pmol/l

0.03

Myocardial infarction, strict

197

1062

1.31

3.30

1.3

1.2

99.12

109.66

pmol/l

0.52

197

1062

Crowding of teeth, including avohilmo

252

1.72

3.29

1.1

1.2

114.67

118.42

pmol/l

0.22

252

Other psoriatic arthropathies

345

1.66

3.29

1.2

107.07

109.49

pmol/l

0.14

345

Other and unspecified vascular occlusions

277

1.74

3.29

1.3

1.2

96.17

107.09

pmol/l

0.62

277

Organ-limited amyloidosis

8.80

3.28

1.0

1.4

108.17

111.29

pmol/l

—

Disorders of optic nerve, not elsewhere classified

2.81

3.27

1.3

1.1

101.00

101.09

pmol/l

0.00

Social phobias

248

1.78

3.26

1.2

1.1

116.84

119.29

pmol/l

0.12

248

Glaucoma suspect

188

1435

1.31

3.26

1.2

113.54

107.78

pmol/l

0.81

188

1435

Inflammatory bowel disease, strict (require KELA)

123

880

1.40

3.26

1.2

107.96

111.54

pmol/l

0.36

123

880

Foreign body in alimentary tract

149

2.03

3.25

1.6

1.1

97.70

108.50

pmol/l

0.75

149

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

2.31

3.25

1.2

108.91

116.09

pmol/l

0.24

Secondary uncertain malignant neoplasm

377

1.62

3.25

1.2

110.41

103.12

pmol/l

0.46

377

Secondary and unspecified malignant neoplasm of lymph nodes

234

1.80

3.25

1.2

112.14

104.74

pmol/l

0.39

234

Macular pucker

519

1.53

3.25

1.2

106.87

104.08

pmol/l

0.19

519

Other blood glucose lowering drugs, excl. Insulins

503

1.54

3.25

1.8

1.2

85.86

106.01

pmol/l

4.08

503

Other neurotic disorders

129

2.11

3.24

1.1

1.2

106.41

105.35

pmol/l

0.03

129

COPD-related respiratory insufficiency

339

1.66

3.24

1.1

1.2

91.13

98.99

pmol/l

0.53

339

Other local infections of skin and subcutaneous tissue

347

1.65

3.23

1.2

110.70

107.39

pmol/l

0.21

347

Superficial injury of head

127

914

1.39

3.23

1.2

105.84

112.59

pmol/l

0.75

127

914

Fibrosis and cirrhosis of liver

242

1.79

3.22

1.9

1.2

91.19

104.96

pmol/l

1.14

242

Disorders of myoneural junction and muscle in diseases classified elsewhere

4.27

3.22

1.8

1.2

104.70

104.83

pmol/l

—

Diabetes insipidus

4.26

3.22

1.5

1.2

120.40

110.21

pmol/l

—

Unspecified contracted kidney

6.53

3.21

1.0

1.4

67.00

108.55

pmol/l

—

Postmenopausal atrophic vaginitis

149

592

1.38

3.21

1.2

1.1

120.05

112.50

pmol/l

0.39

149

592

DVT of lower extremities

642

1.47

3.21

1.2

96.74

110.59

pmol/l

1.50

642

Emotional disorders and disorders of social functioning with onset specific to childhood

140

2.04

3.19

1.3

1.2

109.17

120.57

pmol/l

0.71

140

Other menopausal disorders

156

640

1.36

3.18

1.1

112.45

112.16

pmol/l

0.02

156

640

Mucosal proctocolitis

419

1.58

3.16

1.1

1.2

106.02

110.54

pmol/l

0.32

419

Lichen planus

483

1.54

3.15

1.1

1.2

101.45

110.38

pmol/l

0.95

483

Trigger finger

523

1.52

3.14

1.1

1.2

108.92

112.12

pmol/l

0.22

523

Crohn disease (strict definition, all UC cases excluded)

158

1.98

3.14

1.3

1.1

106.00

113.09

pmol/l

0.43

158

Superficial injury of wrist and hand

114

811

1.41

3.13

1.2

112.71

114.89

pmol/l

0.20

114

811

Acquired absence of limb

4.58

3.13

1.1

1.2

68.56

111.35

pmol/l

—

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

402

1.59

3.13

1.3

1.2

122.89

114.25

pmol/l

0.91

402

Effects of foreign body entering through natural orifice

116

828

1.40

3.13

1.4

1.2

110.01

108.28

pmol/l

0.14

116

828

Late syphilis

3.49

3.12

1.1

1.2

79.67

104.86

pmol/l

0.93

Caries of dentine, including avohilmo

419

1782

1.20

3.12

1.2

110.34

110.92

pmol/l

0.04

419

1782

Encephalitis

2.31

3.11

1.1

112.29

107.80

pmol/l

0.13

Iron deficiency

105

2.21

3.10

1.2

1.1

117.65

112.21

pmol/l

0.28

105

Disorder of the sleep-wake schedule

2.83

3.10

2.0

1.2

117.14

107.16

pmol/l

0.33

Other ulcerative colitis

173

1.92

3.09

1.1

99.82

107.92

pmol/l

0.54

173

Benign neoplasm: Tongue

2.35

3.09

1.3

1.1

91.10

100.90

pmol/l

0.40

Peripheral arterial reconstruction

469

1.54

3.09

1.2

73.82

104.12

pmol/l

5.30

469

Spirochaetal infections, other/unspecified

298

1.69

3.08

1.2

108.14

107.54

pmol/l

0.03

298

Diabetic neuropathy

350

1.63

3.08

1.1

1.2

83.14

100.23

pmol/l

1.39

350

Anankastic personality disorder

132

2.06

3.07

1.7

1.1

123.74

113.36

pmol/l

0.46

132

Herpesviral keratitis and keratoconjunctivitis

132

2.06

3.07

1.3

1.2

121.89

106.36

pmol/l

0.60

132

Other noninflammatory disorders of uterus, except cervix

120

571

1.41

3.07

1.2

1.1

112.46

112.42

pmol/l

0.00

120

571

Malnutrition

2.61

3.05

1.3

1.2

102.50

101.53

pmol/l

0.02

Other specified disorders of muscle

2.52

3.05

1.0

1.1

111.06

116.25

pmol/l

0.14

Delirium, not induced by alcohol and other psychoactive substances

383

1.59

3.04

1.1

1.2

83.54

106.28

pmol/l

2.51

383

therapeutic use

2.28

3.04

1.2

1.1

100.43

110.35

pmol/l

0.38

Other inflammatory liver diseases

210

1.82

3.04

2.0

1.1

112.68

106.15

pmol/l

0.16

210

Ulcerative enterocolitis

2.28

3.04

1.0

1.1

128.19

109.35

pmol/l

0.92

Acidosis

2.92

3.03

1.0

1.2

85.69

105.93

pmol/l

1.01

Amputation of toe

203

1.83

3.03

1.4

1.2

68.65

100.19

pmol/l

4.86

203

Degenerative macular diseases

377

1.60

3.02

1.3

1.2

113.03

108.54

pmol/l

0.19

377

Superficial injury of lower leg

144

1072

1.35

3.01

1.2

110.66

114.85

pmol/l

0.43

144

1072

Glucosamine medication

230

1450

1.27

3.01

1.2

101.07

107.04

pmol/l

1.17

230

1450

Nonhereditary hypogammaglobulinemia

3.62

3.01

1.2

1.1

147.09

112.39

pmol/l

0.67

Retinal vascular occlusion

354

1.62

3.01

1.4

1.2

96.46

106.34

pmol/l

0.66

354

Amyloidosis, other/unspecified

2.78

3.00

1.6

1.1

83.79

114.25

pmol/l

1.78

Any operation in hilmo

2.83

3.00

1.0

1.1

114.25

121.59

pmol/l

0.25

Eosinophilic disease (BM)

3.89

2.99

1.0

1.1

100.70

109.12

pmol/l

—

Systemic sclerosis

2.43

2.98

1.7

1.1

90.61

110.99

pmol/l

1.07

Secondary parkinsonism

2.42

2.98

1.1

115.28

103.27

pmol/l

0.32

Secondary parkinsonism+Parkinsonism in other disease

2.42

2.98

1.1

115.28

103.39

pmol/l

0.31

Hypertrophy of breast in women and men

117

845

1.39

2.97

1.2

114.99

114.31

pmol/l

0.05

117

845

Asthma mixed form (mode), excluding more controls

127

2.06

2.96

1.2

1.1

103.19

124.00

pmol/l

0.63

127

Disorders of globe

2.56

2.96

1.4

1.1

119.62

101.25

pmol/l

1.05

Hallux valgus (acquired)

173

942

1.32

2.96

1.1

1.2

117.80

112.70

pmol/l

0.73

173

942

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

604

1.46

2.96

1.2

107.85

105.53

pmol/l

0.15

604

Optic neuritis

141

2.00

2.96

1.0

1.1

115.50

113.01

pmol/l

0.08

141

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

114

2.12

2.95

1.0

1.1

111.25

114.22

pmol/l

0.10

114

Other encephalitis

2.30

2.95

1.1

103.85

107.70

pmol/l

0.14

Other and unspecified injuries of forearm

4.80

2.93

1.3

1.1

112.75

104.47

pmol/l

—

Other disorders of eye and adnexa

540

1.49

2.93

1.1

1.2

118.22

110.36

pmol/l

0.70

540

Secondary right heart disease

121

2.08

2.93

1.1

93.52

103.68

pmol/l

0.56

121

Smoking dependency

280

1.69

2.92

1.4

1.2

106.34

110.62

pmol/l

0.24

280

Muscle strain

2.33

2.92

1.1

114.74

114.67

pmol/l

0.00

Reactive arthropathies

250

1.73

2.91

1.2

108.44

110.03

pmol/l

0.09

250

Infections with a predominantly sexual mode of transmission, including avohilmo

217

1568

1.27

2.91

1.1

1.2

110.45

117.46

pmol/l

1.63

217

1568

Autonomic disorders

2.39

2.90

1.2

109.44

110.59

pmol/l

0.04

Fenamates

331

1.53

2.90

1.2

1.3

114.84

104.09

pmol/l

0.96

331

Cardiac arrest

102

2.09

2.89

1.0

1.1

70.48

112.58

pmol/l

4.49

102

Mental and behavioural disorders due to tobacco

281

1.68

2.89

1.4

1.2

106.34

110.05

pmol/l

0.20

281

Abnormalities of gait and mobility

374

1.58

2.88

1.9

1.2

109.27

102.61

pmol/l

0.43

374

Nontoxic diffuse goitre

102

2.18

2.88

1.1

95.36

112.06

pmol/l

1.01

102

Coxarthrosis, primary

295

2002

1.22

2.87

1.2

101.33

107.66

pmol/l

1.50

295

2002

Other symptoms and signs involving the urinary system

312

1.64

2.87

1.2

106.71

104.21

pmol/l

0.11

312

Diabetic retinopathy

174

825

1.31

2.86

1.2

1.3

89.40

100.11

pmol/l

1.67

174

825

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

155

1177

1.32

2.86

1.2

105.10

116.73

pmol/l

2.36

155

1177

Retinal vascular disorders

359

1.59

2.86

1.4

1.2

96.46

106.16

pmol/l

0.65

359

Childhood allergy (age < 16)

392

1.52

2.85

1.3

1.1

124.90

120.63

pmol/l

0.31

392

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

332

1.61

2.85

1.1

1.3

91.56

95.98

pmol/l

0.38

332

Panniculitis affecting regions of neck and back

109

2.13

2.85

1.2

87.00

110.23

pmol/l

2.05

109

Female infertility, cervical, vaginal, other or unspecified origin

145

691

1.35

2.85

1.2

1.1

118.59

115.49

pmol/l

0.36

145

691

Mental and behavioural disorders due to psychoactive substance use

292

2189

1.22

2.85

1.2

99.20

110.78

pmol/l

3.73

292

2189

Fall on and from stairs and steps

136

1014

1.34

2.84

1.1

1.2

113.77

111.17

pmol/l

0.26

136

1014

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

585

1.46

2.84

1.1

104.76

114.57

pmol/l

1.09

585

Rash and other nonspecific skin eruption

321

1.63

2.83

1.2

103.37

107.51

pmol/l

0.38

321

Systemic sclerosis, icd10

2.36

2.83

1.7

1.1

90.61

110.26

pmol/l

1.01

Cholangitis (primary sclerosing, PSC)

186

1.84

2.83

1.1

93.15

106.03

pmol/l

0.83

186

Amenorrhoea

230

1.75

2.83

1.1

124.90

122.90

pmol/l

0.08

230

Contusion of toe(s) without damage to nail

2.36

2.82

1.3

1.2

123.00

111.55

pmol/l

0.36

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

619

1.44

2.81

1.1

1.2

108.47

109.85

pmol/l

0.10

619

Hypertrichosis

2.42

2.81

1.3

1.1

101.94

114.17

pmol/l

0.50

Benign neoplasm: Skin of lower limb, including hip

2.24

2.81

1.1

118.55

107.58

pmol/l

0.53

Burns and corrosions

456

1.52

2.81

1.2

113.09

110.51

pmol/l

0.19

456

Seronegative juvenile rheumatoid arthritis

2.67

2.80

1.5

1.1

92.00

112.32

pmol/l

1.36

Nonischemic cardiomyopathy

268

1.68

2.80

1.2

110.53

106.52

pmol/l

0.16

268

Meningitis

151

1.93

2.80

1.1

105.97

108.71

pmol/l

0.14

151

Routine general health check-up of defined subpopulation

2.49

2.80

1.1

124.94

115.62

pmol/l

0.25

Primary open-angle glaucoma

151

1102

1.32

2.79

1.3

1.2

109.15

104.24

pmol/l

0.57

151

1102

Malignant melanoma

481

1.50

2.79

1.1

1.2

112.74

104.60

pmol/l

0.79

481

Neovascular glaucoma

110

2.11

2.79

2.2

1.1

106.91

107.05

pmol/l

0.00

110

Malignant melanoma of skin, including Hilmo

441

1.52

2.78

1.2

116.79

104.69

pmol/l

1.30

441

Dental caries, including avohilmo

379

1620

1.20

2.77

1.2

109.95

110.19

pmol/l

0.01

379

1620

Hereditary hypogammaglobulinemia

8.59

2.77

2.2

1.5

94.80

127.50

pmol/l

—

Primary open-angle glaucoma, strict

123

905

1.36

2.76

1.2

110.50

106.18

pmol/l

0.40

123

905

Carrier of infectious disease

2.33

2.75

1.1

99.56

110.51

pmol/l

0.61

Hypoplasia of dental enamel, prenatal , including avohilmo

5.16

2.75

1.6

1.3

77.00

119.64

pmol/l

—

Substance abuse

281

2137

1.22

2.75

1.2

99.73

110.69

pmol/l

3.29

281

2137

Corneal scars and opacities

2.33

2.75

1.8

1.1

103.89

105.22

pmol/l

0.03

Speech disturbances, not elsewhere classified

293

1.65

2.74

1.2

98.29

101.78

pmol/l

0.20

293

Arthropathic psoriasis

371

1.57

2.74

1.2

107.79

109.81

pmol/l

0.12

371

Schizophrenia or delusion

158

1211

1.31

2.74

1.2

102.78

112.32

pmol/l

1.77

158

1211

Infections with a predominantly sexual mode of transmission

164

1261

1.30

2.73

1.2

107.24

118.27

pmol/l

2.63

164

1261

Magnesium deficiency

6.24

2.73

1.0

1.4

119.33

95.60

pmol/l

—

Injury of eye and orbit

476

1.50

2.71

1.3

1.2

109.17

109.97

pmol/l

0.05

476

Myopia

468

1.50

2.71

1.1

1.2

143.81

115.51

pmol/l

0.95

468

Disorders of oesophagus in diseases classified elsewhere

2.53

2.71

1.2

1.1

105.20

105.75

pmol/l

0.01

Other acute disseminated demyelination

3.51

2.71

1.1

104.30

112.41

pmol/l

—

Foreign body in respiratory tract

153

1.91

2.70

1.3

1.1

117.93

109.73

pmol/l

0.27

153

Intracranial and intraspinal abscess and granuloma

3.50

2.70

1.0

1.1

105.80

97.93

pmol/l

—

Female genital prolapse

160

676

1.32

2.70

1.2

1.1

111.06

114.26

pmol/l

0.30

160

676

Autism spe, excluding more controls

2.44

2.70

1.2

99.25

126.73

pmol/l

1.45

Schizophrenia, schizotypal and delusional disorders

158

1214

1.30

2.70

1.2

102.83

112.22

pmol/l

1.72

158

1214

Isolated proteinuria

2.30

2.68

1.1

80.22

103.86

pmol/l

1.29

Otitis externa, unspecified

405

1.54

2.68

1.1

1.2

104.73

109.90

pmol/l

0.41

405

Manic episode

2.19

2.68

1.4

1.1

84.40

113.20

pmol/l

2.39

Fracture of foot, except ankle

130

973

1.34

2.67

1.4

1.2

107.67

112.23

pmol/l

0.53

130

973

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

212

1.75

2.67

1.1

1.2

105.11

110.13

pmol/l

0.26

212

Benign neoplasm: Skin, unspecified

119

2.03

2.66

1.4

1.1

115.33

107.54

pmol/l

0.37

119

Hypertrophy of tongue papillae

2.83

2.66

1.1

125.83

109.23

pmol/l

0.72

Viral conjunctivitis, including avohilmo

133

1.97

2.66

1.3

1.1

112.46

113.35

pmol/l

0.03

133

Motorcycle rider injured in other and unspecified transport accidents

147

1.91

2.65

1.3

1.2

104.89

113.52

pmol/l

0.57

147

Thrombocytopenia, unspecified

220

1.74

2.64

1.2

104.66

104.17

pmol/l

0.02

220

Other, unspecified and serous retinal detachments

2.23

2.64

1.1

101.11

109.90

pmol/l

0.42

Allergic urticaria

304

1.62

2.64

1.1

1.2

108.84

111.32

pmol/l

0.13

304

Other peripheral vascular diseases

281

1.65

2.64

1.3

1.2

110.93

109.45

pmol/l

0.08

281

Fracture at wrist and hand level

172

1337

1.28

2.63

1.2

109.19

111.45

pmol/l

0.28

172

1337

Other and unspecified haemorrhagic conditions

2.96

2.63

1.1

1.2

139.75

106.10

pmol/l

0.87

Primary Sclerosing Cholangitis, IBD and UDCA required

2.48

2.63

1.3

1.1

94.07

116.79

pmol/l

1.54

Charcot foot

2.96

2.63

3.8

1.2

81.67

113.59

pmol/l

1.24

Malignant neoplasm of bone and articular cartilage, including Hilmo

2.58

2.63

1.3

1.2

90.64

110.47

pmol/l

1.03

Personal history of other diseases and conditions

413

1.52

2.62

1.3

1.2

125.86

118.82

pmol/l

0.63

413

Background retinopathy and retinal vascular changes

2.57

2.62

2.0

1.2

110.71

101.87

pmol/l

0.23

Ventral hernia

117

865

1.36

2.62

1.2

99.89

110.44

pmol/l

1.44

117

865

Extreme obesity with alveolar hypoventilation

120

2.01

2.61

1.0

1.1

110.25

108.15

pmol/l

0.05

120

Dislocation, sprain and strain of joints and ligaments of elbow

221

1.73

2.61

1.2

112.16

113.18

pmol/l

0.05

221

In situ neoplasms

210

1680

1.25

2.61

1.2

109.20

110.27

pmol/l

0.10

210

1680

Disorders of tooth development and eruption

462

1.45

2.60

1.3

1.2

102.49

111.99

pmol/l

0.77

462

Lichen simplex chronicus and prurigo

199

1.77

2.60

1.2

114.09

106.34

pmol/l

0.26

199

Otitis externa

120

892

1.35

2.60

1.1

1.2

121.17

110.59

pmol/l

0.29

120

892

Stenosis and insufficiency of lacrimal passages

329

1.59

2.59

1.3

1.2

103.52

107.22

pmol/l

0.26

329

Otitis media, unspecified

353

1.54

2.59

1.2

114.08

117.58

pmol/l

0.24

353

Sequelae of injuries, of poisoning and of other consequences of external causes

119

884

1.35

2.59

1.1

1.2

110.08

110.96

pmol/l

0.07

119

884

Endometriosis of rectovaginal septum and vagina

252

1.67

2.58

1.1

117.88

122.01

pmol/l

0.15

252

Acute mastoiditis

4.07

2.58

1.1

1.2

89.25

98.05

pmol/l

—

Unknown and unspecified causes of morbidity

192

1.78

2.58

1.1

1.2

121.79

112.83

pmol/l

0.68

192

Scleritis

3.10

2.58

1.2

112.09

115.64

pmol/l

0.08

Other hyperalimentation

7.38

2.57

1.2

1.4

151.00

89.29

pmol/l

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

330

1.58

2.56

1.3

1.2

101.42

107.27

pmol/l

0.39

330

Other disorders of carbohydrate metabolism

5.60

2.56

1.7

1.2

86.83

120.91

pmol/l

—

Achilles tendinitis

338

1.57

2.56

1.2

103.96

113.91

pmol/l

0.67

338

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

121

2.00

2.56

1.1

86.12

114.02

pmol/l

2.22

121

Dissociative [conversion] disorders

121

2.00

2.56

1.2

1.1

118.29

118.17

pmol/l

0.00

121

Infection due to other mycobacteria

2.76

2.56

1.3

1.1

105.50

108.41

pmol/l

0.08

Postzoster neuralgia

2.76

2.56

1.0

1.2

126.67

100.93

pmol/l

0.88

Malignant melanoma of skin

354

1.56

2.55

1.2

115.60

104.65

pmol/l

0.91

354

Vulvovaginal ulceration/inflammation in other diseases

276

1.64

2.55

1.3

1.2

119.36

118.04

pmol/l

0.06

276

Agoraphobia

2.14

2.55

1.1

118.70

119.89

pmol/l

0.03

Status post-ami

520

1.40

2.55

1.2

85.60

104.28

pmol/l

3.92

520

Type 1 diabetes, wide definition, subgroup 1

101

732

1.38

2.55

1.2

95.45

114.97

pmol/l

2.91

101

732

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

220

1190

1.25

2.54

1.1

1.2

111.98

105.17

pmol/l

0.35

220

1190

Fissure and fistula of anal and rectal regions

115

853

1.35

2.53

1.3

1.2

102.27

112.20

pmol/l

1.78

115

853

Dystonia

186

1.79

2.53

1.1

1.2

114.82

109.10

pmol/l

0.33

186

Benign neoplasm of mouth and pharynx

363

1.55

2.53

1.1

1.2

101.23

107.48

pmol/l

0.43

363

Other infectious diseases, including avohilmo

293

1.61

2.50

1.2

90.53

105.38

pmol/l

1.52

293

Other and unspecified acne

3.01

2.50

1.1

126.55

108.38

pmol/l

0.52

Haemangioma and lymphangioma, any site

309

1.59

2.49

1.1

1.2

113.53

108.54

pmol/l

0.28

309

Presbycusis

423

1.50

2.49

1.3

1.2

91.03

100.65

pmol/l

0.80

423

Anorexia (incl.atypical)

187

1.77

2.48

1.2

1.1

124.64

113.26

pmol/l

0.71

187

Benign neoplasm of meninges

373

1.54

2.47

1.3

1.2

106.96

107.08

pmol/l

0.01

373

Abnormal involuntary movements

470

1.47

2.47

1.2

106.26

108.07

pmol/l

0.13

470

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

2.48

2.46

1.0

1.2

83.93

111.09

pmol/l

1.68

Ovarian dysfunction

279

1.62

2.45

1.1

1.2

132.38

117.80

pmol/l

1.20

279

Use of interferon beta-1a

2.26

2.45

1.1

137.76

114.47

pmol/l

0.60

Mental disorders, not otherwise specified

287

1.61

2.45

1.1

107.96

113.98

pmol/l

0.51

287

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

188

1.76

2.45

1.6

1.3

117.24

102.57

pmol/l

0.87

188

Biological medication for rheuma

671

1.39

2.44

1.3

1.2

109.10

116.23

pmol/l

0.94

671

Allergic colitis

2.26

2.44

1.2

127.24

121.62

pmol/l

0.17

Use of disulfiram, acamprosate or naltrexone

241

1.67

2.44

1.2

1.1

108.20

111.60

pmol/l

0.20

241

Malignant neoplasm of corpus uteri, including Hilmo

327

1.57

2.43

1.2

107.39

108.51

pmol/l

0.07

327

Ulcerative colitis

121

912

1.33

2.41

1.1

1.2

109.66

111.91

pmol/l

0.18

121

912

Other and unspecified disorders of psychological development

3.40

2.40

1.1

1.2

100.67

112.46

pmol/l

—

Otalgia

312

1.58

2.40

1.4

1.2

104.49

112.23

pmol/l

0.61

312

Unspecified urinary incontinence

320

1.57

2.40

1.8

1.2

90.06

109.78

pmol/l

3.25

320

Sulfasalazine

130

991

1.31

2.40

1.2

104.89

114.54

pmol/l

1.55

130

991

Other coagulation defects

250

1.65

2.39

1.1

111.24

109.26

pmol/l

0.09

250

Type 1 diabetes, wide definition

105

775

1.36

2.39

1.2

97.27

114.07

pmol/l

2.35

105

775

Hyperhidrosis

2.13

2.39

1.1

105.53

117.87

pmol/l

0.80

Contact with heat and hot substances

153

1.84

2.38

1.1

114.68

107.54

pmol/l

0.33

153

Other disorders of iris and ciliary body

2.23

2.38

1.5

1.2

106.88

96.29

pmol/l

0.38

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

2.23

2.38

1.0

1.3

132.47

100.94

pmol/l

0.86

Chronic lymphocytic leukaemia, helper endpoint

2.23

2.38

1.0

1.3

132.47

100.94

pmol/l

0.86

Chronic lymphocytic leukaemia

2.23

2.38

1.0

1.3

132.47

100.94

pmol/l

0.86

Microscopic polyangiitis

4.22

2.38

1.1

1.2

104.86

100.47

pmol/l

—

Bullous pemphigoid

2.44

2.38

1.1

1.2

95.57

95.52

pmol/l

0.00

Thrombotic microangiopathy

4.21

2.38

1.0

1.2

105.43

108.65

pmol/l

—

Endometriosis ASRM stages 3,4

133

1019

1.31

2.37

1.1

1.2

119.67

117.49

pmol/l

0.20

133

1019

Other specified/unspecified disorders of bone/cartilage

2.43

2.37

1.1

101.07

103.16

pmol/l

0.07

Event of undetermined intent

190

1.75

2.37

1.1

102.33

109.14

pmol/l

0.40

190

Prophylactic surgery

4.19

2.37

1.4

1.1

91.57

107.76

pmol/l

—

Infection due to other mycobacteria, including avohilmo

2.64

2.37

1.3

1.1

105.50

109.63

pmol/l

0.12

Disorder of external ear, unspecified

104

2.04

2.37

1.1

104.62

107.09

pmol/l

0.10

104

Combinations of oral blood glucose lowering drugs

124

941

1.32

2.36

1.4

1.2

90.04

111.90

pmol/l

5.17

124

941

Fall on same level involving ice and snow

307

2580

1.19

2.36

1.2

111.03

111.09

pmol/l

0.01

307

2580

Diseases of tongue

198

1.73

2.35

1.4

1.2

112.41

110.85

pmol/l

0.06

198

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

221

1.68

2.34

1.2

108.62

114.44

pmol/l

0.39

221

Sub-endpoint used in defining T1D endpoints

134

1013

1.30

2.33

1.3

1.2

92.27

110.89

pmol/l

3.14

134

1013

Haemangioma, any site

291

1.59

2.33

1.1

1.2

111.11

108.76

pmol/l

0.11

291

Alcohol use disorder, ICD-based

183

1463

1.25

2.33

1.2

96.21

109.74

pmol/l

3.53

183

1463

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

145

1127

1.29

2.33

1.2

108.81

112.04

pmol/l

0.31

145

1127

Benign neoplasm: Adrenal gland

260

1.62

2.32

1.1

1.2

105.90

106.30

pmol/l

0.02

260

Other forms of systemic lupus erythematosus

3.28

2.32

1.1

1.2

110.89

108.96

pmol/l

—

Palmar fascial fibromatosis [Dupuytren]

403

1.49

2.32

1.1

1.2

114.35

99.66

pmol/l

1.55

403

Ptosis of eyelid

379

1.51

2.32

1.0

1.2

114.39

103.44

pmol/l

0.85

379

Unspecified event, undetermined intent

2.33

2.32

1.1

105.00

105.51

pmol/l

0.01

Organic, including symptomatic, mental disorders

234

1345

1.23

2.32

1.2

98.33

105.46

pmol/l

1.27

234

1345

Vitreous haemorrhage

315

1.56

2.32

1.3

1.2

89.96

104.08

pmol/l

1.27

315

Specific development disorders of scholastic skills

137

1.87

2.32

1.5

1.2

102.96

120.36

pmol/l

1.61

137

Brachial plexus disorders

339

1.54

2.32

1.1

1.2

107.23

113.65

pmol/l

0.47

339

Femoral hernia

133

1.89

2.31

1.2

101.32

105.22

pmol/l

0.15

133

Other disorders of bladder

339

1.54

2.31

1.1

1.2

99.25

105.01

pmol/l

0.42

339

Female infertility

151

701

1.29

2.31

1.2

1.1

120.34

115.74

pmol/l

0.57

151

701

Glaucoma secondary to other eye disorders

119

1.95

2.31

2.2

1.1

106.91

105.92

pmol/l

0.03

119

Malignant neoplasm of corpus uteri

292

1.58

2.30

1.2

106.20

109.16

pmol/l

0.18

292

Scleritis and episcleritis

207

1.70

2.30

1.4

1.1

120.49

111.42

pmol/l

0.37

207

Other secondary gout

4.80

2.30

1.0

1.2

99.33

105.69

pmol/l

—

Radial styloid tenosynovitis [de Quervain]

192

1.73

2.30

1.2

1.1

120.61

115.21

pmol/l

0.34

192

Cirrhosis of liver, NAS

155

1.82

2.30

2.3

1.1

81.46

107.03

pmol/l

2.15

155

Family history of malignant neoplasm

437

1.47

2.29

1.2

114.87

116.15

pmol/l

0.08

437

Polyarteritis nodosa and related conditions

2.98

2.29

1.0

1.2

100.00

111.41

pmol/l

—

Dilated cardiomyopathy

332

1.54

2.29

1.1

1.2

88.02

99.18

pmol/l

1.00

332

malignant neoplasm of female genital organs

590

1.40

2.29

1.2

113.85

110.15

pmol/l

0.20

590

Other specified/unspecified bacterial intestinal infections

215

1.68

2.29

1.2

1.1

110.22

108.29

pmol/l

0.09

215

Myotonic disorders

3.54

2.28

1.3

97.62

102.65

pmol/l

—

Other disorders of conjunctiva

487

1.44

2.28

1.2

135.41

106.00

pmol/l

0.55

487

Personal history of medical treatment

3.52

2.28

1.8

1.2

101.25

104.52

pmol/l

—

Other/unspecified enthesopathies of lower limb, excluding foot

246

1.63

2.27

1.2

115.92

112.22

pmol/l

0.16

246

Exposure to other and unspecified forces of nature

3.97

2.27

1.0

1.3

104.14

99.06

pmol/l

—

Carcinoma in situ of skin of trunk

2.04

2.26

1.1

1.2

97.15

96.54

pmol/l

0.02

COPD, hospital admissions 3, with asthma pneumonia sepsis

115

743

1.33

2.26

1.1

1.2

91.83

103.72

pmol/l

1.47

115

743

Pustular psoriasis

156

1.81

2.26

1.0

1.1

115.25

112.57

pmol/l

0.10

156

Vasculitis limited to skin, not elsewhere classified

2.17

2.25

1.1

107.76

108.20

pmol/l

0.02

Diseases of pulp and periapical tissues, including avohilmo

568

2581

1.14

2.25

1.2

112.20

111.37

pmol/l

0.08

568

2581

Problems related to social environment

2.17

2.25

1.1

99.24

108.96

pmol/l

0.32

Caries of enamel

523

2997

1.14

2.25

1.2

112.90

111.75

pmol/l

0.23

523

2997

Autism

2.17

2.25

1.2

102.00

122.77

pmol/l

1.02

Dermatophytosis, including avohilmo

337

2811

1.18

2.25

1.3

1.2

110.25

111.23

pmol/l

0.14

337

2811

Reactive arthropathies, FINNGEN

201

1.70

2.24

1.2

108.12

109.67

pmol/l

0.08

201

Use of teriflunomide

3.15

2.24

1.1

1.0

127.89

118.52

pmol/l

—

Congenital malformation syndromes predominantly affecting facial appearance

5.76

2.24

1.2

1.0

109.20

118.78

pmol/l

—

Diseases of middle ear and mastoid

299

2055

1.19

2.23

1.2

110.77

114.34

pmol/l

0.55

299

2055

Pituitary-dependent Cushing's disease

5.75

2.23

1.0

1.4

104.60

90.56

pmol/l

—

Myotonic dystrophy (Steinert)

5.74

2.23

1.2

1.4

82.20

101.78

pmol/l

—

Diseases of appendix

392

3018

1.16

2.23

1.2

110.40

112.33

pmol/l

0.37

392

3018

Lactose intolerance

2.11

2.23

1.3

1.1

95.61

118.85

pmol/l

1.55

Amputation of foot

2.35

2.22

1.3

1.2

67.43

100.78

pmol/l

1.83

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

194

1.71

2.22

1.3

1.2

110.33

107.13

pmol/l

0.12

194

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

2.90

2.22

1.0

1.1

88.00

103.54

pmol/l

—

Fracture of skull and facial bones

101

752

1.35

2.22

1.3

1.2

104.69

108.27

pmol/l

0.35

101

752

Benign neoplasm: Cerebral meninges

343

1.52

2.21

1.3

1.2

104.46

107.78

pmol/l

0.21

343

Special screening examination for neoplasms

157

1.79

2.21

1.1

116.86

104.15

pmol/l

0.51

157

Other specified and unspecified disorders of eye and adnexa

121

1.91

2.21

1.0

1.1

114.83

108.69

pmol/l

0.18

121

Other and unspecified coagulation defects

172

1.75

2.21

1.2

1.1

118.83

110.19

pmol/l

0.47

172

Oesophageal varices

100

2.01

2.21

2.8

1.2

94.35

107.37

pmol/l

0.32

100

Nonsuppurative otitis media, including avohilmo

166

1141

1.26

2.19

1.1

1.2

117.40

115.95

pmol/l

0.12

166

1141

Superficial injury of thorax

516

1.42

2.19

1.3

1.2

114.90

106.37

pmol/l

0.89

516

Other and unspecified disorders of pigmentation

3.40

2.19

1.0

1.2

101.13

110.75

pmol/l

—

Lactose intolerance, other/unspecified

2.14

2.19

1.3

1.1

95.29

117.38

pmol/l

1.32

Benign intracranial hypertension

3.38

2.19

1.0

151.63

125.17

pmol/l

—

Adenocarcinoma and Papillary adenocarcinoma of kidney

3.38

2.19

1.0

1.2

120.63

96.71

pmol/l

—

Emotionally unstable personality disorder

450

1.45

2.19

1.2

109.77

117.65

pmol/l

0.62

450

Asthma mixed form (mode)

143

1.83

2.18

1.2

103.19

106.73

pmol/l

0.14

143

Injury of muscle and tendon at lower leg level

475

1.44

2.18

1.2

110.31

107.35

pmol/l

0.20

475

Gluteal tendinitis

158

1.78

2.18

1.4

1.2

113.89

113.35

pmol/l

0.02

158

Small fibre neuropathy

2.09

2.17

2.9

1.1

91.50

104.72

pmol/l

0.47

Female infertility, associated with anovulation

257

1.60

2.17

1.1

124.71

122.24

pmol/l

0.13

257

COPD

194

1276

1.24

2.16

1.2

97.64

107.39

pmol/l

1.58

194

1276

Polyarteritis nodosa

4.36

2.16

1.0

1.2

104.17

105.50

pmol/l

—

Abnormal findings on diagnostic imaging of central nervous system

151

1.80

2.16

1.4

1.1

102.81

109.99

pmol/l

0.29

151

Gastrojejunal ulcer

3.04

2.15

1.0

1.1

106.22

97.03

pmol/l

—

Hirsutism in women

2.32

2.15

1.4

1.1

106.64

112.30

pmol/l

0.17

Benign neoplasm of urinary organs

144

1.82

2.14

1.3

1.1

87.42

104.20

pmol/l

1.84

144

Examination and encounter for administrative purposes

181

1.72

2.14

1.2

103.84

97.83

pmol/l

0.32

181

Adenomyosis (Endometriosis of uterus)

501

1.42

2.14

1.2

1.1

110.25

115.73

pmol/l

0.34

501

Unspecified privation

354

1.50

2.14

1.2

106.55

107.74

pmol/l

0.06

354

Other infectious diseases

235

1.62

2.13

1.2

87.82

105.27

pmol/l

1.65

235

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

206

1665

1.22

2.13

1.2

115.70

114.76

pmol/l

0.11

206

1665

Injuries to the wrist and hand

551

3225

1.13

2.13

1.2

108.63

112.09

pmol/l

1.01

551

3225

Thyrotoxicosis with toxic multinodular goitre

220

1.65

2.12

1.1

1.2

113.97

107.27

pmol/l

0.29

220

Other hearing loss

128

961

1.29

2.12

1.2

98.66

106.25

pmol/l

0.87

128

961

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

123

1.88

2.12

1.3

1.1

107.39

110.02

pmol/l

0.10

123

Other symptoms and signs involving general sensations and perceptions

123

1.88

2.12

1.5

1.2

98.30

107.83

pmol/l

0.37

123

Other fall from one level to another

106

801

1.33

2.11

1.1

1.2

110.12

108.26

pmol/l

0.16

106

801

Maternal care for other known or suspected fetal problems

137

667

1.29

2.11

1.4

1.1

121.38

118.56

pmol/l

0.26

137

667

Other obstructive and reflux uropathy

116

1.91

2.11

1.2

1.1

91.27

115.55

pmol/l

1.23

116

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

102

1.97

2.10

1.1

113.05

111.38

pmol/l

0.07

102

Ulcerative colitis (strict definition, require KELA)

571

1.39

2.10

1.1

1.2

105.58

110.21

pmol/l

0.37

571

Shock, not elsewhere classified

3.24

2.10

1.5

1.1

85.13

107.28

pmol/l

—

Other follicular disorders

244

1.61

2.10

1.5

1.1

114.49

109.66

pmol/l

0.26

244

Synovial cyst of popliteal space [Baker]

213

1.65

2.09

1.1

1.2

110.83

108.38

pmol/l

0.10

213

Suicide or other Intentional self-harm

120

925

1.30

2.09

1.2

99.78

114.95

pmol/l

2.96

120

925

Other and unspecified pemphigus

5.16

2.09

1.2

1.3

143.40

102.10

pmol/l

—

Respiratory disorders in diseases classified elsewhere

2.59

2.09

1.2

1.1

114.36

105.65

pmol/l

0.19

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

555

1.39

2.09

1.1

1.2

105.19

110.33

pmol/l

0.41

555

Unspecified visual impairment (binocular)

2.59

2.09

1.5

1.2

125.73

101.47

pmol/l

1.31

Qualitative platelet defects

5.14

2.09

1.4

117.60

111.60

pmol/l

—

Thyrotoxicosis with toxic single thyroid nodule

2.95

2.09

1.2

1.1

143.22

109.77

pmol/l

—

Unspecified chronic bronchitis

2.14

2.08

1.1

95.94

104.47

pmol/l

0.24

Hypertrophy of breast

103

778

1.33

2.08

1.1

1.2

118.01

115.57

pmol/l

0.18

103

778

Atypical facial pain

183

1.70

2.08

1.2

1.1

91.55

110.96

pmol/l

2.12

183

Other aneurysm

153

1.77

2.08

1.1

1.2

110.15

106.08

pmol/l

0.10

153

Lichen planus, including avohilmo

101

761

1.33

2.07

1.1

1.2

101.77

109.92

pmol/l

1.10

101

761

Disorders of plasma-protein metabolism, not elsewhere classified

3.57

2.07

1.0

1.3

123.43

112.40

pmol/l

—

Poor fetal growth

506

1.41

2.06

1.1

119.31

122.69

pmol/l

0.23

506

ILD medications: pirfenidone

3.55

2.06

1.1

1.2

111.43

89.10

pmol/l

—

Thyroiditis

269

1.57

2.06

1.2

1.1

121.21

111.41

pmol/l

0.76

269

Other acute skin changes due to ultraviolet radiation

1.99

2.06

1.1

122.74

102.92

pmol/l

0.52

COPD, hospital admission 2, with asthma infections

136

917

1.28

2.05

1.2

94.80

105.18

pmol/l

1.27

136

917

Carcinoma in situ of skin of lower limb, including hip

2.20

2.05

1.5

1.2

100.20

100.01

pmol/l

0.01

Pure hyperglyceridaemia

2.34

2.05

1.0

1.2

68.69

112.13

pmol/l

4.37

Drug-induced headache, not elsewhere classified

4.08

2.05

1.0

1.3

94.67

109.13

pmol/l

—

Selective deficiency of immunoglobulin G [IgG] subclasses

4.07

2.05

1.0

1.3

133.83

101.80

pmol/l

—

malignant neoplasm of female genital organs, including Hilmo

661

1.34

2.03

1.2

112.78

110.78

pmol/l

0.11

661

Dysplasia of cervi uteri

125

680

1.30

2.03

1.2

1.1

119.69

114.88

pmol/l

0.43

125

680

Other noninfective disorders of lymphatic vessels and lymph nodes

125

1.85

2.03

1.1

1.2

102.22

107.74

pmol/l

0.27

125

Chronic periodontitis, complicated

277

2285

1.18

2.02

1.2

104.71

109.71

pmol/l

0.84

277

2285

Combined immunodeficiencies

3.12

2.02

1.5

1.2

90.88

107.62

pmol/l

—

Toxic effects of substances chiefly nonmedicinal as to source

367

1.48

2.02

1.2

1.1

96.26

110.87

pmol/l

1.61

367

Anosmia

2.67

2.02

1.3

1.0

89.50

114.83

pmol/l

—

Suppurative and unspecified otitis media

178

1278

1.23

2.02

1.1

1.2

108.57

115.46

pmol/l

1.39

178

1278

conjunctival degenerations and deposits

2.24

2.01

1.3

1.1

108.64

108.95

pmol/l

0.01

Appendicitis, broad definition

385

2998

1.15

2.01

1.2

110.00

112.53

pmol/l

0.51

385

2998

Umbilical hernia

122

948

1.29

2.01

1.4

1.2

105.44

107.10

pmol/l

0.15

122

948

Pustulosis palmaris et plantaris

140

1.80

2.01

1.0

1.1

117.76

111.96

pmol/l

0.22

140

Benign lipomatous neoplasm

141

1116

1.27

2.01

1.2

110.38

pmol/l

0.00

141

1116

Other disorders of breast

585

1.37

2.01

1.3

1.2

122.87

115.47

pmol/l

0.66

585

Acute gastritis

208

1.64

2.01

1.2

102.94

pmol/l

0.00

208

Emotional disorders starting during childhood or adolescence

146

1.77

2.00

1.3

1.2

109.92

119.36

pmol/l

0.49

146

Arthropod-borne viral fevers and viral haemorrhagic fevers

295

1.53

2.00

1.2

95.49

108.79

pmol/l

1.15

295

Coxarthrosis, primary, with hip surgery

218

1676

1.21

2.00

1.2

100.73

107.26

pmol/l

1.33

218

1676

Unspecified jaundice

133

1.81

1.99

1.0

1.2

96.96

106.98

pmol/l

0.30

133

Pedestrian injured in transport accident

224

1.61

1.99

1.1

117.11

110.03

pmol/l

0.47

224

Exposure to other and unspecified inanimate mechanical forces

224

1.61

1.99

2.6

1.1

100.58

110.44

pmol/l

0.69

224

Polyhydramnios

178

1.70

1.99

1.1

111.97

119.19

pmol/l

0.32

178

Other and unspecified acute skin changes due to ultraviolet radiation

2.16

1.99

1.0

1.2

116.00

98.21

pmol/l

0.35

Campylobacter enteritis

2.16

1.99

1.0

1.1

122.73

109.40

pmol/l

0.34

Sequelae of other external causes

178

1.69

1.99

1.3

1.1

103.40

107.86

pmol/l

0.20

178

Raynaud syndrome

320

1.51

1.98

1.2

122.56

110.78

pmol/l

1.00

320

Isolated growth hormone deficiency

3.40

1.98

1.4

1.2

132.71

112.71

pmol/l

—

Assault

435

1.43

1.97

1.3

1.1

101.79

113.03

pmol/l

1.10

435

Conductive hearing loss, unspecified

272

1.55

1.97

1.4

1.2

99.17

108.03

pmol/l

0.68

272

Pemphigoid

2.09

1.97

1.1

1.2

94.88

101.39

pmol/l

0.29

Benign neoplasm: Choroid

217

1.62

1.97

1.3

1.2

107.34

105.39

pmol/l

0.13

217

Acute pharyngitis

531

1.38

1.96

1.3

1.2

110.72

117.05

pmol/l

0.66

531

Monoarthritis, not elsewhere classified

105

1.91

1.95

1.1

1.2

83.40

110.23

pmol/l

3.33

105

Polyarthritis, unspecified

1.99

1.95

1.1

1.3

102.06

111.68

pmol/l

0.44

Disorders of purine and pyrimidine metabolism

4.62

1.95

1.0

1.4

99.60

111.09

pmol/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

205

1145

1.22

1.95

1.1

1.2

111.98

104.89

pmol/l

0.34

205

1145

Chronic myeloid leukaemia

3.84

1.95

1.3

1.1

127.50

108.12

pmol/l

—

Inhalation and ingestion of other objects causing obstruction of respiratory tract

4.62

1.95

1.0

1.2

66.00

103.00

pmol/l

—

Other congenital malformations of peripheral vascular system

2.59

1.95

1.1

1.2

107.70

113.87

pmol/l

—

Hereditary retinal dystrophy

2.59

1.95

1.0

1.3

101.30

105.28

pmol/l

—

Carcinoma in situ of skin, other sites/unspecified

2.59

1.95

1.1

1.2

101.80

94.28

pmol/l

—

Neuroendocrine tumor and carcinoma of pancreas

3.82

1.94

1.0

1.1

160.83

106.25

pmol/l

—

Acute suppurative otitis media

126

920

1.28

1.94

1.2

105.96

116.93

pmol/l

2.21

126

920

Superficial injury of ankle and foot

445

1.42

1.94

1.1

1.2

123.73

112.04

pmol/l

1.18

445

Primary adrenocortical insufficiency

2.76

1.94

1.6

1.2

127.33

105.61

pmol/l

—

Seropositive rheumatoid arthritis, wide

132

1042

1.27

1.94

1.2

101.13

111.13

pmol/l

1.52

132

1042

Wegener granulomatosis

2.47

1.94

1.0

1.1

113.27

104.27

pmol/l

0.20

Use of glatiramer acetate

2.47

1.94

1.0

1.1

132.18

122.49

pmol/l

0.13

Acne, including avohilmo

109

677

1.30

1.93

1.2

1.1

122.25

119.97

pmol/l

0.21

109

677

Hidradenitis suppurativa

120

1.84

1.93

1.7

1.1

116.86

111.95

pmol/l

0.16

120

Other noninflammatory disorders of vulva and perineum

355

1.47

1.92

1.1

109.87

121.51

pmol/l

0.70

355

Isolated patent ductus arteriosus

2.57

1.92

1.1

1.2

92.50

117.28

pmol/l

—

Malignant neoplasm of colon

446

1.42

1.92

1.1

1.2

98.11

101.83

pmol/l

0.22

446

Autism spe

2.07

1.91

1.2

99.25

119.87

pmol/l

0.97

Short Achilles tendon (acquired)

2.07

1.91

1.0

1.1

135.75

111.97

pmol/l

0.63

Endocarditis

2.06

1.91

1.0

1.2

90.50

109.06

pmol/l

1.03

Right hemicolectomy

165

1.71

1.91

1.2

1.1

103.21

101.55

pmol/l

0.07

165

Tonsillectomy and adenotomy

301

1789

1.17

1.91

1.2

115.74

116.18

pmol/l

0.05

301

1789

Pedestrian injured in collision with pedal cycle

1.97

1.90

1.2

1.1

118.17

105.96

pmol/l

0.59

Viral infections of the central nervous system

227

1.59

1.90

1.2

123.00

109.78

pmol/l

0.74

227

Other and unspecified iridocyclitis

158

1.72

1.89

1.9

1.1

114.63

108.18

pmol/l

0.29

158

Other corneal oedema

3.23

1.89

1.3

98.43

102.82

pmol/l

—

Follicular cysts of skin and subcutaneous tissue

669

1.33

1.89

1.2

101.66

108.92

pmol/l

0.92

669

Glaucoma secondary to eye inflammation

3.23

1.89

2.1

1.3

123.14

91.00

pmol/l

—

Urethral stricture

143

1.76

1.89

1.3

1.2

103.56

96.93

pmol/l

0.31

143

Primary biliary cholangitis (PBC)

2.17

1.89

1.1

1.2

101.14

102.78

pmol/l

0.05

CR(E)ST syndrome

2.34

1.89

1.3

1.1

89.92

111.33

pmol/l

0.91

Folate deficiency anaemia

3.22

1.88

1.0

1.2

71.43

100.86

pmol/l

—

Hypermetropia

251

1.56

1.88

1.3

1.2

100.38

111.45

pmol/l

0.80

251

Mixed connective tissue disease

2.33

1.88

1.2

1.1

87.08

112.44

pmol/l

1.09

Pulmonary eosinophilia, not elsewhere classified

2.68

1.87

1.1

1.2

101.67

105.62

pmol/l

—

264

2001

1.18

1.87

1.2

95.22

109.99

pmol/l

5.49

264

2001

Other chondrocalcinosis

2.68

1.87

1.1

1.2

101.67

91.47

pmol/l

—

Asthma and opportunity respiratory infection

151

1.73

1.87

1.4

1.2

108.54

107.24

pmol/l

0.04

151

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

2.67

1.87

1.1

107.33

109.29

pmol/l

—

Panniculitis, unspecified

2.89

1.87

1.0

1.1

107.13

109.46

pmol/l

—

Papilloedema, unspecified

2.10

1.87

1.4

1.1

117.47

111.90

pmol/l

0.14

Other and unspecified vasculitis limited to skin

2.10

1.87

1.1

111.87

108.08

pmol/l

0.14

Dislocation, sprain and strain of joints and ligaments of thorax

107

1.88

1.86

1.2

1.1

88.70

105.67

pmol/l

1.27

107

Bacterial meningitis

100

1.91

1.86

1.2

1.1

106.05

105.19

pmol/l

0.04

100

Other congenital malformations of tongue, mouth and pharynx

2.66

1.86

1.4

1.2

118.22

119.06

pmol/l

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

191

1564

1.21

1.86

1.2

97.09

109.43

pmol/l

3.03

191

1564

Granulomatous disorders of skin and subcutaneous tissue

1.95

1.85

1.6

1.1

100.44

110.88

pmol/l

0.57

Wide developmental disorders

114

1.85

1.2

109.81

118.98

pmol/l

0.41

114

Acne

356

1.46

1.85

1.1

124.37

118.15

pmol/l

0.49

356

Other/unspecified crystal arthropathies

3.59

1.85

1.5

1.4

120.33

92.82

pmol/l

—

Fracture of shoulder and upper arm

175

1433

1.22

1.84

1.2

106.04

110.55

pmol/l

0.57

175

1433

Congenital malformations of ear causing impairment of hearing

4.28

1.84

2.0

1.3

97.80

124.50

pmol/l

—

Other predominantly sexually transmitted diseases, not elsewhere classified

655

1.33

1.84

1.2

107.20

118.45

pmol/l

1.77

655

Moderate visual impairment, monocular

4.25

1.83

2.2

1.3

109.20

114.33

pmol/l

—

Other chronic obstructive pulmonary disease

183

1231

1.22

1.83

1.1

1.2

97.37

107.05

pmol/l

1.47

183

1231

Subacute thyroiditis

115

1.84

1.83

1.1

122.81

113.77

pmol/l

0.43

115

Crohn disease (strict definition, require KELA)

206

1.61

1.82

1.2

1.1

105.33

112.31

pmol/l

0.36

206

Artificial joint re-operation

230

1.57

1.81

1.2

103.28

101.29

pmol/l

0.09

230

Postprocedural musculoskeletal disorders, not elsewhere classified

238

1.56

1.81

1.1

1.2

107.73

103.20

pmol/l

0.32

238

Viral infections of the central nervous system, including avohilmo

238

1.56

1.81

1.2

124.24

109.63

pmol/l

0.87

238

Hepatic failure, not elsewhere classified

101

1.89

1.81

2.8

1.1

78.05

108.86

pmol/l

1.88

101

Lesion of femoral nerve

3.09

1.81

1.0

1.2

107.00

106.22

pmol/l

—

Polycystic ovarian syndrome

191

1.63

1.81

1.2

1.1

132.32

118.42

pmol/l

0.93

191

Other disorders of central nervous system

2.60

1.81

1.0

1.2

122.00

114.57

pmol/l

—

Covid-19 suspected case

108

840

1.29

1.81

1.1

1.2

124.18

114.35

pmol/l

0.40

108

840

Use of dimethyl fumarate

3.09

1.81

1.0

103.57

119.17

pmol/l

—

Hypersomnia

2.60

1.81

1.2

116.78

103.43

pmol/l

—

Contact with other hot fluids

2.01

1.80

1.3

1.1

124.88

114.36

pmol/l

0.35

Crohn's disease NAS

199

1.61

1.80

1.3

1.1

107.13

111.52

pmol/l

0.22

199

Somnolence

2.79

1.80

2.4

1.2

116.25

101.14

pmol/l

—

Hallux rigidus

444

1.40

1.79

1.3

1.2

112.40

109.91

pmol/l

0.16

444

Psychotic depression

176

1.65

1.79

1.1

1.3

102.28

111.30

pmol/l

0.48

176

Premature rupture of membranes

122

683

1.27

1.78

1.2

124.08

117.62

pmol/l

0.54

122

683

Respiratory conditions due to other external agents

2.19

1.78

1.2

77.08

102.33

pmol/l

1.38

Burn and corrosion of head and neck

2.36

1.78

1.3

1.1

111.91

98.60

pmol/l

0.59

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

487

1.38

1.78

1.4

1.2

109.31

109.12

pmol/l

0.01

487

Perineal laceration during delivery

625

0.71

1.78

1.3

1.1

128.87

118.44

pmol/l

0.85

625

Other infective otitis externa

192

1.62

1.78

1.3

1.1

114.39

107.40

pmol/l

0.30

192

Behavioural disorders, excluding more controls

2.35

1.77

1.5

1.1

104.55

116.98

pmol/l

0.31

Amiodarone users

296

1.49

1.77

1.1

1.2

99.32

100.01

pmol/l

0.03

296

Other/unspecified synovitis and tenosynovitis

370

1.44

1.77

1.2

106.57

112.94

pmol/l

0.40

370

Other disorders of cornea

337

1.46

1.77

1.2

115.10

105.75

pmol/l

0.97

337

Redundant prepuce, phimosis and paraphimosis

513

1.36

1.76

1.2

105.28

103.17

pmol/l

0.14

513

Other specified and unspecified retinal disorders

102

1.87

1.76

1.6

1.1

127.89

104.18

pmol/l

0.93

102

Pemphigus

3.39

1.75

1.2

130.33

94.44

pmol/l

—

Explicit fungal Sepsis

3.38

1.75

1.5

1.2

86.00

117.56

pmol/l

—

Explicit fungal Sepsis, including avohilmo

3.38

1.75

1.5

1.2

86.00

117.56

pmol/l

—

Retinal detachment with retinal break

404

1.41

1.75

1.2

109.89

103.30

pmol/l

0.39

404

Effects of heat and light

3.38

1.75

2.0

1.2

86.83

102.89

pmol/l

—

Hyperaldosteronism

2.04

1.75

1.0

1.1

106.80

106.45

pmol/l

0.01

Schizophrenia

531

1.36

1.75

1.3

1.2

97.97

112.04

pmol/l

1.85

531

Kela reimbursement Agammaglobulinemia (D80-84)

3.37

1.75

1.3

143.83

111.33

pmol/l

—

Injury of muscle and tendon at hip and thigh level

346

1.45

1.75

1.2

108.40

108.39

pmol/l

0.00

346

Effects of other external causes

1.99

1.75

1.1

1.2

112.25

106.23

pmol/l

0.22

Melanocytic naevi of trunk

438

1.40

1.75

1.1

1.2

119.38

109.34

pmol/l

0.97

438

Secondary thrombocytopenia

2.53

1.75

1.0

1.2

106.89

107.78

pmol/l

—

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

2.53

1.74

1.1

114.11

109.42

pmol/l

—

Hypotension due to drugs

2.52

1.74

1.0

1.2

98.78

89.92

pmol/l

—

Other abnormalities of plasma proteins

2.52

1.74

1.0

1.2

90.67

99.78

pmol/l

—

Propionic acid derivatives

129

512

1.27

1.74

1.2

1.3

107.10

104.57

pmol/l

0.25

129

512

Recurrent dislocation and subluxation of joint

193

1.61

1.74

1.2

110.77

115.31

pmol/l

0.25

193

Delayed milestone in childhood

2.18

1.74

1.2

1.3

108.77

122.78

pmol/l

0.50

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

626

1.33

1.74

1.3

1.2

104.35

106.08

pmol/l

0.13

626

Benign neoplasm of breast

498

1.37

1.74

1.1

1.2

120.22

113.82

pmol/l

0.42

498

Benign neoplasm: Skin of eyelid, including canthus

575

1.34

1.73

1.3

1.2

109.99

108.58

pmol/l

0.09

575

2.96

1.73

1.4

1.2

125.71

105.63

pmol/l

—

Exposure to unspecified smoke, fire and flames

2.95

1.73

1.4

1.2

113.14

98.58

pmol/l

—

Hydrocele

241

1.54

1.72

1.1

1.2

90.19

95.02

pmol/l

0.30

241

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

3.91

1.72

1.0

1.2

63.60

84.92

pmol/l

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

127

1015

1.25

1.72

1.3

1.2

101.80

111.27

pmol/l

1.35

127

1015

Abnormal findings in nipple discharge synovial fluid wound secretions

2.32

1.71

2.0

1.2

108.91

109.50

pmol/l

0.01

Recurrent dislocation of patella

163

1.66

1.71

1.1

1.3

112.48

119.79

pmol/l

0.32

163

Overexertion and strenuous or repetitive movements

323

1.46

1.71

1.3

1.2

111.49

110.12

pmol/l

0.07

323

Scissor bite

2.02

1.71

1.1

1.2

115.00

112.92

pmol/l

0.05

Diabetic retinopathy, strict definition

526

1.34

1.70

1.2

1.3

81.14

101.73

pmol/l

2.70

526

Infective dermatitis

373

1.43

1.70

1.2

100.70

105.64

pmol/l

0.36

373

Congenital iodine-deficiency syndrome/hypothyroidism

1.92

1.70

1.2

1.1

96.41

111.67

pmol/l

0.64

Other and unspecified mononeuropathies of upper limb

1.92

1.70

1.1

91.76

110.02

pmol/l

0.92

Other and unspecified nail disorders

2.02

1.70

1.3

1.1

94.53

106.45

pmol/l

0.42

Superficial injury of abdomen, lower back and pelvis

560

1.34

1.70

1.2

104.47

108.82

pmol/l

0.40

560

Alcohol-induced acute pancreatitis

1.96

1.70

1.2

1.1

97.63

101.44

pmol/l

0.16

Other/unspecified seropositive rheumatoid arthritis

129

1035

1.25

1.69

1.2

102.07

111.16

pmol/l

1.29

129

1035

Appendectomy

340

2829

1.14

1.68

1.2

112.57

113.16

pmol/l

0.07

340

2829

Crohn disease (strict definition, require KELA, min 2 HDR)

203

1.58

1.68

1.2

1.1

104.66

112.57

pmol/l

0.41

203

Blepharochalasis

140

1135

1.24

1.68

1.1

1.2

109.63

108.99

pmol/l

0.06

140

1135

Acute laryngitis and tracheitis

418

1.39

1.67

1.3

1.2

100.80

118.97

pmol/l

2.05

418

Other and unspecified primary disorders of muscles

3.20

1.67

1.0

1.3

103.00

88.74

pmol/l

—

Sequelae of injuries of head

149

1.69

1.67

1.2

1.1

103.24

105.36

pmol/l

0.07

149

Viral conjunctivitis

2.11

1.66

1.2

1.1

118.77

109.06

pmol/l

0.32

Congenital obstruction of the pelviureteric junction

2.84

1.66

1.0

1.2

89.57

109.16

pmol/l

—

Other and unspecified acquired haemolytic anaemias

2.83

1.65

1.0

1.2

125.71

107.32

pmol/l

—

Alcohol-induced chronic pancreatitis

157

1.66

1.65

1.3

1.2

87.50

102.39

pmol/l

1.01

157

Other localized connective tissue disorders

2.05

1.65

1.2

1.1

97.29

109.72

pmol/l

0.64

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

2.46

1.65

1.3

1.1

107.70

111.49

pmol/l

—

Suppurative and necrotic conditions of lower respiratory tract

142

1.70

1.64

1.3

1.2

111.71

99.49

pmol/l

0.44

142

Congenital malformations of the circulatory system

480

1.36

1.64

1.1

1.2

99.75

111.39

pmol/l

1.40

480

Other meningitis

2.27

1.64

1.0

1.1

99.36

110.49

pmol/l

0.66

Mixed and other personality disorders

277

1.49

1.63

1.2

109.71

112.41

pmol/l

0.14

277

Other superficial mycoses, including avohilmo

368

1.42

1.63

1.2

1.1

114.75

112.39

pmol/l

0.17

368

Adalimumab

335

1.44

1.63

1.4

1.2

99.75

112.50

pmol/l

1.55

335

Other endophthalmitis

3.63

1.62

1.0

1.2

121.80

102.29

pmol/l

—

Infarction of spleen

3.62

1.62

1.0

1.1

80.80

102.64

pmol/l

—

Other mental disorders due to brain damage and dysfunction and to physical disease

377

1.41

1.62

1.4

1.2

106.25

105.87

pmol/l

0.02

377

Other specified/unspecified nutritional deficiencies

3.62

1.62

1.4

1.3

158.20

97.07

pmol/l

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

3.61

1.62

1.0

1.3

56.40

80.86

pmol/l

—

Haemorrhage, not elsewhere classified

1.85

1.62

1.0

1.2

87.72

106.08

pmol/l

1.11

Melanocytic naevi, other sites/unspecified

286

1.47

1.61

1.2

1.1

107.64

111.28

pmol/l

0.22

286

Open wound of ankle and foot

319

1.45

1.61

1.3

1.2

85.91

106.66

pmol/l

3.17

319

Other noninflammatory disorders of vagina

278

1.48

1.61

1.1

119.46

114.92

pmol/l

0.25

278

Other appendicitis

270

1.49

1.61

1.0

1.2

104.20

109.80

pmol/l

0.42

270

Temporal arteritis

113

1.78

1.61

1.1

99.20

103.52

pmol/l

0.19

113

Acute posthaemorrhagic anaemia

1.88

1.60

1.0

1.1

105.29

109.52

pmol/l

0.10

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

548

1.33

1.60

1.3

1.2

106.64

106.50

pmol/l

0.01

548

Other disorders originating in the perinatal period

2.53

1.60

1.0

1.3

115.25

pmol/l

—

Colon adenocarcinoma

336

1.43

1.60

1.1

1.2

106.69

100.70

pmol/l

0.32

336

Other factor of the environment

2.52

1.60

1.3

1.1

109.63

98.06

pmol/l

—

Failure and rejection of transplanted organs and tissues

2.35

1.59

1.2

77.10

113.88

pmol/l

—

HSIL lesion of the vagina

2.35

1.59

1.0

1.1

141.30

112.35

pmol/l

—

Idiopathic pulmonary fibrosis

230

1.53

1.59

1.5

1.2

105.51

97.15

pmol/l

0.51

230

223

0.49

1.59

1.2

90.36

96.34

pmol/l

0.23

223

Fibrosis of liver

3.04

1.59

1.2

84.33

110.30

pmol/l

—

Other and unspecified nonscarring hair loss

2.73

1.59

1.3

1.1

132.57

114.04

pmol/l

—

Cervical polyps

362

1.41

1.59

1.2

1.1

111.35

115.62

pmol/l

0.23

362

Hypertrophy of (infrapatellar) fat pad

2.72

1.58

1.0

1.2

125.57

105.04

pmol/l

—

Nonsuppurative otitis media

108

742

1.26

1.57

1.2

118.09

116.17

pmol/l

0.12

108

742

Toxic effect of carbon monoxide

2.22

1.57

1.5

1.1

100.55

101.40

pmol/l

0.02

Diseases of spleen

2.22

1.57

1.2

1.1

71.55

102.72

pmol/l

1.69

Schizoaffective disorder

247

1.50

1.57

1.0

1.1

93.84

112.48

pmol/l

1.54

247

Graves disease, strict definition

405

1.39

1.57

1.2

116.61

112.49

pmol/l

0.27

405

Giant cell arteritis

129

1.72

1.57

1.2

1.1

98.14

102.54

pmol/l

0.22

129

Acute appendicitis

356

2914

1.13

1.56

1.2

110.30

112.57

pmol/l

0.42

356

2914

Achalasia of cardia

2.29

1.56

1.3

1.1

122.70

102.57

pmol/l

—

Sequelae of injuries of lower limb

305

1.45

1.56

1.2

117.23

111.81

pmol/l

0.33

305

Barrett oesophagus

137

1.69

1.55

1.0

1.1

99.43

104.59

pmol/l

0.26

137

Renal cell carcinoma of kidney

1.89

1.55

1.0

1.3

84.75

96.81

pmol/l

0.41

Benign neoplasm: Rectosigmoid junction

122

1.73

1.55

1.4

1.1

100.67

105.41

pmol/l

0.14

122

Burn and corrosion of shoulder and upper limb, except wrist and hand

2.05

1.54

1.2

125.85

101.36

pmol/l

1.67

Nonpyogenic thrombosis of intracranial venous system

2.45

1.54

1.1

1.2

94.00

107.61

pmol/l

—

Ocular pain

314

1.44

1.54

1.1

1.2

125.76

111.24

pmol/l

1.09

314

Hodgkin lymphoma, hilmo

2.04

1.54

1.1

101.15

107.27

pmol/l

0.21

Other autoimmune haemolytic anaemias

2.45

1.54

1.3

1.2

113.88

103.00

pmol/l

—

Tinnitus

112

896

1.25

1.54

1.2

110.66

109.74

pmol/l

0.08

112

896

Open bite

192

1.57

1.54

1.2

1.1

114.83

115.28

pmol/l

0.02

192

Vascular disorders of the intestines

200

1.55

1.53

1.1

1.2

87.16

105.08

pmol/l

1.29

200

Colonic or urogenital fistula

125

1013

1.24

1.53

1.2

102.71

110.95

pmol/l

1.39

125

1013

Complications of other internal prosthetic devices, implants and grafts

130

1.70

1.53

1.2

1.1

89.95

109.44

pmol/l

1.48

130

Whooping cough

3.38

1.53

1.2

1.0

80.40

115.07

pmol/l

—

Parkinson's disease, including avohilmo

484

1.35

1.53

1.2

106.72

104.54

pmol/l

0.12

484

Varicella [chickenpox], including avohilmo

153

1.64

1.53

1.2

99.56

111.62

pmol/l

0.52

153

Basal cell carcinoma, including Hilmo

203

1162

1.18

1.52

1.1

1.2

112.73

105.07

pmol/l

0.37

203

1162

Hyperkinetic disorders (excl. ADHD)

2.18

1.52

1.0

1.2

123.18

119.70

pmol/l

0.10

Follicular adenocarcinoma of thyroid gland, including Hilmo

2.62

1.52

1.1

114.29

103.74

pmol/l

—

Assault by other specified means

2.62

1.52

1.1

108.29

110.70

pmol/l

—

Congenital musculoskeletal deformities of head, face, spine and chest

2.62

1.52

1.0

1.3

144.14

105.85

pmol/l

—

Other disorders of the genitourinary system

502

1.34

1.52

1.1

1.2

106.43

111.56

pmol/l

0.38

502

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

146

1204

1.21

1.52

1.2

109.21

114.08

pmol/l

0.66

146

1204

Excessive vomiting in pregnancy

332

1.42

1.51

1.2

116.85

116.75

pmol/l

0.00

332

Desensitization to allergens

177

1.59

1.51

1.0

1.2

118.07

114.74

pmol/l

0.16

177

Parkinson's disease

459

1.35

1.51

1.2

106.05

99.60

pmol/l

0.52

459

Episcleritis

185

1.57

1.51

1.4

1.2

122.28

111.36

pmol/l

0.39

185

Use of levodopa decarboxylase inhibitor

425

1.37

1.51

1.1

1.2

102.57

99.24

pmol/l

0.22

425

Golimumab

123

1.72

1.51

1.4

1.1

113.52

109.64

pmol/l

0.20

123

Colitis due to radiation

2.89

1.51

1.0

1.2

114.00

90.43

pmol/l

—

Foreign body in genitourinary tract

2.89

1.51

2.0

1.2

89.50

97.48

pmol/l

—

UC patients in KELA-register (code 208), prior to 1994

123

1.72

1.51

1.1

112.86

103.30

pmol/l

0.46

123

Malignant neoplasm of other connective and soft tissue, including Hilmo

123

1.72

1.51

1.9

1.2

111.48

105.80

pmol/l

0.26

123

Visual field defects

266

1.47

1.51

1.4

1.2

141.64

104.67

pmol/l

0.64

266

Crohn's disease of large intestine

154

1.63

1.50

1.1

102.48

110.94

pmol/l

0.35

154

Deficiency of other B group vitamins

2.08

1.49

1.2

1.1

131.33

105.48

pmol/l

0.65

Heterophoria

283

1.45

1.49

1.2

1.1

124.46

110.97

pmol/l

0.88

283

Diffuse brain injury

1.91

1.49

1.1

89.20

110.96

pmol/l

0.78

Calculus of lower urinary tract

131

1.69

1.49

1.0

1.2

125.91

94.16

pmol/l

2.48

131

Erythema multiforme

1.96

1.49

1.6

1.2

96.50

110.46

pmol/l

0.68

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

2.16

1.49

1.4

1.3

129.18

111.24

pmol/l

0.41

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

226

1.51

1.49

1.2

1.1

105.26

111.32

pmol/l

0.32

226

Acute appendicitis, no complications

278

2409

1.15

1.49

1.2

111.31

111.98

pmol/l

0.09

278

2409

Maternal care for known or suspected malpresentation of fetus

104

588

1.26

1.48

1.2

1.1

119.57

118.40

pmol/l

0.10

104

588

Thyrotropin deficiency

2.46

1.48

1.0

1.2

139.22

107.11

pmol/l

—

Other/unspecified reactive arthropathies

202

1.54

1.48

1.2

1.1

106.61

107.67

pmol/l

0.05

202

Other sexually transmitted chlamydial diseases

194

1.55

1.48

1.0

1.1

105.67

119.41

pmol/l

1.07

194

Lichen ruber planus, wide definition including periferal and oral lichen planus

114

919

1.24

1.48

1.1

1.2

102.86

109.60

pmol/l

0.92

114

919

Misadventures to patients during surgical and medical care

522

1.33

1.47

1.1

1.2

102.86

106.48

pmol/l

0.27

522

Eosinophilia

2.24

1.47

1.0

1.1

100.70

104.44

pmol/l

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

243

1.49

1.47

1.1

1.2

98.31

107.44

pmol/l

0.59

243

Use of amantadine

2.24

1.47

1.0

1.1

134.60

106.36

pmol/l

—

Other strabismus

105

836

1.25

1.47

1.2

114.40

112.54

pmol/l

0.16

105

836

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

227

1.51

1.46

1.2

98.74

111.36

pmol/l

1.10

227

Injuries to unspecified part of trunk, limb or body region

343

1.40

1.46

1.1

1.2

96.44

107.06

pmol/l

0.85

343

Dissocial personality disorder

2.39

1.46

2.9

1.2

78.11

108.29

pmol/l

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

171

1.59

1.46

1.3

1.1

124.33

108.14

pmol/l

0.93

171

Malignant immunoproliferative diseases

2.53

1.46

1.0

1.3

67.14

94.75

pmol/l

—

Malignant neoplasm of bone and articular cartilage

2.53

1.46

1.3

1.2

83.57

107.18

pmol/l

—

Cyst of kidney

211

1.52

1.46

1.2

94.78

103.67

pmol/l

0.58

211

Glaucoma-related operations

187

1.56

1.45

1.4

1.2

106.72

98.67

pmol/l

0.45

187

Acute bronchiolitis

161

1.57

1.45

1.3

1.2

107.61

120.50

pmol/l

0.62

161

COPD related to multimorbidity

161

1136

1.20

1.45

1.1

1.2

96.55

105.04

pmol/l

1.05

161

1136

Congenital malformations of breast

2.13

1.45

1.2

1.1

125.09

117.27

pmol/l

0.25

Burn and corrosion of trunk

1.89

1.45

1.0

1.1

123.47

106.10

pmol/l

0.84

Acquired clawhand, clubhand, clawfoot and clubfoot

3.17

1.44

1.4

1.3

120.40

117.25

pmol/l

—

Other hereditary haemolytic anaemias

3.17

1.44

1.6

1.3

86.80

105.63

pmol/l

—

Undescended testis, unilateral

3.16

1.44

1.6

1.3

122.60

96.94

pmol/l

—

Osteomalacia

2.76

1.44

1.5

1.1

124.50

97.09

pmol/l

—

Congenital malformations of breast, including avohilmo

2.05

1.44

1.2

1.1

127.67

115.58

pmol/l

0.46

Eustachian salpingitis and obstruction

269

1.45

1.44

1.5

1.2

114.38

116.17

pmol/l

0.10

269

Horner syndrome

2.33

1.43

1.2

121.44

105.05

pmol/l

—

Other or ill-defined heart diseases

125

1.69

1.43

1.2

111.05

113.20

pmol/l

0.07

125

Undescended testicle

2.74

1.43

1.5

1.2

124.50

111.77

pmol/l

—

Anomalies of dental arch relationship, including avohilmo

680

1.27

1.43

1.3

1.2

115.11

116.91

pmol/l

0.14

680

Medial epicondylitis

110

1.74

1.43

1.3

1.1

99.37

115.51

pmol/l

0.97

110

Any death

293

1794

1.14

1.42

1.3

1.2

92.34

108.05

pmol/l

5.66

293

1794

Presbyopia

278

1.44

1.42

1.9

1.2

127.63

111.42

pmol/l

1.54

278

Other inflammation of vagina/vulva

141

1.64

1.42

1.0

1.1

105.70

113.30

pmol/l

0.39

141

Idiopathic thrombocytopenic purpura

1.83

1.42

1.3

1.1

109.31

103.05

pmol/l

0.13

Injury of muscle and tendon at shoulder and upper arm level

154

1287

1.20

1.41

1.2

107.48

106.81

pmol/l

0.07

154

1287

Giant cell arteritis with polymyalgia rheumatica

118

1.70

1.41

1.1

99.20

102.86

pmol/l

0.16

118

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

103

1.76

1.41

1.7

1.1

104.17

103.51

pmol/l

0.02

103

Postprocedural disorders of digestive system, not elsewhere classified

103

1.76

1.41

1.1

91.28

108.96

pmol/l

0.65

103

Toxic effect of ethanol

103

1.76

1.41

1.2

1.1

87.44

112.09

pmol/l

1.21

103

Procedures for purposes other than remedying health state

1.86

1.40

1.1

115.73

113.37

pmol/l

0.08

Benign neoplasm of ovary

729

1.27

1.40

1.2

110.58

116.12

pmol/l

0.48

729

Malignant neoplasm of small intestine, including Hilmo

1.86

1.40

1.5

1.3

111.33

102.93

pmol/l

0.35

Other and unspecified psoriasis

205

1.52

1.40

1.1

1.2

108.35

107.49

pmol/l

0.04

205

Chronic myeloid leukaemia, including Hilmo

2.44

1.40

1.3

1.1

126.71

101.69

pmol/l

—

Other osteochondrodysplasias, including avohilmo

2.43

1.39

1.0

1.2

100.43

103.21

pmol/l

—

Spontaneous rupture of synovium and tendon

246

1.47

1.39

1.2

90.47

107.47

pmol/l

1.89

246

Clear cell adenocarcinoma of kidney

134

1.65

1.39

1.0

1.2

91.59

103.11

pmol/l

0.54

134

Other surgical follow-up care

1.78

1.39

1.4

1.1

92.94

113.83

pmol/l

0.83

Dermatitis due to ingested food

106

1.72

1.39

1.9

1.2

124.32

121.25

pmol/l

0.10

106

Other bursitis of hip

2.09

1.39

1.2

1.1

122.64

114.21

pmol/l

0.27

Other female pelvic inflammatory diseases

686

1.27

1.38

1.3

1.2

109.56

115.37

pmol/l

0.68

686

Conduct disorder

2.01

1.38

1.5

1.1

103.42

114.50

pmol/l

0.30

Other diseases of pericardium

119

1.69

1.37

1.2

100.40

109.13

pmol/l

0.31

119

Melanocytic naevi of other and unspecified parts of face

198

1.52

1.37

1.2

1.1

105.27

112.40

pmol/l

0.51

198

Moderate visual impairment, binocular

1.81

1.37

1.2

81.13

104.80

pmol/l

1.65

Osteitis due to dental implant

2.64

1.37

1.2

124.33

108.35

pmol/l

—

Disorders of puberty

2.21

1.37

1.1

1.2

149.11

118.22

pmol/l

—

Drug-induced obesity

2.64

1.37

2.0

1.2

157.67

104.09

pmol/l

—

Personality and behavioural disorders due to brain disease, damage and dysfunction

2.21

1.37

1.6

1.2

90.67

99.29

pmol/l

—

Benign neoplasm: Kidney

104

1.74

1.37

1.3

1.1

84.50

107.03

pmol/l

1.97

104

Burn and corrosion of wrist and hand

104

1.74

1.37

1.3

1.2

101.11

109.81

pmol/l

0.46

104

Abscess of anal and rectal regions

239

1.47

1.36

1.1

1.2

104.46

112.87

pmol/l

0.55

239

Factitial dermatitis

2.99

1.36

1.2

1.3

152.60

99.59

pmol/l

—

Other and unspecified vaccines and biological substances

2.98

1.36

1.4

1.2

145.20

103.53

pmol/l

—

Acromegaly and pituitary gigantism

2.98

1.36

1.0

1.4

83.20

97.53

pmol/l

—

Complications following abortion and ectopic and molar pregnancy

135

1.64

1.36

1.1

1.2

117.18

113.40

pmol/l

0.12

135

Other specified disorders of kidney and ureter

1.84

1.36

1.5

1.1

85.33

107.27

pmol/l

0.98

Foreign body entering into or through eye or natural orifice

223

1.48

1.35

1.0

1.1

112.12

108.67

pmol/l

0.17

223

Sequelae of cerebrovascular disease

152

1087

1.20

1.35

1.1

1.2

94.37

105.77

pmol/l

1.67

152

1087

Lichen simplex chronicus

1.76

1.35

1.4

1.1

98.41

106.53

pmol/l

0.26

Mixed conductive and sensorineural hearing loss

400

1.35

1.2

89.30

102.86

pmol/l

1.55

400

Use of cabergoline

0.00

1.35

0.0

1.2

—

109.89

—

Carcinoma in situ of skin of scalp and neck

1.88

1.34

1.1

1.3

87.21

98.09

pmol/l

0.47

Glaucoma, exfoliation

349

1.38

1.34

1.5

1.2

100.50

104.60

pmol/l

0.19

349

Disorders of iron metabolism

2.15

1.34

2.2

1.2

129.20

112.57

pmol/l

—

Thyroiditis, unspecified

2.16

1.34

1.3

1.1

128.78

121.60

pmol/l

—

Drug-induced hypoglycaemia without coma

2.16

1.34

1.1

73.67

98.10

pmol/l

—

Acute and transient psychotic disorders

392

1.36

1.34

1.4

1.1

92.30

112.30

pmol/l

3.17

392

Malignant neoplasm of breast, HER-negative

756

1.25

1.33

1.3

1.2

112.90

110.78

pmol/l

0.16

756

Benign neoplasm: Conjunctiva

105

1.72

1.33

1.2

1.1

107.83

110.72

pmol/l

0.12

105

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

100

806

1.24

1.33

1.2

109.75

118.80

pmol/l

1.43

100

806

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

321

2210

1.13

1.33

1.2

114.60

113.59

pmol/l

0.14

321

2210

Maternal care for known or suspected fetal abnormality and damage

583

1.27

1.33

1.2

1.1

111.45

119.02

pmol/l

1.03

583

Other and unspecified injuries of ankle and foot

136

1.62

1.32

1.2

110.23

111.78

pmol/l

0.05

136

Other specified/unspecified dorsopathies

113

1.69

1.32

1.0

1.2

90.32

110.58

pmol/l

1.23

113

Ulcer of oesophagus

192

1.52

1.32

1.2

100.00

100.07

pmol/l

0.00

192

Status epilepticus

1.82

1.31

1.0

1.1

81.27

110.65

pmol/l

1.88

Intermittent heterotropia

200

1.50

1.31

1.2

1.1

116.07

116.38

pmol/l

0.01

200

Anogenital herpesviral [herpes simplex] infection, including avohilmo

428

1.34

1.31

1.1

1.2

127.14

118.32

pmol/l

0.91

428

Bacterial, viral and other infectious agents

258

1.44

1.31

1.1

102.84

109.84

pmol/l

0.55

258

Malignant neoplasm of parotid gland, including Hilmo

2.52

1.31

1.2

1.3

87.00

104.46

pmol/l

—

Benign neoplasm: Spinal meninges

2.52

1.31

1.0

1.2

145.33

105.62

pmol/l

—

Varicella [chickenpox]

121

1.66

1.30

1.3

1.2

101.05

108.88

pmol/l

0.25

121

Benign neoplasm: Stomach

334

1.38

1.30

1.3

1.2

112.17

106.49

pmol/l

0.27

334

Spirochaetal infections, other/unspecified, including avohilmo

165

1400

1.18

1.30

1.2

122.73

109.21

pmol/l

1.07

165

1400

Sequelae of injuries of neck and trunk

1.85

1.30

1.1

98.50

108.25

pmol/l

0.44

Impotence

129

1.63

1.30

1.0

1.2

88.38

93.58

pmol/l

0.22

129

Other peripheral vertigo

326

1.38

1.29

1.3

1.2

112.40

106.78

pmol/l

0.39

326

Tumor necrosis factor alpha inhibitors

604

1.28

1.29

1.3

1.1

107.51

115.24

pmol/l

0.91

604

Benign neoplasm of bone and articular cartilage

284

1.41

1.29

1.2

121.88

111.32

pmol/l

0.60

284

Malignant neoplasm of other and unspecified major salivary glands, including Hilmo

2.81

1.29

1.0

1.2

108.20

103.61

pmol/l

—

Necrosis of pulp, including avohilmo

300

2628

1.13

1.29

1.2

109.27

112.26

pmol/l

0.50

300

2628

Mantle cell lymphoma

2.80

1.29

1.0

1.3

150.80

94.61

pmol/l

—

Pedestrian injured in collision with car, pick-up truck or van

1.90

1.29

1.1

1.2

116.15

111.46

pmol/l

0.14

Malignant neoplasm of colon, including Hilmo

549

1.29

1.2

100.04

101.33

pmol/l

0.07

549

Contraceptive management

209

1260

1.16

1.29

1.2

121.80

113.71

pmol/l

0.68

209

1260

Impacted cerumen

395

1.35

1.28

1.2

112.51

102.92

pmol/l

0.55

395

Polycystic ovarian syndrome, broad definition

447

1.32

1.28

1.1

127.05

119.91

pmol/l

0.62

447

Hyphaema and other vascular disorders of iris and ciliary body

2.01

1.27

1.7

1.2

97.27

101.25

pmol/l

0.10

Benign leiomyoma with endometriosis

659

1.26

1.27

1.2

119.33

116.25

pmol/l

0.19

659

Benign neoplasm: Connective and other soft tissue, unspecified

2.31

1.27

2.1

1.1

110.25

103.20

pmol/l

—

Alopecia areata

1.80

1.27

1.0

1.1

139.20

109.86

pmol/l

2.06

Cluster headache, strict

1.72

1.27

1.1

107.53

112.13

pmol/l

0.16

Infection of intervertebral disc (pyogenic)

2.31

1.27

1.1

102.87

104.83

pmol/l

—

Benign neoplasm: Other and unspecified parts of small intestine

2.06

1.27

1.2

1.1

118.89

106.98

pmol/l

—

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

2.06

1.27

1.1

98.33

95.89

pmol/l

—

Anti-inflammatory and antirheumatic products, non-steroids

124

512

1.22

1.27

1.1

1.3

107.52

104.57

pmol/l

0.29

124

512

Other keratitis

396

1.34

1.27

1.2

120.91

110.05

pmol/l

0.83

396

Ectropion of eyelid

107

1.69

1.26

1.4

1.2

101.72

94.43

pmol/l

0.22

107

Lyme disease, including avohilmo

163

1388

1.18

1.25

1.2

122.72

108.99

pmol/l

1.08

163

1388

Lyme disease

163

1388

1.18

1.25

1.2

122.72

108.99

pmol/l

1.08

163

1388

Impacted maxillary canine

2.42

1.25

1.2

1.4

106.17

108.60

pmol/l

—

Other congenital malformations of nervous system

2.42

1.25

2.3

1.1

120.17

117.12

pmol/l

—

Pregnancy, childbirth and the puerperium

119

752

0.82

1.24

1.1

1.2

117.73

112.50

pmol/l

0.55

119

752

Acute lymphadenitis

187

1.50

1.24

1.3

1.1

127.25

111.67

pmol/l

0.87

187

Other spirochaetal diseases

165

1408

1.17

1.23

1.2

122.49

109.20

pmol/l

1.04

165

1408

Other abnormal findings in urine

2.01

1.23

1.0

1.2

87.89

96.31

pmol/l

—

Benign neoplasm: Connective and other soft tissue of head, face and neck

2.01

1.23

1.7

1.1

116.67

103.33

pmol/l

—

Open wound of wrist and hand

206

1727

1.15

1.23

1.3

1.2

107.53

111.45

pmol/l

0.65

206

1727

Parkinson's disease, strict definition

433

1.32

1.23

1.2

108.82

99.07

pmol/l

0.86

433

Left ventricular outflow tract obstruction (LVOTO), broad definition

304

1.39

1.23

1.1

1.2

101.62

109.26

pmol/l

0.46

304

Vertigo of central origin

2.06

1.22

1.1

108.90

101.43

pmol/l

—

Accessory breast

2.66

1.22

1.2

126.40

109.05

pmol/l

—

Aortic valve malfunction, age under 60 years

279

1.40

1.22

1.1

1.2

104.87

108.19

pmol/l

0.16

279

Congenital malformations of eye, ear, face and neck

204

1.48

1.22

1.4

1.2

116.87

113.35

pmol/l

0.15

204

Endometriosis of fallopian tube

2.66

1.22

1.0

120.60

121.74

pmol/l

—

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

2.18

1.22

1.1

1.2

120.38

85.41

pmol/l

—

Other disorders of patella

619

1.26

1.21

1.1

1.2

117.78

114.85

pmol/l

0.23

619

Mental and behavioural disorders due to alcohol

221

1838

1.15

1.21

1.2

96.97

109.75

pmol/l

3.66

221

1838

Specific development disorders of speech and language

181

1.50

1.21

1.1

110.89

114.94

pmol/l

0.10

181

Unspecified lump in breast

682

1.25

1.21

1.4

1.1

118.14

113.25

pmol/l

0.45

682

Injury of unspecified body region

246

1.43

1.21

1.2

98.06

106.05

pmol/l

0.45

246

Benign neoplasm: Rectum, anus and anal canal

700

1.25

1.20

1.3

1.2

101.41

109.67

pmol/l

0.75

700

Calcific tendinitis of shoulder

172

1.52

1.20

1.1

110.04

114.27

pmol/l

0.17

172

Other disorders of pigmentation

164

1.53

1.20

1.6

1.2

102.32

107.31

pmol/l

0.28

164

Prepatellar bursitis

101

1.69

1.20

1.1

1.2

104.35

109.68

pmol/l

0.21

101

Other spirochaetal diseases, including avohilmo

166

1422

1.17

1.19

1.2

122.39

109.28

pmol/l

1.03

166

1422

Malignant neoplasm of breast, ER-negative, including Hilmo

104

798

1.22

1.19

1.3

1.2

111.84

110.73

pmol/l

0.08

104

798

Alzheimer disease, excluding more controls

330

1.30

1.19

1.1

1.2

108.32

109.98

pmol/l

0.08

330

Abrasion of teeth

181

1562

1.16

1.19

1.1

1.2

113.28

111.21

pmol/l

0.25

181

1562

Benign neoplasm: Rectum

621

1.26

1.19

1.3

1.2

100.88

105.48

pmol/l

0.37

621

Toxic liver disease

2.12

1.18

1.0

1.1

131.75

104.55

pmol/l

—

Malignant neoplasm of eye and adnexa, including Hilmo

2.12

1.18

1.0

1.1

106.25

97.13

pmol/l

—

Exposure to smoke, fire and flames

1.89

1.18

1.4

1.1

95.17

103.70

pmol/l

0.33

Scoliosis

298

1.38

1.18

1.2

107.68

113.20

pmol/l

0.32

298

Disorders of speech understanding and production

138

1.57

1.17

1.0

1.2

110.36

115.23

pmol/l

0.10

138

Other sexually transmitted chlamydial diseases, including avohilmo

324

1.36

1.17

1.0

1.1

104.48

122.33

pmol/l

2.18

324

Pervasive developmental disorders excl. Autism + Asperger

2.09

1.17

1.3

116.50

115.18

pmol/l

—

Speech therapy

120

1002

1.20

1.17

1.1

1.2

103.37

110.95

pmol/l

0.89

120

1002

Alzheimer’s disease (Early onset)

127

0.47

1.16

1.0

1.2

89.33

100.68

pmol/l

—

127

Other and unspecified injuries of head

248

1.42

1.16

1.3

1.1

94.26

105.56

pmol/l

0.85

248

Long labour

945

0.81

1.16

1.3

1.2

124.01

116.97

pmol/l

0.84

945

Spondylopathies in diseases classified elsewhere

2.07

1.15

1.3

1.2

103.25

99.74

pmol/l

—

Atlantoaxial subluxation

2.53

1.15

1.0

1.2

74.20

114.60

pmol/l

—

Gingival hyperplasia

110

1.64

1.15

1.2

1.1

103.00

107.74

pmol/l

0.14

110

Pseudomembranous colitis

2.52

1.15

1.0

1.2

111.20

101.95

pmol/l

—

Urticaria due to cold and heat

2.52

1.15

1.2

91.20

104.45

pmol/l

—

Cardiomyopathy, Hypertrophic obstructive

2.06

1.15

1.1

111.00

115.15

pmol/l

—

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.82

1.15

1.3

1.1

127.54

116.85

pmol/l

0.36

Normotensive glaucoma

291

1.38

1.15

1.2

119.07

102.64

pmol/l

1.53

291

Other and unspecified tonsillitis

150

1061

1.18

1.15

1.2

110.77

117.23

pmol/l

0.92

150

1061

Tongue abnormality

207

1.45

1.15

1.5

1.1

113.97

107.91

pmol/l

0.41

207

Sudden idiopathic hearing loss

334

1.35

1.15

1.1

1.2

111.27

105.51

pmol/l

0.26

334

Dermatophytosis

447

1.30

1.14

1.4

1.2

103.98

104.26

pmol/l

0.02

447

Other congenital malformations of skin

126

1.59

1.14

1.2

1.1

141.40

111.08

pmol/l

2.24

126

Impacted maxillary molar

199

1.46

1.14

1.0

1.1

123.62

115.18

pmol/l

0.29

199

Ganglion

814

1.22

1.13

1.2

118.45

115.40

pmol/l

0.23

814

Congenital malformations of the nervous system

1.86

1.13

2.1

1.2

114.25

113.54

pmol/l

0.02

Astigmatism

199

1.46

1.13

1.1

1.2

107.72

113.19

pmol/l

0.25

199

Abscess of Bartholin gland

103

1.66

1.13

1.1

110.71

115.61

pmol/l

0.15

103

Thiazolidinediones

335

1.35

1.13

1.2

82.11

106.49

pmol/l

2.79

335

Injury of nerves at lower leg level

2.36

1.13

1.1

1.2

114.43

97.53

pmol/l

—

Spinal osteochondrosis

2.35

1.13

1.0

1.2

100.86

105.90

pmol/l

—

Early lumbar disc prolapse, operated

318

1.36

1.12

1.2

109.56

120.33

pmol/l

0.96

318

Hypothyroidism due to medicaments and other exogenous substances

2.02

1.12

2.1

1.2

88.25

112.82

pmol/l

—

Tic and related disorders

2.34

1.12

1.3

112.43

115.87

pmol/l

—

Insulin, fast-acting (human)

466

1.29

1.12

1.1

1.2

87.60

111.80

pmol/l

3.99

466

Dermatopolymyositis (FG)

2.01

1.12

1.4

1.1

74.75

105.03

pmol/l

—

Bitten or struck by other mammals

431

1.30

1.12

1.3

1.2

110.80

114.37

pmol/l

0.30

431

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

2.01

1.12

1.1

1.3

139.88

102.30

pmol/l

—

Other bullous disorders

1.71

1.11

1.3

1.1

99.60

106.90

pmol/l

0.32

Ischaemic Stroke, excluding all haemorrhages

238

1545

1.13

1.11

1.2

98.03

107.67

pmol/l

1.96

238

1545

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

2.27

1.10

1.0

1.2

144.14

110.74

pmol/l

—

Other bursitis of knee

2.27

1.10

1.0

1.2

122.00

107.23

pmol/l

—

Gestational diabetes (for exclusion)

202

1213

1.15

1.10

1.3

1.2

121.39

119.16

pmol/l

0.22

202

1213

Malignant neoplasm of adrenal gland, including Hilmo

2.41

1.09

1.0

1.2

158.80

95.00

pmol/l

—

Other osteochondrodysplasias

2.40

1.09

1.0

1.1

92.60

109.95

pmol/l

—

COPD, early/later onset

184

1342

1.15

1.09

1.1

1.2

97.15

106.12

pmol/l

1.34

184

1342

Use of rasagiline

1.83

1.09

1.2

1.1

108.58

101.06

pmol/l

0.17

Erythema intertrigo

1.74

1.09

1.7

1.1

97.21

107.30

pmol/l

0.53

Convergence insufficiency and excess

1.97

1.09

1.0

1.1

104.13

113.56

pmol/l

—

Other and unspecified visual disturbances

372

1.32

1.09

1.2

102.86

109.61

pmol/l

0.44

372

Other disorders of male genital organs

1.73

1.09

1.5

1.3

116.29

102.27

pmol/l

0.33

Other diseases of arteries and capillaries

303

1.36

1.08

1.1

1.2

89.39

106.34

pmol/l

1.56

303

Hypertension, Pulmonary Arterial

2.21

1.08

1.1

1.2

98.43

123.12

pmol/l

—

Separation of retinal layers (serosa)

120

1.59

1.08

1.2

1.1

95.95

107.76

pmol/l

0.45

120

Benign neoplasm: Sigmoid colon

665

1.24

1.08

1.3

1.2

102.65

106.23

pmol/l

0.25

665

Striking against or struck by other objects

150

1285

1.17

1.08

1.3

1.2

111.18

111.69

pmol/l

0.05

150

1285

Isolated proteinuria with specified morphological lesion

2.21

1.08

1.3

1.1

98.71

112.34

pmol/l

—

Lifestyle-related condition

2.21

1.08

1.3

1.2

96.43

99.12

pmol/l

—

Lesion of lateral popliteal nerve

136

1.55

1.08

1.1

103.38

109.74

pmol/l

0.23

136

Adult respiratory distress syndrome

2.20

1.08

1.1

1.2

90.71

95.69

pmol/l

—

Mantle cell lymphoma, including Hilmo

2.20

1.08

1.0

1.2

138.29

98.59

pmol/l

—

Basal cell carcinoma

189

1121

1.15

1.08

1.1

1.2

113.68

104.60

pmol/l

0.42

189

1121

Thoracic aortic aneurysm

399

1.31

1.07

1.1

1.2

102.23

102.22

pmol/l

0.00

399

Diabetic maculopathy

393

1.30

1.07

1.2

69.83

102.84

pmol/l

4.21

393

Acne vulgaris

269

1.38

1.07

1.1

123.59

118.59

pmol/l

0.30

269

Stroke, excluding SAH

255

1635

1.13

1.07

1.2

97.66

108.17

pmol/l

2.43

255

1635

COPD, hospital admissions

182

1334

1.15

1.07

1.1

1.2

97.54

106.27

pmol/l

1.28

182

1334

Anisometropia and aniseikonia

1.66

1.07

1.7

1.1

104.75

107.68

pmol/l

0.10

Dislocation, sprain and strain of joints and ligaments at neck level

559

1.25

1.06

1.1

1.2

123.69

112.92

pmol/l

1.04

559

Granuloma annulare

1.94

1.06

2.0

1.1

92.40

113.79

pmol/l

—

Causalgia

1.94

1.06

1.1

126.20

111.42

pmol/l

—

Disorders of puberty, all

1.94

1.06

1.1

1.3

140.90

119.23

pmol/l

—

Use of galantamine

242

0.62

1.06

1.1

1.2

107.13

106.19

pmol/l

0.02

242

Ulcerative colitis (strict definition, all Crohn cases excluded)

488

1.27

1.06

1.1

1.2

106.56

110.77

pmol/l

0.27

488

Pyothorax

105

1.63

1.06

1.2

1.1

111.59

101.89

pmol/l

0.22

105

Other diseases of appendix

2.14

1.06

1.3

1.2

132.43

108.30

pmol/l

—

Amblyopia ex anopsia

129

1.56

1.05

1.5

1.2

118.25

116.22

pmol/l

0.07

129

Flat foot [pes planus] (acquired)

322

1.34

1.05

1.2

121.42

116.53

pmol/l

0.28

322

Viral hepatitis, IBD co-morbidity

129

1.55

1.05

1.7

1.1

81.95

128.00

pmol/l

3.34

129

Other/unspecified soft tissue disorders related to use, overuse and pressure

1.72

1.05

1.1

113.21

113.84

pmol/l

0.02

Polypectomy (DHB20)

178

1.47

1.05

1.2

102.88

106.63

pmol/l

0.17

178

Other protozoal intestinal diseases, including avohilmo

1.80

1.05

1.3

1.1

123.42

113.07

pmol/l

0.22

Acute alcohol intoxication ICD-9

1.80

1.04

1.6

1.1

66.75

99.76

pmol/l

1.56

Later onset COPD, excluding more controls

405

1.26

1.04

1.1

1.2

88.87

104.88

pmol/l

1.39

405

Marginal zone B-cell lymphoma, including Hilmo

1.97

1.04

2.1

1.1

112.33

108.70

pmol/l

—

Stroke, including SAH

271

1738

1.12

1.04

1.2

98.48

108.73

pmol/l

2.43

271

1738

Malignant neoplasm of oropharynx, including Hilmo

1.97

1.04

1.3

1.2

112.56

106.30

pmol/l

—

Sequelae of injuries of upper limb

306

1.34

1.03

1.1

1.2

106.93

109.26

pmol/l

0.11

306

Other prurigo

2.08

1.03

1.0

1.1

86.00

104.56

pmol/l

—

Other nonscarring hair loss

2.08

1.03

1.3

1.1

132.57

111.53

pmol/l

—

Atopic conjunctivitis

146

1.51

1.03

1.0

1.1

113.64

112.36

pmol/l

0.04

146

Primary ovarian failure

1.85

1.03

1.0

1.1

135.27

107.83

pmol/l

0.82

Toxic effect of other and unspecified substances

2.07

1.03

1.0

1.1

101.00

110.06

pmol/l

—

Tic disorders

2.07

1.03

1.3

1.2

112.43

108.74

pmol/l

—

Other articular cartilage disorders

1.84

1.03

1.5

1.1

97.91

112.77

pmol/l

0.30

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

106

1.61

1.03

1.1

1.2

109.59

113.28

pmol/l

0.14

106

Cluster headache, wide

106

1.61

1.03

1.1

107.53

113.55

pmol/l

0.22

106

Oligomenorrhoea

114

1.59

1.02

1.1

126.72

120.80

pmol/l

0.16

114

Hypertrophic cardiomyopathy

114

1.59

1.02

1.4

1.1

94.39

103.63

pmol/l

0.38

114

Other and unspecified abdominal hernia

122

1.56

1.02

1.2

1.1

113.42

110.02

pmol/l

0.08

122

Localized scleroderma [morphea]

1.93

1.02

1.1

96.11

111.57

pmol/l

—

Residual foreign body in soft tissue

122

1.56

1.02

1.4

1.1

117.16

115.15

pmol/l

0.08

122

Other lack of coordination

1.93

1.02

1.3

1.2

86.00

99.06

pmol/l

—

Whooping cough, including avohilmo

1.93

1.02

1.1

105.00

119.15

pmol/l

—

Tobacco use

171

1.47

1.02

1.3

1.1

98.80

109.85

pmol/l

0.39

171

Lesion of plantar nerve

213

1.41

1.01

1.3

1.2

93.10

111.15

pmol/l

2.21

213

Need for immunization against other single viral diseases

1.90

1.01

1.1

1.2

80.30

103.45

pmol/l

—

Myelodysplastic syndrome, including Hilmo

1.69

1.01

1.1

1.3

101.14

103.37

pmol/l

0.05

Congenital malformations of heart and great arteries

408

1.29

1.01

1.1

1.2

100.74

112.40

pmol/l

1.14

408

Complications of labour and delivery

287

1773

0.90

1.01

1.2

122.05

113.84

pmol/l

1.03

287

1773

Dementia in Alzheimer disease

491

0.77

1.00

1.1

1.2

95.69

99.79

pmol/l

0.24

491

Other disorders of the musculoskeletal system and connective tissue

519

1.25

1.00

1.1

1.2

110.57

106.08

pmol/l

0.34

519

Benign neoplasm of other and unspecified intrathoracic organs

2.02

1.00

1.0

1.2

105.43

100.77

pmol/l

—

Other acute viral hepatitis

2.01

1.00

1.9

1.2

87.00

108.09

pmol/l

—

Von Willebrand disease

2.01

1.00

1.0

1.1

93.43

114.80

pmol/l

—

Anoxic brain damage

2.01

1.00

1.0

1.1

87.14

98.09

pmol/l

—

Sequelae of other accidents

2.01

1.00

1.3

1.2

143.14

101.43

pmol/l

—

Use of ropinirole

1.62

1.00

1.3

1.1

103.69

106.13

pmol/l

0.08

Other and unspecified corneal deformities and disorders

1.62

1.00

1.3

1.1

127.81

112.10

pmol/l

1.21

Spondyloarthritis

591

1.24

1.00

1.2

101.74

106.57

pmol/l

0.53

591

Early complications of trauma

131

1.53

1.00

1.2

1.1

92.25

106.20

pmol/l

0.76

131

!Aliquae complicationes praecoces traumatis

131

1.53

1.00

1.2

1.1

92.25

106.20

pmol/l

0.76

131

Distal bite

122

1.55

0.99

1.2

121.89

121.26

pmol/l

0.02

122

Other and unspecified types of non-Hodgkin lymphoma, hilmo

115

1.57

0.99

1.1

1.2

111.72

102.97

pmol/l

0.28

115

Non-Hodgkin lymphoma, all

115

1.57

0.99

1.4

1.2

128.67

98.26

pmol/l

1.24

115

Chronic Coagulation defects

1.72

0.99

1.1

105.31

113.50

pmol/l

0.31

Other specified/unspecified spondylopathies

1.72

0.99

1.0

1.2

105.15

103.39

pmol/l

0.04

Post-traumatic wound infection, not elsewhere classified

1.72

0.99

1.1

93.08

107.67

pmol/l

0.70

Laparoscopic left hemicolectomy

1.85

0.99

1.4

1.2

105.56

91.57

pmol/l

—

Dermatitis herpetiformis

1.85

0.99

1.6

1.1

94.44

104.35

pmol/l

—

Ill-defined and unknown causes of mortality

285

0.67

0.99

1.0

1.2

86.32

105.60

pmol/l

1.06

285

Toxic effect of alcohol

1.81

0.98

1.0

1.1

71.45

108.84

pmol/l

1.38

Strabismus

123

1046

1.17

0.98

1.2

114.38

112.66

pmol/l

0.14

123

1046

Hyperfunction of pituitary gland

156

1.48

0.98

1.0

1.1

113.52

109.65

pmol/l

0.14

156

Onycholysis

2.20

0.98

1.0

1.1

116.80

103.17

pmol/l

—

Melanocytic naevi of eyelid, including canthus

2.19

0.98

1.0

1.2

122.80

102.35

pmol/l

—

Arnold-Chiari syndrome

2.19

0.98

2.6

1.1

110.80

117.09

pmol/l

—

Benign neoplasm: Bladder

2.19

0.98

1.4

1.2

91.20

94.74

pmol/l

—

Spondylopathies (FG)

432

1.28

0.98

1.2

101.69

115.25

pmol/l

1.50

432

Dislocation, sprain and strain of joints and ligaments of head

140

1.51

0.97

1.1

114.38

111.54

pmol/l

0.10

140

Malignant neoplasm of digestive organs, including Hilmo

172

1104

1.15

0.97

1.3

1.2

109.54

104.04

pmol/l

0.66

172

1104

Tic and related disorders

1.96

0.97

1.3

112.43

104.81

pmol/l

—

Maternal care for known or suspected abnormality of pelvic organs

134

775

1.17

0.97

1.1

1.2

112.88

117.43

pmol/l

0.66

134

775

Optic atrophy, wide definition

1.81

0.97

1.3

1.1

105.33

104.26

pmol/l

—

Carcinoma in situ of other and unspecified digestive organs

124

1.54

0.97

1.2

1.1

105.74

101.11

pmol/l

0.16

124

Mental and behavioural disorders due to opioids

100

1.61

0.96

1.4

1.1

87.06

114.08

pmol/l

1.62

100

Lung diseases due to external agents

415

1.28

0.96

1.3

1.2

89.91

101.66

pmol/l

1.00

415

Melanocytic naevi of scalp and neck

1.75

0.96

1.1

109.08

106.23

pmol/l

0.09

Somnolence, stupor and coma

108

1.58

0.96

1.6

1.2

115.71

109.56

pmol/l

0.30

108

Other osteochondropathies

207

1.40

0.96

1.3

1.1

108.28

109.92

pmol/l

0.07

207

Macular hole

182

1.43

0.96

1.2

139.31

105.45

pmol/l

1.52

182

Anogenital herpesviral [herpes simplex] infection

216

1.39

0.95

1.1

118.10

115.80

pmol/l

0.11

216

Tuberculosis of other organs

1.77

0.94

1.6

1.2

83.00

99.78

pmol/l

—

N06DA Anticholinesterases

104

948

0.84

0.94

1.1

1.2

98.37

101.24

pmol/l

0.24

104

948

Use of anticholinesterases

104

948

0.84

0.94

1.1

1.2

98.37

101.24

pmol/l

0.24

104

948

Femoral hernia, unilateral

1.66

0.94

1.1

1.2

113.29

107.35

pmol/l

0.15

Inguinal of femoral hernia, unilateral

1.66

0.94

1.1

1.2

113.29

107.35

pmol/l

0.15

Inguinal hernia, unilateral

1.66

0.94

1.1

1.2

113.29

107.35

pmol/l

0.15

Universal erythroderma, KELA reimbursement

1.90

0.94

1.3

112.57

96.81

pmol/l

—

Other diseases of blood and blood-forming organs

208

1.40

0.94

1.4

1.2

102.31

108.29

pmol/l

0.29

208

Nystagmus and other irregular eye movements

1.90

0.94

1.1

1.2

103.00

108.35

pmol/l

—

Family history of other conditions

1.90

0.94

1.1

1.2

133.71

123.84

pmol/l

—

Cystic disease of liver

2.25

0.94

2.7

1.2

95.33

101.11

pmol/l

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

2.24

0.94

1.0

1.2

130.17

99.04

pmol/l

—

Benign neoplasm: Scapula and long bones of upper limb

2.24

0.94

1.7

1.1

129.33

107.22

pmol/l

—

Car occupant injured in other and unspecified transport accidents

678

1.21

0.94

1.2

108.07

111.65

pmol/l

0.31

678

Other and unspecified aplastic anaemias

2.24

0.94

1.0

1.2

82.83

109.85

pmol/l

—

Other and unspecified erythematous conditions

109

1.57

0.93

1.2

1.1

119.53

109.28

pmol/l

0.32

109

Injury of nerves at wrist and hand level

101

1.59

0.93

1.1

113.94

110.35

pmol/l

0.14

101

Lung cancer and mesothelioma

406

1.25

0.93

1.2

100.23

108.89

pmol/l

0.54

406

Intentional self-harm by sharp object

1.72

0.92

1.7

1.2

81.50

112.31

pmol/l

1.59

Other and unspecified intracranial injuries

1.72

0.92

1.1

1.2

117.08

105.30

pmol/l

0.37

Viral encephalitis, not elsewhere classified/unspecified

1.74

0.92

1.0

1.2

113.44

102.27

pmol/l

—

Acute nephritic syndrome

1.83

0.92

1.0

1.1

91.60

101.11

pmol/l

—

Left bundle-branch block

209

1.39

0.92

1.1

1.2

114.14

110.96

pmol/l

0.12

209

Encephalopathy

2.16

0.92

1.3

1.1

77.00

101.96

pmol/l

—

Pigmented purpuric dermatosis

2.16

0.92

3.0

1.2

107.50

103.86

pmol/l

—

Corneal ulcer

689

1.21

0.92

1.3

1.2

117.45

109.36

pmol/l

0.89

689

Coronary artery bypass grafting

475

1.22

0.91

1.3

1.2

79.41

104.23

pmol/l

6.21

475

Carcinoma in situ of colon

1.67

0.91

1.2

1.1

107.08

99.71

pmol/l

0.23

Trigeminal neuralgia

201

1.40

0.91

1.0

1.1

115.82

111.31

pmol/l

0.14

201

Malignant neoplasm of eye, brain and central nervous system

126

1.51

0.91

1.4

1.2

114.05

107.65

pmol/l

0.18

126

Cholesteatoma of middle ear

126

1.51

0.91

1.9

1.1

103.26

104.45

pmol/l

0.04

126

1.72

0.91

1.2

1.3

102.92

129.16

pmol/l

0.96

Viral meningitis

118

1.53

0.91

1.3

1.1

135.44

111.61

pmol/l

1.23

118

Other and unspecified follicular disorders

118

1.53

0.91

1.2

1.1

114.78

105.50

pmol/l

0.45

118

Chronic hepatitis, not elsewhere classified

110

1.55

0.90

1.3

1.1

123.65

107.24

pmol/l

0.36

110

Meralgia paraesthetica

102

1.58

0.90

1.5

1.1

118.56

110.31

pmol/l

0.29

102

Male infertility

1.60

0.90

1.1

1.2

102.67

108.28

pmol/l

0.13

Intussusception

1.76

0.90

1.2

1.1

114.45

113.22

pmol/l

0.04

Behavioural disorders

1.76

0.90

1.5

1.1

104.55

113.75

pmol/l

0.22

Abnormal findings in secretions and smears from cervix uteri vagina vulva

284

1892

1.11

0.90

1.2

115.79

116.70

pmol/l

0.12

284

1892

126

1.51

0.90

1.4

1.1

91.21

106.87

pmol/l

1.15

126

Carcinoma in situ of skin of other and unspecified parts of face

279

1.33

0.90

1.5

1.2

97.54

106.41

pmol/l

0.42

279

Other congenital malformations of intestine

2.09

0.89

1.5

1.2

85.50

111.24

pmol/l

—

Systemic sclerosis,strict definition

2.09

0.89

2.2

1.1

88.50

102.93

pmol/l

—

Unspecified threat to breathing

2.09

0.89

1.8

1.1

161.17

110.52

pmol/l

—

Gastrointestinal stromal tumor and sarcoma

2.08

0.89

1.7

1.1

111.67

108.21

pmol/l

—

Atypical mycobacterium lung infection

2.08

0.89

1.3

1.2

115.83

101.83

pmol/l

—

Other chronic obstructive pulmonary disease, including avohilmo

225

1654

1.12

0.89

1.1

1.2

96.20

107.35

pmol/l

2.39

225

1654

Medical abortion

308

1832

0.91

0.89

1.2

116.10

115.54

pmol/l

0.07

308

1832

679

1.20

0.89

1.1

1.2

89.17

101.73

pmol/l

1.60

679

Disorders in reading

1.92

0.88

1.4

1.2

98.75

114.10

pmol/l

—

Alzheimer disease, including avohilmo

114

920

0.86

0.88

1.1

1.2

103.86

101.19

pmol/l

0.22

114

920

Autoimmune thyroiditis

1.80

0.88

1.2

125.40

110.96

pmol/l

—

Complications of genitourinary prosthetic devices, implants and grafts

1.62

0.88

1.4

1.1

103.64

114.95

pmol/l

0.50

Pathological resorption of teeth

111

1.54

0.88

1.1

95.65

107.63

pmol/l

0.55

111

Shoulder region

1.87

0.87

1.0

1.2

91.38

102.81

pmol/l

—

Other protozoal intestinal diseases

1.87

0.87

1.1

119.38

111.53

pmol/l

—

Other other unspecified disorders of the circulatory system

103

1.56

0.87

1.1

96.44

109.01

pmol/l

0.71

103

Other and unspecified injuries of abdomen, lower back and pelvis

1.87

0.87

1.3

1.2

114.00

106.91

pmol/l

—

Benign neoplasm of male genital organs

1.87

0.87

1.4

1.1

83.63

101.49

pmol/l

—

Nonalcoholic steatohepatitis

2.02

0.87

1.2

81.33

101.37

pmol/l

—

Calcific tendinitis

2.02

0.87

1.2

101.33

104.40

pmol/l

—

Other bacterial agents as the cause of diseases classified to other chapters

2.01

0.87

1.0

1.2

102.17

99.07

pmol/l

—

Localized skin eruption due to drugs and medicaments

2.01

0.87

1.7

1.2

119.50

106.17

pmol/l

—

Occlusion and stenosis of arteries, not leading to stroke

2.01

0.87

1.0

1.2

106.17

88.33

pmol/l

—

Other obstructed labour

311

0.71

0.86

2.5

1.2

126.55

115.87

pmol/l

0.40

311

Epilepsy

125

1078

1.16

0.86

1.2

106.86

112.12

pmol/l

0.45

125

1078

Communicating hydrocephalus

1.73

0.86

1.2

1.1

91.27

99.91

pmol/l

0.35

malignant neoplasm of male genital organs, including Hilmo

436

1.20

0.86

1.1

1.3

101.66

94.02

pmol/l

0.77

436

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

1.83

0.86

1.0

1.1

106.38

118.70

pmol/l

—

1.73

0.86

1.1

1.3

101.55

127.37

pmol/l

0.84

Discitis, unspecified

1.83

0.86

1.1

1.2

90.13

104.45

pmol/l

—

Perforation of tympanic membrane

334

1.29

0.86

1.2

101.35

109.19

pmol/l

0.59

334

Malignant neoplasm of prostate, including Hilmo

407

1.20

0.85

1.1

1.3

101.35

92.75

pmol/l

0.87

407

Viral meningitis, including avohilmo

120

1.51

0.85

1.3

1.1

135.44

110.48

pmol/l

1.32

120

Malignant neoplasm of mesothelium and soft tissue

120

1.51

0.85

1.2

120.50

103.59

pmol/l

0.60

120

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

273

1.32

0.85

1.2

111.33

110.32

pmol/l

0.04

273

Hereditary deficiency of other clotting factors

1.95

0.84

1.2

119.17

114.03

pmol/l

—

Exclusion endpoint for supernumerary teeth

1.95

0.84

1.2

106.83

114.00

pmol/l

—

Malignant neoplasm of heart, mediastinum and pleura

1.95

0.84

1.2

1.1

168.00

94.81

pmol/l

—

Disorder of thyroid, unspecified

1.79

0.84

1.7

1.1

112.88

110.87

pmol/l

—

Spinal instabilities

1.60

0.84

1.1

101.07

112.03

pmol/l

0.49

Assault by sharp object

1.79

0.84

2.5

1.2

87.37

109.62

pmol/l

—

Ankyloglossia

1.78

0.84

1.4

1.2

144.63

111.49

pmol/l

—

Later onset COPD

714

0.83

0.84

1.1

1.2

89.19

100.75

pmol/l

1.12

714

Peritonsillar abscess

724

1.19

0.84

1.1

1.2

109.98

110.81

pmol/l

0.06

724

Helminthiases, including avohilmo

139

0.57

0.83

1.0

1.1

106.50

110.82

pmol/l

—

139

Endometriosis diagnosis and infertility diagnosis occurring together

443

1.24

0.83

1.1

1.2

117.87

118.70

pmol/l

0.05

443

Other disorders of thyroid

1.75

0.83

1.8

1.1

112.88

107.76

pmol/l

—

Dermatopolymyositis

1.75

0.83

1.4

1.1

74.75

102.83

pmol/l

—

Pre-eclampsia or poor fetal growth

160

1408

1.13

0.82

1.1

1.2

113.25

118.81

pmol/l

0.75

160

1408

Amputation of thigh

1.70

0.82

1.9

1.2

79.00

101.15

pmol/l

0.67

Other ill-defined and unspecified causes of mortality

261

0.69

0.82

1.0

1.2

85.50

106.62

pmol/l

1.11

261

Viral infections of central nervous system, not elsewhere classified/unspecified

1.89

0.82

1.5

1.2

135.50

104.94

pmol/l

—

Colorectal cancer

740

1.18

0.82

1.2

101.87

102.84

pmol/l

0.07

740

Hereditary ataxia

1.89

0.82

1.0

1.2

100.83

101.53

pmol/l

—

Mature T/NK-cell lymphomas, hilmo

1.89

0.82

1.0

1.2

121.50

94.66

pmol/l

—

Operations for atrial fibrillation

1.88

0.82

1.5

1.2

99.50

97.25

pmol/l

—

Sequelae of tuberculosis

1.88

0.82

1.3

106.00

92.88

pmol/l

—

Urethritis and urethral syndrome

1.65

0.82

1.1

1.2

111.25

114.71

pmol/l

0.10

Persons encountering health services in circumstances related to reproduction

283

1727

1.10

0.82

1.3

1.2

117.77

111.88

pmol/l

0.64

283

1727

Bronchitis, not specified as acute or chronic

258

1.32

0.81

1.2

110.47

106.27

pmol/l

0.18

258

Anorexia

1.71

0.81

1.0

1.1

86.63

113.04

pmol/l

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

245

1.33

0.81

1.1

1.2

109.39

114.78

pmol/l

0.31

245

Optic atrophy

1.71

0.81

1.4

1.1

87.38

101.91

pmol/l

—

Family history of certain disabilities and chronic diseases leading to disablement

172

1.40

0.81

1.4

1.1

139.75

115.79

pmol/l

1.17

172

Alcohol abuse, main dg, excluding more controls

427

1.24

0.80

1.2

100.32

110.77

pmol/l

0.82

427

Unspecified nephritic syndrome

1.73

0.80

1.0

1.2

84.30

103.05

pmol/l

—

Benign neoplasm: Uterine tubes and ligaments

0.00

0.79

0.0

1.2

—

102.50

—

Colorectal adenocarcinoma

583

1.20

0.79

1.3

1.2

108.07

100.78

pmol/l

0.58

583

Puerperal sepsis

531

0.79

1.0

1.2

118.02

116.38

pmol/l

0.08

531

Lesion of sciatic nerve

114

1.50

0.79

1.4

1.1

99.35

100.77

pmol/l

0.04

114

Disorders of porphyrin and bilirubin metabolism

1.83

0.79

1.2

1.1

153.67

110.58

pmol/l

—

Fasciculation

1.83

0.79

1.0

1.1

107.83

108.03

pmol/l

—

Alcohol induced polyneuropathy

0.00

0.79

0.0

1.2

—

97.32

—

Malignant neoplasm of lip, including Hilmo

0.00

0.79

0.0

1.2

—

92.60

—

Crushed, pushed or stepped on by crowd or human stampede

233

1.33

0.79

1.0

1.1

128.61

113.33

pmol/l

0.68

233

Hyperprolactinaemia

106

1.52

0.79

1.0

1.1

127.69

111.18

pmol/l

0.76

106

Contact with and exposure to communicable diseases

141

1236

1.14

0.78

1.1

1.2

118.28

118.17

pmol/l

0.01

141

1236

Other conjunctival vascular disorders and cysts

1.63

0.78

1.0

1.1

88.75

107.91

pmol/l

0.72

Cutaneous lupus erythematosus

1.63

0.78

1.1

99.67

111.92

pmol/l

0.50

Vasomotor rhinitis (mode)

251

1.32

0.78

1.4

1.2

125.79

108.94

pmol/l

1.54

251

Pneumococcal septicemia

1.56

0.78

1.2

1.1

97.14

106.49

pmol/l

0.29

Preterm labour and delivery

135

1186

1.14

0.78

1.4

1.2

120.62

114.08

pmol/l

0.32

135

1186

Suppurative otitis media, unspecified

1.59

0.78

1.1

99.00

108.62

pmol/l

0.28

Other disorders of penis

216

1.34

0.78

1.2

113.31

101.66

pmol/l

0.44

216

Trichomoniasis

0.00

0.78

0.0

1.2

—

99.30

—

Respiratory and cardiovascular disorders specific to the perinatal period

1.63

0.77

1.2

1.3

93.75

126.21

pmol/l

1.26

Congenital malformations of cardiac septa

218

1.34

0.77

1.1

1.2

101.93

115.50

pmol/l

0.78

218

Alzheimer’s disease, strict definition

701

0.84

0.76

1.1

1.2

99.78

99.75

pmol/l

0.00

701

Benign neoplasm: Bones of skull and face

1.78

0.76

1.2

1.1

129.33

110.15

pmol/l

—

Migraine with aura, drug-induced

1.78

0.76

1.0

1.1

137.50

111.47

pmol/l

—

Other injuries of upper limb, level unspecified

1.77

0.76

1.2

1.3

89.33

100.09

pmol/l

—

Benign neoplasm: Skin of lip

1.77

0.76

1.2

123.83

106.71

pmol/l

—

Open wound of forearm

296

1.29

0.76

1.3

1.2

112.76

107.66

pmol/l

0.28

296

Sequelae of tuberculosis, including avohilmo

1.77

0.76

1.3

106.00

91.21

pmol/l

—

Arterial embolism and thrombosis

157

1.40

0.76

1.1

1.2

100.68

103.24

pmol/l

0.06

157

Benign neoplasm: Skin of upper limb, including shoulder

1.70

0.76

2.4

1.1

112.20

108.56

pmol/l

—

Generalized epilepsy, strict definition

1.70

0.76

1.1

1.2

118.90

104.97

pmol/l

—

Use of donepezil

650

0.82

0.76

1.1

1.2

95.30

100.27

pmol/l

0.34

650

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

1.71

0.75

1.0

1.2

113.44

101.15

pmol/l

—

Benign neoplasm: Skin of other and unspecified parts of face

359

1.26

0.75

1.3

1.2

109.82

105.33

pmol/l

0.22

359

False labour

160

881

1.13

0.75

1.1

1.2

125.21

117.68

pmol/l

1.15

160

881

Other misadventures during surgical and medical care

1.65

0.75

1.1

87.91

104.09

pmol/l

0.63

Certain zoonotic bacterial diseases, including avohilmo

1.54

0.75

1.4

1.1

104.57

104.88

pmol/l

0.01

Bacterial, viral and other infectious agents, including avohilmo

288

1.29

0.75

1.1

102.84

109.61

pmol/l

0.53

288

Nonspecific lymphadenitis

192

1.36

0.75

1.5

1.2

114.23

112.82

pmol/l

0.06

192

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

192

1.36

0.75

1.2

1.1

108.92

105.69

pmol/l

0.19

192

Benign neoplasm: Bone and articular cartilage, unspecified

2.10

0.75

1.6

1.2

147.20

109.42

pmol/l

—

Heberden's nodes [with arthropathy]

2.10

0.75

1.0

1.2

117.80

109.04

pmol/l

—

Traumatic subdural haemorrhage

319

1.26

0.75

1.1

1.2

91.84

106.29

pmol/l

1.00

319

Certain zoonotic bacterial diseases

1.68

0.74

1.0

1.1

100.33

99.69

pmol/l

—

Injury of other and unspecified intrathoracic organs

175

1.37

0.74

1.2

1.1

101.37

107.50

pmol/l

0.26

175

Systemic atrophies primarily affecting the central nervous system

116

1.47

0.74

1.1

103.12

104.47

pmol/l

0.05

116

Other congenital malformations of intestine, including avohilmo

1.86

0.74

1.4

1.3

90.71

110.11

pmol/l

—

Other abnormal auditory perceptions

1.85

0.74

1.0

1.2

120.00

102.32

pmol/l

—

Unspecified maternal hypertension

1.85

0.74

1.1

95.71

113.95

pmol/l

—

Other mycoses, not elsewhere classified/unspecified, including avohilmo

1.64

0.73

1.3

1.1

99.89

111.56

pmol/l

—

Motor neuron disease ALS

1.64

0.73

1.1

103.44

104.15

pmol/l

—

Maltreatment syndromes

167

1.38

0.73

1.5

1.1

100.00

113.75

pmol/l

0.52

167

Other and unspecified pemphigoid

2.01

0.73

1.2

88.40

95.04

pmol/l

—

Protein-energy malnutrition of moderate and mild degree

2.01

0.73

1.8

1.2

103.00

102.28

pmol/l

—

Melanoma of uvea

2.01

0.73

1.0

1.2

116.00

90.00

pmol/l

—

IBD (strict) with PSC

2.01

0.73

1.0

1.1

94.40

104.16

pmol/l

—

Other deformities of toe(s)

100

1.51

0.73

1.5

1.3

118.67

108.15

pmol/l

0.47

100

Contusion of toe(s) with damage to nail

2.01

0.73

1.0

1.2

123.40

109.68

pmol/l

—

Superficial injury of forearm

352

1.25

0.73

1.4

1.1

112.91

110.97

pmol/l

0.11

352

Cauda equina syndrome

1.81

0.72

1.0

1.2

119.14

103.77

pmol/l

—

Alzheimer’s disease (Late onset)

657

0.84

0.72

1.1

1.2

101.07

99.19

pmol/l

0.11

657

Cerebral atherosclerosis

2.00

0.72

1.2

75.80

85.08

pmol/l

—

Other bursal cyst

1.80

0.72

1.4

1.1

97.71

110.59

pmol/l

—

Pulmonary oedema

1.80

0.72

1.9

1.3

70.86

89.05

pmol/l

—

Benign neoplasm of brain and other parts of central nervous system

202

1.34

0.72

1.2

109.93

107.41

pmol/l

0.09

202

Primary coxarthrosis, bilateral

117

1025

1.14

0.72

1.1

1.2

94.80

105.27

pmol/l

2.05

117

1025

Injury of nerves and spinal cord at neck level

1.67

0.72

1.0

1.2

121.10

100.75

pmol/l

—

Benign neoplasm of middle ear and respiratory system

237

1.31

0.72

1.4

1.2

110.97

105.55

pmol/l

0.23

237

Secondary polycythaemia

1.67

0.72

1.8

1.1

78.00

102.52

pmol/l

—

Other superficial mycoses

1.59

0.72

1.1

103.50

115.00

pmol/l

0.55

Prurigo nodularis

1.59

0.72

1.0

1.1

152.75

105.96

pmol/l

0.87

Benign neoplasm: Small intestine

117

1.46

0.72

1.1

101.06

106.50

pmol/l

0.23

117

Cluster headache, strict, including avohilmo

168

1.37

0.71

1.0

1.1

109.74

111.96

pmol/l

0.08

168

Malignant neoplasm of tonsil, including Hilmo

1.76

0.71

1.4

1.2

122.43

107.25

pmol/l

—

Other epidermal thickening

151

1.40

0.71

1.5

1.1

111.67

110.88

pmol/l

0.01

151

Lymphoid leukaemia

151

1.39

0.71

1.0

1.3

127.90

100.80

pmol/l

0.93

151

Polymyositis

1.94

0.71

1.6

1.2

67.20

102.77

pmol/l

—

Blindness, monocular

1.94

0.71

1.0

1.2

86.80

101.27

pmol/l

—

Liposarcoma, including Hilmo

1.94

0.71

3.4

1.1

118.80

105.19

pmol/l

—

Severe visual impairment, monocular

1.93

0.71

2.4

1.2

121.40

92.50

pmol/l

—

Colitis, primary sclerosing, strict definition

1.93

0.71

1.0

1.2

95.40

108.15

pmol/l

—

Alzheimer’s disease (Late onset), excluding more controls

269

1.23

0.70

1.1

1.2

109.02

108.35

pmol/l

0.02

269

Carcinoma in situ of cervix uteri, endocervix

1.72

0.70

1.0

1.1

182.29

115.05

pmol/l

—

Malignant neoplasm of cervix uteri

1.56

0.70

1.7

1.2

158.89

119.90

pmol/l

—

Motor neuron disease (with DMD)

1.56

0.70

1.1

1.2

103.44

103.83

pmol/l

—

Other facial nerve disorders

1.51

0.69

1.1

119.14

109.42

pmol/l

0.35

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

1.51

0.69

1.9

1.0

108.79

115.58

pmol/l

0.33

Non-small cell lung cancer

262

1.28

0.69

1.2

101.12

98.39

pmol/l

0.13

262

Other erythematous conditions

118

1.45

0.69

1.2

1.1

119.53

107.43

pmol/l

0.40

118

Certain conditions originating in the perinatal period

243

1.28

0.69

1.3

1.1

107.89

120.49

pmol/l

1.08

243

Drug-induced systemic lupus erythematosus

1.87

0.69

1.0

1.1

109.00

110.00

pmol/l

—

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

1.86

0.68

1.8

1.2

107.60

99.96

pmol/l

—

Other specific arthropathies, wide

1.65

0.68

1.3

1.1

113.90

111.25

pmol/l

—

Other specified and unspecified disorders of conjunctiva

1.86

0.68

1.6

1.1

94.60

101.78

pmol/l

—

Other specified and unspecified disorders of eyelid

1.68

0.68

1.3

1.1

121.29

100.83

pmol/l

—

Acute epiglottitis

1.67

0.68

1.1

140.43

100.05

pmol/l

—

Other disorders of binocular movement

1.60

0.68

1.0

1.1

109.64

113.20

pmol/l

0.10

Oral lichen planus, including avohilmo , including avohilmo

262

0.72

0.68

1.4

1.2

108.42

111.99

pmol/l

0.13

262

Labour and delivery complicated by umbilical cord complications

204

0.68

1.0

1.2

121.14

111.90

pmol/l

0.28

204

Malignant neoplasm of head and neck, including Hilmo

257

1.29

0.68

1.1

1.2

94.00

100.57

pmol/l

0.42

257

Disturbances of smell and taste

127

1.42

0.68

1.3

1.1

101.28

109.22

pmol/l

0.29

127

HSIL lesion of the cervix uteri

797

1.16

0.68

1.1

1.2

118.16

118.40

pmol/l

0.01

797

Mandibular retrognathia AND surgery (BSSO)

0.54

0.67

1.0

1.1

114.80

111.68

pmol/l

—

Family history of other specific disorders

1.64

0.67

1.3

1.1

134.71

121.49

pmol/l

—

Heart failure and hypertrophic cardiomyopathy

1.63

0.67

1.4

1.1

103.29

99.79

pmol/l

—

Hypothermia

1.63

0.67

1.0

1.1

92.43

92.23

pmol/l

—

Respiratory tuberculosis, confirmed

1.63

0.67

1.0

1.2

76.14

95.35

pmol/l

—

Respiratory tuberculosis, confirmed, including avohilmo

1.63

0.67

1.0

1.2

76.14

95.35

pmol/l

—

Use of selegiline

119

1.43

0.67

1.0

1.1

115.29

102.68

pmol/l

0.58

119

conjunctival haemorrhage

258

1.28

0.67

1.3

1.2

174.88

103.57

pmol/l

0.67

258

Morphin

1.63

0.67

1.1

1.2

105.43

107.26

pmol/l

—

Alzheimer disease

811

0.87

0.67

1.1

1.2

103.27

100.38

pmol/l

0.23

811

Pneumonia derived septicemia

1.49

0.67

1.2

1.1

97.14

107.21

pmol/l

0.32

Open bite that required surgery (Lefort1 or BSSO)

1.80

0.66

1.2

1.1

93.80

117.68

pmol/l

—

Occupational exposure to risk-factors

1.52

0.66

1.1

86.77

106.28

pmol/l

0.92

Malignant neoplasm of brain, including Hilmo

145

1.38

0.65

1.1

1.2

107.15

108.73

pmol/l

0.04

145

Myeloid leukaemia

1.54

0.65

1.3

1.1

112.50

100.45

pmol/l

0.47

Respiratory tuberculosis, bacteriologically and histologically confirmed

1.60

0.65

1.0

1.3

76.14

95.86

pmol/l

—

Central retinal artery occlusion

1.60

0.65

1.0

1.2

71.86

98.20

pmol/l

—

Scar conditions and fibrosis of skin

154

1.37

0.65

1.2

1.1

118.67

114.53

pmol/l

0.12

154

Periapical abscess

178

1962

0.91

0.65

1.2

108.08

110.89

pmol/l

0.32

178

1962

Inguinal hernia

237

1443

1.09

0.65

1.2

108.58

107.84

pmol/l

0.08

237

1443

Focal brain injury

154

1.37

0.64

1.4

1.3

103.10

106.35

pmol/l

0.14

154

Sequelae of infectious and parasitic diseases, including avohilmo

224

1.30

0.64

1.3

1.2

103.00

108.11

pmol/l

0.33

224

Colorectal cancer, including Hilmo

100

816

1.14

0.64

1.3

1.2

101.86

103.54

pmol/l

0.13

100

816

Other bursitis, not elsewhere classified

1.73

0.64

1.0

1.1

158.20

116.28

pmol/l

—

Contact with venomous snakes and lizards

1.73

0.64

1.0

1.2

133.20

107.86

pmol/l

—

382

0.78

0.64

1.0

1.2

130.93

121.54

pmol/l

0.61

382

Supervision of normal pregnancy

584

0.87

0.63

1.5

1.2

114.75

117.96

pmol/l

0.33

584

Other maltreatment syndromes

1.52

0.62

1.2

88.42

111.06

pmol/l

1.06

1.64

0.62

1.5

1.1

79.88

122.98

pmol/l

—

Flatulence and related conditions

1.67

0.61

1.0

1.2

109.60

103.83

pmol/l

—

Tibial collateral bursitis [Pellegrini-Stieda]

1.67

0.61

1.0

1.2

95.60

104.30

pmol/l

—

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

1.67

0.61

1.0

1.1

144.40

116.80

pmol/l

—

Alzheimer’s disease (Early onset), excluding more controls

100

0.56

0.61

1.0

1.2

89.33

124.78

pmol/l

—

100

Monoplegia

1.61

0.61

1.0

1.1

86.00

104.34

pmol/l

—

Maxillary retrognathism

1.61

0.61

1.0

1.2

117.63

101.70

pmol/l

—

Aortic aneurysm

615

1.16

0.61

1.1

1.2

103.37

101.01

pmol/l

0.14

615

All dysplastic lesions of the cervix uteri, vagina or vulva

154

1357

1.11

0.60

1.2

118.27

117.63

pmol/l

0.05

154

1357

Duodenal ulcer

289

1.25

0.60

1.4

1.2

89.00

98.11

pmol/l

0.63

289

Arterial embolism and thrombosis of lower extremity artery

1.48

0.60

1.0

1.1

117.92

106.88

pmol/l

0.24

Alzheimer’s disease (undefined), excluding more controls

0.00

0.60

0.0

1.2

—

94.20

—

Pedal cyclist injured in noncollision transport accidents

398

1.21

0.60

1.2

109.88

110.56

pmol/l

0.04

398

Hereditary corneal dystrophies

122

1.40

0.60

1.0

1.1

108.76

105.59

pmol/l

0.11

122

Early lumbar disc prolapse operation

362

1.22

0.60

1.2

109.36

115.46

pmol/l

0.46

362

Abnormal findings on diagnostic imaging of breast

1.55

0.59

1.4

1.1

96.50

111.44

pmol/l

—

Habit and impulse disorders

1.54

0.59

1.0

1.2

129.38

116.35

pmol/l

—

Hypertrophic scar

183

1.31

0.59

1.3

1.1

121.75

112.30

pmol/l

0.34

183

Atrial septal defect

130

1.38

0.59

1.2

100.06

114.80

pmol/l

0.66

130

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

344

0.78

0.59

1.0

1.2

100.67

112.57

pmol/l

0.84

344

Spasmodic torticollis

114

1.41

0.59

1.1

114.69

111.11

pmol/l

0.13

114

Alcohol withdrawal state with delirium

174

0.69

0.59

1.0

1.2

95.00

100.78

pmol/l

0.14

174

Autoimmune hepatitis

0.00

0.58

0.0

1.1

—

99.87

—

Malignant neoplasm of prostate

399

1.16

0.58

1.1

1.3

100.19

92.57

pmol/l

0.71

399

Other specified and unspecified strabismus

1.72

0.58

1.7

1.1

112.67

111.89

pmol/l

—

Pedal cyclist injured in transport accident

847

1.13

0.57

1.3

1.2

105.89

112.13

pmol/l

0.81

847

Superficial injury of neck

1.49

0.57

1.8

1.2

95.50

112.52

pmol/l

—

Malignant neoplasm of tonsil and base of tongue, including Hilmo

1.49

0.57

1.4

1.1

114.25

107.83

pmol/l

—

Malignant neoplasm, without specification of site

1.49

0.57

1.3

1.2

113.42

103.43

pmol/l

0.21

All dysplastic lesions of the cervix uteri

133

1179

1.11

0.57

1.2

118.51

119.04

pmol/l

0.04

133

1179

Other and unspecified bullous disorders

1.68

0.57

1.0

1.2

107.33

99.67

pmol/l

—

Melanoma in situ of other and unspecified parts of face

1.68

0.57

1.0

1.3

91.67

90.64

pmol/l

—

Early syphilis, including avohilmo

1.67

0.57

1.8

1.2

111.00

108.11

pmol/l

—

Personal history of risk-factors, not elsewhere classified

1.67

0.57

1.3

1.2

89.67

107.00

pmol/l

—

Congenital malformations of aortic and mitral valves

115

1.39

0.56

1.1

97.37

112.58

pmol/l

0.77

115

Assault by bodily force

247

1.26

0.56

1.1

102.74

111.81

pmol/l

0.57

247

Benign neoplasm: Skin of trunk

141

1.35

0.56

1.5

1.1

109.89

107.50

pmol/l

0.08

141

Malignant neoplasm of stomach, including Hilmo

141

1.35

0.56

1.4

1.3

133.21

99.00

pmol/l

1.81

141

Foreign body in ear

1.46

0.56

1.0

1.1

88.88

105.56

pmol/l

—

Pedal cyclist injured in collision with motor vehicle

0.57

0.56

1.0

1.1

100.80

109.05

pmol/l

—

Oral leukoplakia, including avohilmo

0.56

1.0

1.1

73.60

104.91

pmol/l

—

Foreign body or object entering through skin

195

0.72

0.56

1.3

1.1

109.21

111.23

pmol/l

0.06

195

Colon adenocarcinoma, helper endpoint

402

1.20

0.56

1.1

1.2

106.69

99.29

pmol/l

0.42

402

Hordeolum and other deep inflammation of eyelid

194

1.29

0.55

1.1

111.92

110.88

pmol/l

0.05

194

Malignant neoplasm of tonsil

1.63

0.55

1.3

1.2

111.67

109.73

pmol/l

—

Chronic mastoiditis

1.54

0.55

1.1

101.80

99.80

pmol/l

—

Superficial injury of hip and thigh

532

1.17

0.55

1.1

1.2

109.82

109.17

pmol/l

0.03

532

Contusion of other and unspecified parts of foot

168

1.31

0.55

1.1

1.2

127.45

110.30

pmol/l

1.29

168

Cluster headache, wide,, including avohilmo

177

1.30

0.54

1.0

1.1

109.74

111.96

pmol/l

0.08

177

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

1.59

0.54

1.0

1.1

102.17

102.32

pmol/l

—

Periodontal disease, other/unspecified

1.47

0.54

1.0

1.1

114.17

109.35

pmol/l

0.22

Tuberculosis of other organs, strict

1.50

0.54

1.6

1.2

83.00

97.93

pmol/l

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

303

1.22

0.54

1.2

113.73

107.95

pmol/l

0.21

303

Alcohol dependence

852

1.13

0.54

1.3

1.2

97.13

109.10

pmol/l

1.42

852

Tuberculosis of other organs, strict, including avohilmo

1.48

0.53

1.6

1.2

83.00

97.70

pmol/l

—

Burn and corrosion of hip and lower limb, except ankle and foot

1.48

0.53

1.0

1.2

124.56

103.56

pmol/l

—

Ulcerative rectosigmoiditis

249

1.25

0.53

1.1

1.2

104.94

110.12

pmol/l

0.27

249

Pneumonitis due to solids and liquids

231

1.26

0.53

1.1

1.2

93.66

100.52

pmol/l

0.29

231

Congenital deformities of feet

1.49

0.53

1.9

1.1

112.91

111.99

pmol/l

0.03

Tularaemia

1.54

0.53

1.0

1.2

104.17

99.82

pmol/l

—

Tularaemia, including avohilmo

1.46

0.53

1.0

1.1

106.89

102.50

pmol/l

—

Anxious personality disorder

1.46

0.53

1.0

1.1

111.00

111.68

pmol/l

—

HSIL lesion of the cervix uteri, vagina or vulva

100

891

1.12

0.53

1.1

1.2

119.46

117.75

pmol/l

0.11

100

891

Contact with nonpowered hand tool

108

1.39

0.53

1.1

100.87

109.04

pmol/l

0.34

108

Dental pulpitis, including avohilmo

467

2834

1.06

0.53

1.2

110.56

112.80

pmol/l

0.46

467

2834

Obstructed labour due to maternal pelvic abnormality

685

0.86

0.53

1.3

1.2

120.61

112.88

pmol/l

0.58

685

Sixth [abducent] nerve palsy

1.43

0.53

1.2

1.1

116.92

109.09

pmol/l

0.16

Dependent personality disorder

1.52

0.52

1.6

1.1

87.40

107.48

pmol/l

—

Contact with sharp object, undetermined intent

1.52

0.52

1.0

1.2

99.40

106.50

pmol/l

—

Other diseases of peritoneum

143

1.33

0.52

1.2

1.1

102.89

109.91

pmol/l

0.30

143

Malignant neoplasm of digestive organs

150

1044

1.10

0.52

1.2

111.05

103.85

pmol/l

0.85

150

1044

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

132

0.68

0.52

1.2

112.89

102.41

pmol/l

—

132

Lagophthalmos

1.51

0.51

1.7

1.2

147.33

102.38

pmol/l

—

Benign neoplasm: Spinal cord

1.51

0.51

1.0

1.2

111.33

100.02

pmol/l

—

Brain meningioma, including Hilmo

161

1.31

0.51

1.3

1.2

105.81

110.99

pmol/l

0.19

161

Antepartum haemorrhage, not elsewhere classified

337

0.80

0.51

1.1

123.30

118.18

pmol/l

0.19

337

Cerebral aneurysm, nonruptured

305

1.22

0.51

1.1

1.2

102.05

110.46

pmol/l

0.59

305

Dislocation, sprain and strain of joints and ligaments of knee

298

2525

1.07

0.51

1.2

110.88

113.63

pmol/l

0.52

298

2525

Single spontaneous delivery

178

1023

0.92

0.51

1.2

114.10

113.01

pmol/l

0.11

178

1023

Malignant neoplasm of other connective and soft tissue

1.47

0.51

1.2

106.91

104.12

pmol/l

0.08

Habitual aborter

1.39

0.50

1.1

1.0

105.33

122.43

pmol/l

—

Other/unspecified disorders of vestibular function

144

1.32

0.50

1.1

110.47

107.31

pmol/l

0.11

144

Allergic purpura

1.42

0.50

1.2

1.1

107.31

107.60

pmol/l

0.01

Abdominal aortic aneurysm (AAA)

223

0.76

0.50

1.1

1.2

87.06

95.12

pmol/l

0.49

223

Antenatal screening

603

0.89

0.50

1.4

1.1

125.03

117.88

pmol/l

0.91

603

Other disorders of optic disc

1.47

0.50

1.3

1.1

112.00

107.71

pmol/l

—

Malignant neoplasm of oropharynx

1.47

0.50

1.3

1.1

111.67

107.46

pmol/l

—

Portal vein thrombosis

1.47

0.50

1.5

1.2

98.00

104.80

pmol/l

—

Maternal care for known or suspected disproportion

156

0.70

0.50

1.0

1.1

124.36

120.37

pmol/l

0.09

156

Bursitis of shoulder

1.50

0.49

1.0

1.1

115.70

116.07

pmol/l

—

Other benign neoplasms of connective and other soft tissue

334

1.20

0.49

1.4

1.2

113.08

106.70

pmol/l

0.45

334

Benign neoplasm: Skin of ear and external auricular canal

127

1.34

0.49

1.1

94.18

108.80

pmol/l

0.72

127

Malignant neoplasm of brain

101

1.39

0.49

1.1

119.14

111.41

pmol/l

0.17

101

Aneurysms, operations, SAH

585

1.15

0.49

1.1

1.2

99.18

109.72

pmol/l

0.93

585

Contact with other sharp object(s)

207

1.26

0.49

1.3

1.1

107.23

111.10

pmol/l

0.15

207

Delivery, wide proxy

148

860

0.91

0.49

1.2

114.52

112.76

pmol/l

0.16

148

860

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

1.56

0.49

1.4

1.2

140.29

107.56

pmol/l

—

Asymmetry of jaw

1.53

0.48

1.0

1.1

103.43

115.09

pmol/l

—

LSIL lesion of the vagina

1.53

0.48

1.0

1.1

110.29

108.59

pmol/l

—

Degeneration of nervous system due to alcohol

1.53

0.48

1.0

1.2

87.43

100.24

pmol/l

—

Degeneration of the brain due to alcohol

1.53

0.48

1.0

1.2

87.43

99.15

pmol/l

—

Artificial opening status

163

1.29

0.48

1.0

1.2

83.33

105.45

pmol/l

1.15

163

Epiphora

1.45

0.48

1.0

1.1

114.27

109.41

pmol/l

0.11

Single delivery by forceps and vacuum extractor

419

0.87

0.48

1.2

1.1

123.18

116.63

pmol/l

0.51

419

Other and unspecified diseases of blood and blood-forming organs

1.45

0.48

1.1

128.64

103.43

pmol/l

1.00

Other and unspecified degenerative diseases of nervous system

1.45

0.48

1.1

1.2

100.18

97.16

pmol/l

0.11

Mental and behavioural disorders due to cannabinoids

1.45

0.48

1.0

1.1

101.27

112.17

pmol/l

0.34

Emphysema

199

1.26

0.47

1.2

89.08

99.78

pmol/l

0.68

199

Kyphosis

1.50

0.47

1.0

1.2

109.14

99.15

pmol/l

—

Carcinoma in situ of breast, intraductal

345

1.19

0.47

1.2

120.83

115.24

pmol/l

0.34

345

Respiratory distress of newborn

1.48

0.47

1.1

1.4

94.57

125.30

pmol/l

—

Melanoma in situ

137

1.32

0.47

1.0

1.1

109.61

105.13

pmol/l

0.17

137

Other and unspecified mononeuropathies, also in other diseases

1.42

0.47

1.0

1.2

104.25

107.33

pmol/l

0.07

Malignant neoplasm of tonsil and base of tongue

1.46

0.47

1.3

1.1

103.86

105.75

pmol/l

—

Other salmonella infections

111

1.35

0.46

1.1

90.27

114.63

pmol/l

1.49

111

L01XX Other antineoplastic agents

182

1.27

0.46

1.1

1.2

116.91

100.25

pmol/l

0.49

182

malignant neoplasm of male genital organs

432

1.13

0.46

1.1

1.3

101.11

93.74

pmol/l

0.69

432

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

1.43

0.46

1.1

89.43

103.78

pmol/l

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

240

1314

1.07

0.46

1.4

1.2

117.13

117.50

pmol/l

0.04

240

1314

Malignant neoplasm of liver and intrahepatic bile ducts

0.61

0.46

1.2

1.3

114.60

106.96

pmol/l

—

Entropion and trichiasis of eyelid

264

1.21

0.45

1.2

99.22

97.34

pmol/l

0.11

264

Carcinoma in situ of skin of upper limb, including shoulder

1.43

0.45

1.3

1.2

84.55

103.29

pmol/l

1.38

Other and unspecified injuries of shoulder and upper arm

1.43

0.45

1.4

1.1

97.82

103.88

pmol/l

0.14

Foreign body on external eye

421

1.17

0.45

1.4

1.2

117.06

105.44

pmol/l

0.94

421

Delivery

180

1025

0.92

0.45

1.2

115.33

113.01

pmol/l

0.26

180

1025

Postpartum haemorrhage

108

983

0.91

0.45

1.2

119.15

117.74

pmol/l

0.11

108

983

Benign neoplasm: Other and unspecified parts of mouth

103

1.36

0.45

1.1

90.36

108.90

pmol/l

0.95

103

Multiple delivery

363

0.82

0.45

1.4

1.2

120.33

115.31

pmol/l

0.18

363

Sequelae of infectious and parasitic diseases

219

1.23

0.45

1.3

1.2

101.67

108.19

pmol/l

0.43

219

Spermatocele

156

1.28

0.45

1.2

105.45

95.22

pmol/l

0.37

156

Benign neoplasm: Caecum

366

1.18

0.45

1.1

1.2

104.72

102.64

pmol/l

0.13

366

Carcinoma in situ of skin

283

1.20

0.45

1.4

1.2

102.65

101.87

pmol/l

0.04

283

Cerebral palsy and other paralytic syndromes

366

1.18

0.45

1.1

1.2

91.93

107.99

pmol/l

1.33

366

Other and unspecified epidermal thickening

1.40

0.44

1.5

1.1

91.00

110.66

pmol/l

0.49

Congenital malformations of uterus and cervix

1.45

0.44

2.4

1.1

111.40

115.52

pmol/l

—

Retinal haemorrhage

1.45

0.44

1.3

1.1

93.90

103.87

pmol/l

—

Pregnancy with abortive outcome

335

1844

0.95

0.44

1.1

1.2

115.66

115.41

pmol/l

0.03

335

1844

Xerosis cutis

1.38

0.44

1.3

1.1

138.00

107.51

pmol/l

—

Disorders of synovium and tendon in diseases classified elsewhere

1.38

0.44

1.0

1.1

107.71

105.55

pmol/l

—

Rheumatic valve diseases

1.38

0.44

1.0

1.2

123.14

91.31

pmol/l

—

Macular cyst

1.37

0.43

2.4

1.2

116.77

100.66

pmol/l

0.72

Use of memantine

754

0.90

0.43

1.1

1.2

100.87

99.44

pmol/l

0.10

754

Use of other anti-dementia drugs

754

0.90

0.43

1.1

1.2

100.87

99.44

pmol/l

0.10

754

Contact with machinery

284

1.20

0.43

1.5

1.2

107.62

99.90

pmol/l

0.57

284

Other nonthrombocytopenic purpura

1.62

0.43

1.0

1.2

101.20

107.03

pmol/l

—

Marginal zone B-cell lymphoma

1.62

0.43

1.2

1.1

121.80

99.81

pmol/l

—

Congenital malformations of eyelid, lacrimal apparatus and orbit, including avohilmo

1.62

0.43

1.0

1.2

132.80

112.84

pmol/l

—

Exfoliative dermatitis

1.62

0.43

1.4

1.2

88.40

103.94

pmol/l

—

Evidence of alcohol involvement determined by level of intoxication

1.62

0.43

2.0

1.2

111.20

108.97

pmol/l

—

Rare circulating lymphoid malignancy, including Hilmo

1.41

0.43

1.0

1.2

135.82

108.50

pmol/l

0.82

Personal history of allergy to drugs, medicaments and biological substances

1.62

0.43

1.0

1.1

132.80

115.16

pmol/l

—

Mesothelioma, including Hilmo

1.62

0.43

1.2

1.3

151.00

94.87

pmol/l

—

Dislocation of lens

1.62

0.43

1.4

1.2

65.40

101.61

pmol/l

—

Persistent delusional disorders

248

1.21

0.42

1.4

1.1

102.33

106.89

pmol/l

0.19

248

Septal defects

216

1.23

0.42

1.1

1.2

105.59

114.91

pmol/l

0.43

216

Alzheimer’s disease (Atypical or mixed), excluding more controls

171

1.22

0.42

1.1

95.04

106.89

pmol/l

0.45

171

Alcoholic liver disease

285

1.19

0.42

1.2

87.91

99.07

pmol/l

0.82

285

Hydrocephalus

230

1.22

0.42

1.1

1.2

103.68

103.10

pmol/l

0.02

230

Benign neoplasm of other and unspecified female genital organs

162

0.74

0.42

1.4

1.1

119.42

109.69

pmol/l

0.60

162

Benign neoplasm: Tonsil

1.57

0.42

1.0

1.2

101.20

105.09

pmol/l

—

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

1.57

0.42

1.0

1.2

114.00

108.25

pmol/l

—

Calcaneal spur

1.57

0.42

1.0

1.1

142.40

108.84

pmol/l

—

Malignant neoplasm of larynx

1.57

0.42

1.0

1.2

65.20

98.72

pmol/l

—

Endometriosis of intestine

1.41

0.42

1.1

130.63

116.53

pmol/l

—

Malignant neoplasm of bronchus and lung

454

0.86

0.42

1.2

101.53

99.60

pmol/l

0.11

454

Malignant neoplasm of stomach

131

1.30

0.42

1.3

133.76

99.95

pmol/l

1.51

131

Acute appendicitis, with complications

698

1.12

0.42

1.2

106.71

108.58

pmol/l

0.14

698

Other arterial embolism and thrombosis

1.43

0.41

1.3

1.1

75.40

106.93

pmol/l

—

Malignant neoplasm of ovary

158

1.27

0.41

1.2

1.1

116.60

112.37

pmol/l

0.13

158

Non-small cell lung cancer, adenocarcinoma

167

1.26

0.41

1.3

110.00

100.40

pmol/l

0.46

167

Bicuspidal aortic valve syndrome

1.36

0.41

1.1

104.69

109.57

pmol/l

0.16

Chromosomal abnormalities, not elsewhere classified

1.38

0.41

1.1

1.2

121.63

110.31

pmol/l

—

Other chromosome abnormalities, not elsewhere classified

0.00

0.41

0.0

1.3

—

108.13

—

Previous suicide attempt

1.52

0.41

1.0

1.2

92.60

110.58

pmol/l

—

1.52

0.41

2.0

1.1

120.60

103.27

pmol/l

—

Ankylosis of joint

0.00

0.41

0.0

1.4

—

102.67

—

Thiamine deficiency

0.00

0.41

0.0

1.3

—

107.67

—

Implicit parasitic Sepsis, including avohilmo

0.00

0.41

0.0

1.3

—

105.93

—

Other rupture of muscle

0.00

0.41

0.0

1.2

—

108.93

—

Contracture of muscle

0.00

0.41

0.0

1.2

—

117.50

—

Necrotizing fasciitis

0.00

0.41

0.0

1.2

—

108.31

—

Vascular dementia (other)

0.00

0.41

0.0

1.2

—

81.69

—

Other and unspecified disease of Bartholin gland

105

1.34

0.41

1.1

109.71

114.15

pmol/l

0.14

105

Vertical strabismus

105

1.34

0.41

1.2

1.1

99.64

110.33

pmol/l

0.54

105

Congenital deformities of hip, including avohilmo

1.36

0.41

1.1

1.2

102.13

110.14

pmol/l

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

0.00

0.41

0.0

1.2

—

100.94

—

Benign neoplasm: Liver

1.40

0.41

1.3

1.1

92.64

111.68

pmol/l

0.89

Intentional self-harm by hanging, strangulation and suffocation

0.00

0.41

0.0

1.1

—

114.82

—

Impacted teeth

624

1.11

0.40

1.2

1.1

117.25

118.98

pmol/l

0.11

624

Contact with sharp glass

114

1.32

0.40

1.1

1.2

115.40

111.45

pmol/l

0.16

114

Hypertrophic disorders of skin

204

1.23

0.40

1.2

1.1

121.48

112.98

pmol/l

0.32

204

Palindromic rheumatism

1.48

0.40

1.4

1.1

127.20

110.09

pmol/l

—

Dysplastic lesion of unknown severity of the cervix uteri

1.48

0.40

1.0

1.1

92.00

119.50

pmol/l

—

Migraine without aura, drug-induced

1.48

0.40

1.0

1.2

116.40

109.00

pmol/l

—

Early syphilis

1.48

0.40

2.0

1.2

102.40

107.94

pmol/l

—

Iliotibial band syndrome

1.48

0.40

1.0

1.1

89.00

120.79

pmol/l

—

Bicipital tendinitis

123

1.30

0.40

1.3

1.1

103.75

112.82

pmol/l

0.40

123

Anomalies of pupillary function

1.34

0.40

1.0

1.2

127.50

114.25

pmol/l

—

Other salmonella infections, including avohilmo

132

1.29

0.40

1.1

93.41

112.91

pmol/l

1.21

132

Malignant neoplasm of pancreas

186

1.24

0.40

1.2

1.3

124.26

101.92

pmol/l

0.72

186

Malignant neoplasm of palate, including Hilmo

0.00

0.40

0.0

1.1

—

94.56

—

Type 1 diabetes, strict (exclude DM2)

314

1.18

0.40

1.2

1.1

108.08

116.21

pmol/l

0.40

314

Type 1 diabetes, definitions combined

314

1.18

0.40

1.2

1.1

108.08

116.32

pmol/l

0.40

314

Atrophic disorders of skin

663

1.12

0.39

1.2

1.1

110.96

113.70

pmol/l

0.19

663

Malignant neoplasm of small intestine

1.31

0.39

1.4

1.2

111.00

108.72

pmol/l

—

Placental disorders

1.43

0.39

1.2

1.1

123.80

116.31

pmol/l

—

Mental and behavioural disorders associated with the puerperium

1.43

0.39

1.0

1.1

144.40

113.43

pmol/l

—

Haemorrhagic disorder due to circulating anticoagulants

1.43

0.39

1.0

1.2

91.20

91.69

pmol/l

—

Intentional self-harm by unspecified means

1.43

0.39

1.8

1.1

109.00

112.29

pmol/l

—

Dronedarone medication

1.41

0.39

1.2

67.70

111.46

pmol/l

—

Multifocal fibrosclerosis

0.00

0.39

0.0

1.2

—

98.26

—

Contact with other specified venomous animals

0.00

0.39

0.0

1.3

—

95.95

—

Unattended death

0.00

0.39

0.0

1.4

—

86.95

—

L02BB Anti-androgens

196

1.23

0.39

1.1

1.2

85.96

90.15

pmol/l

0.19

196

Focal epilepsy, mode (most common among epilepsy diagnosis)

665

0.89

0.39

1.2

108.97

105.81

pmol/l

0.14

665

Unspecified misadventure during surgical and medical care

187

1.23

0.39

1.1

98.87

109.20

pmol/l

0.42

187

Chondrocostal junction syndrome [Tietze]

133

1.28

0.38

1.1

111.82

112.35

pmol/l

0.02

133

Malignant neoplasm, without specification of site, including Hilmo

124

1.29

0.38

1.3

118.31

103.88

pmol/l

0.39

124

Measles

1.39

0.38

1.0

1.1

95.00

123.28

pmol/l

—

Measles, including avohilmo

1.39

0.38

1.0

1.1

95.00

123.28

pmol/l

—

Crushing injury of wrist and hand

1.39

0.38

2.6

1.1

98.80

103.11

pmol/l

—

Spontaneous abortion

223

1585

0.94

0.38

1.2

116.19

115.90

pmol/l

0.03

223

1585

Exposure to other specified electric current

1.35

0.38

1.3

1.1

112.11

113.10

pmol/l

—

Malignant neoplasm of cervix uteri, including Hilmo

1.35

0.38

1.5

1.1

150.42

119.22

pmol/l

0.34

Postpartum hemorraghe, all women as controls

108

1147

0.92

0.37

1.2

119.15

120.29

pmol/l

0.09

108

1147

Maternal care for other conditions predominantly related to pregnancy

104

928

1.09

0.37

1.2

115.38

119.32

pmol/l

0.41

104

928

Benign neoplasm: Ascending colon

467

1.14

0.37

1.2

103.58

106.21

pmol/l

0.16

467

Leiomyoma of uterus

344

1838

1.05

0.37

1.3

1.2

114.22

114.56

pmol/l

0.04

344

1838

Varus deformity, not elsewhere classified

1.36

0.37

1.0

1.2

70.80

111.95

pmol/l

—

Mental and behavioural disorders of puerperium, not classified elsewhere

1.36

0.37

1.0

1.1

144.40

121.81

pmol/l

—

Colitis, primary sclerosing

1.35

0.37

1.0

1.2

95.40

110.38

pmol/l

—

Other disorders of choroid

1.35

0.37

1.0

1.1

73.00

100.11

pmol/l

—

Other orthopaedic follow-up care

170

1.24

0.37

1.4

1.2

83.62

109.19

pmol/l

1.73

170

Caught, crushed, jammed or pinched in or between objects

161

1.24

0.37

1.3

1.1

123.25

107.15

pmol/l

0.75

161

Left ventricular outflow tract obstruction, narrow definition

143

1.26

0.37

1.1

1.2

93.89

109.70

pmol/l

0.91

143

Deep endometriosis

393

1.15

0.36

1.1

1.2

117.71

112.59

pmol/l

0.31

393

Use of levodopa decarbox-comt-inhibitor

1.36

0.36

1.2

97.64

100.23

pmol/l

0.11

Any dementia, excluding more controls

130

826

1.08

0.36

1.1

1.2

101.17

105.03

pmol/l

0.34

130

826

Labour and delivery complicated by fetal stress [distress]

102

723

0.92

0.35

1.1

1.2

124.84

118.35

pmol/l

0.52

102

723

Benign neoplasm: Other/unspecified site

1.43

0.35

1.3

1.1

141.83

96.95

pmol/l

—

Abscess of lung

1.43

0.35

1.5

1.1

112.17

100.62

pmol/l

—

Vascular dementia

257

0.82

0.35

1.1

1.2

94.86

102.45

pmol/l

0.27

257

Ankylosing spondylitis

254

1.18

0.35

1.2

96.40

110.09

pmol/l

1.02

254

Abnormal spermatozoa

277

0.83

0.35

1.1

1.2

106.26

92.68

pmol/l

0.78

277

Dementia, including avohilmo

180

1151

1.07

0.35

1.1

1.2

100.36

104.24

pmol/l

0.45

180

1151

Hemiplegia

144

1.25

0.35

1.1

97.67

109.83

pmol/l

0.40

144

Familial hypercholesterolemia, with ischemic heart disease

236

1.19

0.34

1.4

1.2

98.64

105.16

pmol/l

0.18

236

Other melanin hyperpigmentation

1.37

0.34

1.3

1.1

107.30

102.82

pmol/l

—

Inguinal or femoral hernia, bilateral

264

1.18

0.34

1.2

91.68

97.30

pmol/l

0.43

264

Benign neoplasm: Brain, supratentorial

1.37

0.34

1.2

91.33

105.20

pmol/l

—

Etanercept

227

1.19

0.34

1.2

111.74

113.22

pmol/l

0.07

227

Other and unspecified trigeminal disorders

1.37

0.34

1.0

1.1

154.83

110.00

pmol/l

—

Pedal cyclist injured in other and unspecified transport accidents

386

1.14

0.34

1.5

1.2

104.89

108.40

pmol/l

0.25

386

Other puerperal infections

311

1.16

0.34

1.2

1.1

123.39

119.11

pmol/l

0.25

311

Idiopathic urticaria

1.35

0.34

1.1

125.82

113.52

pmol/l

0.50

Guillain-Barre syndrome

1.34

0.34

1.0

1.2

59.83

100.78

pmol/l

—

severe traumatic brain injury, does not include concussion

700

1.10

0.33

1.2

97.18

105.24

pmol/l

0.77

700

Other disorders of Eustachian tube

100

1.30

0.33

1.1

1.2

115.15

112.30

pmol/l

0.10

100

Abnormalities of forces of labour

453

1.13

0.33

1.2

1.1

115.08

116.72

pmol/l

0.10

453

Tooth agenesis EXCLUDE clefts and syndromes

127

1.26

0.33

1.1

1.2

100.13

118.48

pmol/l

1.12

127

Open wound of thorax

1.31

0.33

2.2

1.1

55.50

103.48

pmol/l

—

Myasthenia gravis

1.31

0.33

1.5

1.1

97.83

105.24

pmol/l

—

Brain glioblastoma and astrocytoma

1.31

0.33

1.0

1.1

141.33

109.65

pmol/l

—

Laparoscopic right hemicolectomy

182

1.21

0.33

1.1

1.2

105.64

99.80

pmol/l

0.21

182

Malignant neoplasm of oesophagus, including Hilmo

0.70

0.33

1.0

1.3

136.50

97.45

pmol/l

—

Varicose veins of other sites

173

1.22

0.33

1.1

1.2

110.19

108.73

pmol/l

0.05

173

Injury of intra-abdominal organs

1.35

0.32

1.6

1.1

88.70

106.69

pmol/l

—

Fistulae involving female genital tract

1.28

0.32

1.2

1.0

135.33

118.49

pmol/l

—

Human immunodeficiency virus [HIV] disease

1.28

0.32

1.2

91.00

109.17

pmol/l

—

Human immunodeficiency virus [HIV] disease, including avohilmo

1.28

0.32

1.2

91.00

109.17

pmol/l

—

Pyoderma

1.28

0.32

1.2

1.1

96.17

102.36

pmol/l

—

Rheumatic fever incl heart disease

1.35

0.32

1.0

1.1

114.10

98.05

pmol/l

—

Other abnormal products of conception

155

1084

0.94

0.32

1.1

1.2

120.52

119.46

pmol/l

0.08

155

1084

Olecranon bursitis

146

1.23

0.32

1.2

1.3

87.06

101.65

pmol/l

0.53

146

Scabies

132

0.76

0.32

1.0

1.1

90.30

107.55

pmol/l

—

132

Deep bite

349

1.13

0.32

1.3

1.2

121.58

115.31

pmol/l

0.35

349

Hypersensitivity pneumonitis due to organic dust

1.35

0.31

2.4

1.2

108.71

100.19

pmol/l

—

Acute nasopharyngitis (common cold)

330

1.14

0.31

1.1

1.2

113.55

111.58

pmol/l

0.11

330

Brain meningioma

156

1.22

0.31

1.3

1.2

97.00

110.42

pmol/l

0.66

156

Hydatidiform mole

1.32

0.31

1.4

1.1

94.14

110.00

pmol/l

—

Other and unspecified injuries of thorax

1.32

0.31

1.9

1.1

91.57

104.49

pmol/l

—

Complications associated with artificial fertilization

1.32

0.31

1.1

1.0

123.14

128.60

pmol/l

—

Malignant neoplasm of pancreas, including Hilmo

230

1.18

0.31

1.2

121.00

101.71

pmol/l

0.68

230

Tuberculosis, IBD comorbidity

193

1.19

0.30

1.2

89.61

101.87

pmol/l

0.76

193

Pediculosis, acariasis and other infestations, including avohilmo

628

1.10

0.30

1.2

116.43

113.18

pmol/l

0.20

628

Other degenerative diseases of the basal ganglia

1.30

0.30

1.0

1.2

80.43

99.96

pmol/l

—

Congenital deformities of hip

1.30

0.30

1.1

1.2

101.57

108.35

pmol/l

—

Benign neoplasm: other/unspecified salivary gland

1.34

0.30

1.1

92.30

102.63

pmol/l

—

Placenta praevia

175

1.20

0.30

1.1

115.71

118.07

pmol/l

0.10

175

Other disorders of amniotic fluid and membranes

570

1.10

0.30

1.2

114.63

118.36

pmol/l

0.30

570

Mixed disorders of conduct and emotions, excluding more controls

1.27

0.30

1.3

1.1

114.57

121.73

pmol/l

—

Fall involving bed

1.29

0.30

1.1

1.2

72.75

104.56

pmol/l

2.25

Vascular diseases of the intestine

111

1.26

0.30

1.1

1.2

95.43

105.50

pmol/l

0.25

111

Malignant neoplasm of head and neck

203

1.18

0.29

1.1

1.2

90.33

100.01

pmol/l

0.62

203

Postpartum hemorraghe, parous women as controls

108

970

0.93

0.29

1.2

119.15

121.03

pmol/l

0.15

108

970

Other infestations, including avohilmo

1.25

0.29

1.1

132.57

105.79

pmol/l

—

Bruxism

1.25

0.29

1.7

1.1

99.14

117.89

pmol/l

—

Loose body in joint

1.25

0.29

1.0

1.2

82.29

111.14

pmol/l

—

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

130

0.77

0.29

1.2

1.3

91.70

99.32

pmol/l

—

130

Car occupant injured in noncollision transport accident

106

0.75

0.29

1.8

1.1

113.50

108.33

pmol/l

—

106

Monoamine oxidase A inhibitors

373

1.13

0.29

1.2

115.48

111.81

pmol/l

0.20

373

Other viral hepatitis

176

1.19

0.28

1.7

1.1

83.81

112.38

pmol/l

2.64

176

Degenerative diseases of the nervous system

119

915

0.93

0.28

1.1

1.2

102.84

101.34

pmol/l

0.13

119

915

Retinal breaks without detachment

583

1.10

0.28

1.2

118.89

110.41

pmol/l

0.76

583

Inguinal hernia, bilateral

260

1.15

0.28

1.2

91.93

97.64

pmol/l

0.42

260

Congenital deformities of feet, including avohilmo

121

1.24

0.28

1.7

1.2

118.20

113.02

pmol/l

0.20

121

Ulcer of vagina/vulva

103

1.27

0.28

1.4

1.1

99.08

110.43

pmol/l

0.38

103

Chondromalacia

1.30

0.28

1.3

1.1

109.82

112.99

pmol/l

0.07

Open wound of hip and thigh

1.28

0.28

1.6

1.1

117.17

109.03

pmol/l

0.23

Other and specified injuries of hip and thigh

1.29

0.28

1.4

1.2

132.50

105.92

pmol/l

—

Myeloproliferative diseases

261

1.15

0.27

1.1

1.2

108.60

103.03

pmol/l

0.28

261

Embedded and impacted teeth

114

865

1.07

0.27

1.1

1.2

117.32

118.86

pmol/l

0.13

114

865

Malignant neoplasm of bronchus and lung, including Hilmo

514

0.91

0.27

1.1

1.2

96.46

99.97

pmol/l

0.24

514

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Calcitriol [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS